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Summary 
Galectins are the family of proteins defined by at least one characteristic 
carbohydrate recognition domain (CRD) with affinity for P-galactosides, sharing 
certain conserved sequence elements and requiring a reducing environment but not 
divalent cations for their binding activity. In the present study a buffalo heart lectin 
was purified and extensively characterized and the effect of deglycosylation on the 
properties of the purified galectin was studied. The immunological properties of the 
purified galectin were studied; its role in oxidative burst and degranulation was 
investigated, and erythrocyte membrane studies were performed. 
Purification and characterization of buffalo heart galectin 
The purified buffalo heart galectin (BfHG-1) was found to be a metal-
independent 14.5 kDa protein. Stokes radius and diffusion coefficient determination 
revealed its homo-dimeric nature. BflG-1 retained 100% activity up to 48°C and 
showed pH stability in the range of 4.5-10.5. 
BfHG-1 agglutinated native human erythrocytes showed marked preference 
for the blood group A and the overall order of preference was A>0>AB>B. Exposed 
thiol group analysis of BfHG-l indicated a molar ratio of 2.9, thus indicating the 
presence of at least three moles of sulfhydryl group per mole of BfHG-1. 
Conformational changes were induced by the interaction of the BfHG-1 with 
thiol blocking reagents, denaturants and detergents. Among thiol blocking reagents, 
the most hydrophobic pHMB maximally inhibited the activity of BfHG-1 followed by 
lesser hydrophobic NEM, iodoacetate and iodoacetamide. The inhibitory effect of 
various chaotropic denaturants showed that urea caused maximum loss in BfHG-1 
activity, followed by GdnHCl and thiourea. SDS, a well known ionic detergent 
denatured B^G-1 even at a very small concentration, while, Tween-20 and Triton X-
100 being neutral detergents were less inhibitory in nature. 
The slope of linear Scatchard plot drawn using equilibrium dialysis data of 
BfHG-1 with lactose was used to calculate binding constant value, which suggested 
the presence of two binding sites per BfHG-1 molecule. 
BfHG-1 exhibited an UV maximum at 280 nm, corresponding to the presence 
of single Trp residue and a large number of other aromatic residues. However, 
oxidation of BfHG-1 in the presence of 5mM H2O2 (without P-ME) resulted in the 
shift of absorption peak to 250nm, suggesting oxidation of Trp residue to an oxindole 
moiety, which absorbs maximally at 250nm. 
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The sequence alignment of BfHG-1 with other GaI-1 showed more than 87% 
identity, in agreement with its high conservation throughout evolution. The 
conservation of amino acid residues that interact with carbohydrate ligands allowed us 
to classify it as having type 1 conserved CRD. 
When excited at 280 nm, BfHG-1 exhibited fluorescence emission spectrum 
maximum around 332 nm, typical to that of a Trp group in hydrophobic environment. 
The fluorescent profile of the oxidized galectin showed a remarkable quenching in the 
fluorescence intensity, accompanied with a decreased activity. However, in the 
presence of lactose, oxidation of Trp was prevented, also revealed by a slight decrease 
in the fluorescence of protein-carbohydrate complex. 
Exposure to pHMB, urea and SDS resulted in remarkable quenching in the 
fluorescence intensity, indicating their damaging effect on the structural integrity of 
BfHG-1. A shift in far and near UV-CD, and FTIR spectra showed a major transition 
of native secondary structure of BfHG-1 from P-pleated form to a more open and 
enriched a-helix conformation, thus clarifying the reason for the loss of activity upon 
oxidation. 
The far UV-CD spectra of BfHG-1 showed a low intensity spectrum with 
minimum around 218 nm, consistent with the presence of large extent of P-sheet 
structural profile as reported for other Gal-1. The FTIR spectrum also correlates with 
the CD analysis; consistent with the presence of large extent of p-sheet structure in 
BfHG-1 as suggested by maximum absorbance peak around 1630 cm''. BfHG-1 FTIR 
spectra were truncated between 1652 and 1576 cm''. Treatment of lactose with the 
native galectin did not cause any significant change in its secondary topology. 
However, exposure of B^G-1 to H2O2, urea, pHMB and SDS caused very marked 
changes in far and near UV-CD, and FTIR spectra, concomitant with the loss of P-
sheet structure and its hemagglutination activity. 
Deglycosylation studies 
Chemical analysis using Dubois phenol-sulphuric acid method revealed the 
presence of 3.55% sugar residues in the purified buffalo heart galectin. In order to 
study the role of glycosylation in galectin functioning, we removed the sugar residues 
using periodate oxidation method. This method completely removed the sugar 
moieties, as confirmed by the Dubois analysis, PAS staining and the difference in the 
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mobility of the native and deglycosylated galectin on SDS-PAGE. Deglycosylated 
galectin eluted later than the native glycosylated protein. 
Deglycosylation resulted in a decrease in the Stokes radius and a 
corresponding increase in the diffusion coefficient of the purified galectin. The 
thermal and pH stabilities of the deglycosylated galectin were also found to be lesser 
than the native glycosylated galectin. 
Deglycosylation did not result in any changes in the preferential action of thiol 
blocking reagents, denaturants and detergents on the inhibition of BfHG-1 activity. 
Although the deglycosylated galectin exhibited a reduced activity profile both before 
and after oxidation, the effect of H2O2 was much more pronounced on the 
deglycosylated form. 
When treated with increasing concentrations of urea, pHMB and SDS, the 
deglycosylated form exhibited higher fluorescence intensity and a greater red shift as 
compared to the native glycosylated galectin. 
The far UV-CD and near UV-CD maxima of native and deglycosylated 
galectins remained unchanged, but the deglycosylated form exhibited decreased 
circular dichroism than the native galectin. When treated with urea, pHMB and SDS, 
the deglycosylated galectin exhibited decreased circular dichroism than the 
glycosylated galectin, thus highlighting the significance of lectin glycosylation. 
The FTIR spectrum maximum of native and deglycosylated galectins 
remained unchanged, but the deglycosylated form exhibited lesser optical density than 
the native galectin. 
Immunological, oxidative burst and degranulation studies 
Double immunodiffusion revealed high immunogenicity of the purified 
galectin in rabbits, as they readily gave a single line of identity indicating 
homogeneity of protein preparations, and indicated that anti-BfHG-1 antibodies are 
quite specific to BfHG-1. The antiserum showed a high titre value (>128000), 
suggesting high immunogenic nature of the purified galectin. Dot blot analysis 
established immunological cross reactivity of BfHG-1 with other galectins. 
A gradual increase in superoxide production and lysozyme release was 
observed when the buffalo neutrophils were treated with the BfHG-1 and/or 
neutrophil activators. 
^ Summary 
The results of lysozyme release by various treatments can be summarized as: 
(BfHG-1 + CB) < (BfHG-1 + CB + fMLP) < (BfHG-1 + CB + PMA) < (BfHG-1 + 
CB + fMLP + PMA) < (BfHG-1 + CB + fMLP + PMA), showing a maximum 
release in the presence of lectin and neutrophil acti\'ators. Ho\ve\'er, lysozyme 
release was found to be approximately three times higher than superoxide 
production under similar conditions. Pre-treatment of buffalo neutrophils with HBSS 
and BfHG-1, followed by stimulation with varying concentrations of fMLP and 
PMA did not produce significant differences in superoxide production and lysozyme 
release from the galectin pre-treated and control neutrophils. 
Erythrocyte membrane studies 
Extent of hemolysis of trypsinized rabbit erythrocytes in the presence and 
absence of BfHG-1 showed that agglutinated erythrocytes were significantly 
hemolysed in comparison to unagglutinated erythrocytes. 
A concentration, temperature and incubation time dependent rise in the 
hemolysis of trypsinized rabbit erythrocytes was observed in the presence of BfHG-1. 
The hemolysis of the erythrocytes in the presence of BfHG-1 showed a sharp rise with 
the increasing pH up to 7.5 and became constant till pH 9.5. 
The exposure of BfHG-1 treated trypsinized rabbit erythrocyte suspension was 
exposed to various sachharides revealed that lactose and sucrose provided maximum 
protection against hemolysis, while glucose and galactose provided lesser protection. 
When exposed to superoxide radicals (O '^) generated from a pyrogallol auto-oxidation 
system, BfHG-1 treated trypsinized rabbit erythrocyte suspension released higher 
oxyhemoglobin in comparison to the unagglutinated erythrocytes. The extent of 
erythrocyte hemolysis was found to be directly proportional to HOCl concentrations. 
No significant change was observed in the hemolysis of BfHG-1 agglutinated 
erythrocytes collected from pre-operated breast and prostate cancer patients as 
compared to the non-agglutinated, whereas significant increase was observed in the 
lectin agglutinated erythrocytes of normal healthy controls and both the post-operated 
cancer patients. In breast cancer patients, lectin agglutinated pre-operated erythrocytes 
showed 36% and 28% decrease in hemolysis as compared to the control and post-
operated erythrocytes, respectively. While, in prostate cancer patients, lectin 
agglutinated pre-operated erythrocytes showed 49% and 28% increase in the 
hemolysis as compared to the control and post-operated erythrocytes, respectively. 
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Introduction 
Galectins are the family of proteins defined by at least one characteristic 
carbohydrate recognition domain (CRD) with affinity for P-galactosides, sharing 
certain conserved sequence elements and requiring a reducing environment but not 
divalent cations for their binding activity (Barondes et al., 1994). They are 
distinguishable from all other animal lectins by their molecular weight and their 
variable sub-cellular locations. Galectin CRD consists of 134 amino acids tightly 
bound into sandwich of a six stranded and a five stranded anti-parallel p-sheets that 
form an extended P-sandwich with a typical jelly-roll topology (Liao et al., 1994). 
Fifteen members of galectin sub-family have now been isolated and characterized 
from vital organs of almost all taxa of living world (Hasan et al., 2007). 
Galectin-1 (Gal-1) is the most abundant member of galectin sub-family 
ubiquitously distributed in animal tissues including heart of mammals (Bardosi et al., 
1990) and has been reportedly involved in a wide range of significant biological 
functions (Hasan et al., 2007). In mammalian heart, Gal-1 is localized mainly in 
endocardial tissue, myocardial cell constituents, connective-tissue elements and 
vascular structures (Bardosi et al., 1990). The basic physiological functions assigned 
to Gal-1 in a healthy individual heart include adhesion, transport and apoptosis. 
Ahhough galectin activity in mammalian heart was first reported almost four decades 
ago (Waard et al., 1976), only few mammalian heart galectins have been thoroughly 
characterized till date. However, Gal-1 involvement in various cardiovascular 
disorders like Chagas' disease (Giordanengo et al., 2001), hypoxia-induced pulmonary 
hypertension (Case et al, 2007), atherogenesis (Chellan et al., 2007), atherosclerosis 
and restenosis (Moiseeva et al., 2003) strongly recommends detailed exploration of 
mammalian heart galectins. 
The present thesis work has been divided into four parts: 
Purification and characterization of buffalo heart lectin 
A soluble P-galactoside binding lectin has been purified from buffalo {Bubalus 
bubalis) heart by Sephadex G50 gel filtration chromatography. An extensive 
characterization of the purified lectin has been carried out to gain an insight into its 
physicochemical properties. Carbohydrate binding specificity has been determined 
and CRD amino acid sequence deduced, so as to confirm inclusion of the purified 
buffalo lectin in Gal-1 sub-family. 
Introduction 
Equilibrium dialysis has been performed to understand the pattern of lactose 
binding to the purified galectin. The fact that galectins remain in active conformation 
in the presence of a reducing agent (Cerra et al., 1985) led us to believe that they 
contain an oxidizable residue whose integrity is crucial for its activity. Therefore, a 
detailed evaluation of the effect of H2O2 on the structure and function of the purified 
galectin has been undertaken. The effect of oxidizing agent, thiol blocking reagents, 
denaturants and detergents on the structural and functional integrity of the purified 
galectin has been investigated by monitoring the changes induced in UV-VIS, 
fluorescence, CD and FTIR spectra. Bioinformatics studies using BLAST, 
CLUSTALW and ExPASy tools have been performed to further corroborate the 
resuks obtained in wet lab. 
Deglycosylation studies 
Further, carbohydrate analysis of the purified galectin was performed and 
revealed it to be glycosylated. This prompted the need to carry out deglycosylation of 
the purified galectin to study the changes in its physico-chemical properties, so as to 
understand the significance of galectin glycosylation. Comparative structural analysis 
of native and deglycosylated galectins and the effect of oxidizing agents, thiol 
blocking reagents, denaturants and detergents on the deglycosylated galectin have 
been monitored by observing changes in UV-VIS, fluorescence, CD and FTIR 
spectra, so as to understand the role of glycosylation in maintaining the regular 
secondary structure of the native galectin. 
Immunological, oxidative burst and degranulation studies 
Immunological studies have been carried out to elucidate the antigenic 
relationship of purified galectin with Gal-1 reported fi-om other species. Double 
immunodiffusion has been performed to test immunogenicity of the purified galectin 
in rabbits, so as to check homogeneity of the protein preparations. Direct binding 
ELISA has been performed to characterize the immune response in rabbits using the 
purified galectin as antigen. The antigenic specificity of the induced antibodies has 
been determined by competition inhibition experiments. The specificity and 
immunological cross-reactivity of the anti-galectin antiserum with other Gal-1 has 
been demonstrated by standard dot blot assay. 
Introduction 
We then investigated biological roles of the purified galectin to be used in 
studies of the activation of homologous neutrophils under the effects of different 
soluble stimuli. We have compared the level of NADPH-oxidase activation from 
buffalo neutrophils, under stimulation with N-formyl-l-methionyl-l-leucyl-1-
phenylalanine (fMLP), phorbol 12-myristate 13-acetate (PMA) and purified buffalo 
heart galectin. For neutrophil degranulation studies, lysozyme release under similar 
experimental procedures has been evaluated. 
Erythrocyte membrane studies 
The hemolytic and cytolytic actions of the purified galectin have been studied 
by monitoring its effect on erythrocyte membrane integrity and permeability, so as to 
understand the role of galectins in cytolytic destruction of foreign cells in mammalian 
nervous system. Since, erythrocytes of various carcinoma cells express a distinct 
glycosylation pattern, which becomes a diagnostic index to examine the presence and 
proliferation of well known cancers; we have also studied the presence and absence of 
P-galactoside sugar residues on the erythrocyte membrane of breast and prostate 
cancer patients using purified buffalo heart galectin as a diagnostic tool. 
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Background 
The term lectin was derived from a latin word 'legere' means 'to choose' to 
describe a class of proteins of plant origin which agglutinates cells and exhibit 
antibody like sugar binding specificity (Boyd and Shapleigh, 1954). The saga began 
in 1886 with Weir Mitchell's observation of agglutinating and lytic activity of snake 
venoms (Kilpatrick, 2002). Two years later, Peter Hermann Stillmark isolated a 
highly toxic hemagglutinin (ricin) from seeds of Ricimts communis (Boyd and 
Shapleigh, 1954). Flexner and Noguchi (1902) discovered first animal lectin when 
they reported the agglutinating and lytic activity of snake venoms. An early plant 
lectin to be isolated was 'abrin' (Tschrich, 1925). The first mammalian lectin was 
reported from rabbit liver. This discovery was a major milestone in the history of 
lectin research in animal kingdom. Since then, lectins have been isolated and 
characterized from a variety of novel animal sources expressed in a wide array of 
different tissues including, heart and lungs (Waard et al., 1976), muscle (Nowak et al, 
1977), brain (Ola et al., 2001; Shahwan et al., 2004), pancreas (Beyer et al., 1979), 
electric organ of electric eel (Levi and Teichberg, 1981), colon (Schoeppner, 1995), 
intestines (Tardy et al., 1995), retina (Uehara et al., 2001), skin (Marschal et al., 
1992), serum (Colley et al., 1988), oocytes (Perillo et al., 1998), placenta (Than et al., 
2004), uterus (Gray et al., 2004) etc. These lectins are dimers with subunit molecular 
weights of 14 kDa, requires reducing agents for their activity and bear specificity for 
p-galactosides. 
Classification of animal lectins 
Based on the primary structure of animal lectins, Drickamer (1988) classified 
them into two structural families: the C-type lectins (requiring Ca^ ^ for activity) and 
S-type lectins (sulfydryl-dependent or P-galactoside binding). Ahhough, C-type and 
S-type domains are completely unrelated to each other, both families possess a 
conserved CRD of approximately 120 amino acid residues. The few exceptions 
known are the members of a heterogenous group referred to as N-type lectins 
(Kilpatrick, 2002). Gradual advancements in the research have vastly enhanced the 
structural and fijnctional information on lectins, thus making it possible to list at least 
fifteen more families of animal lectins (Table 1), Of these, five major classes include 
C-type lectins, P-type lectins, I-type lectins, pentraxins and S-type lectins. 
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Table 1 
Different families of animal lectin with known three dimensional structures 
Family Carbohydrate specificity Fold 
Galectins 
Pentraxins 
C-type lectins 
I-type lectins 
P-type lectins 
Cys-MR and FGF2 
ERGIC-53 
Yml 
HGF/SF(NK1) 
Lectin from spider toxin 
Cobra venom cardiotoxin 
Spermadesins 
TNF 
Calnexins 
Tachylectin 
Strict galactose/lactose 
Variable, often non-carbohydrates 
Highly variable 
Sialic acid 
Mannose-6-phosphate 
Sulfated carbohydrates 
Mannose 
Heparin/heparin sulfate 
Heparin/heparin sulfate 
Heparin 
Mannosamine 
Heparin, often non-carbohydrate 
Chitobiose 
Glucose 
GlcNAc/GalNAc 
P-sandwich 
p-sandwich 
C-type lectin 
Immunoglobulin 
M6P-P-sandwich 
p-trefoil 
P-sandwich 
Chitinase 
Unique 
Unique 
Hevein 
CUB 
TNF-P-sandwich 
P-sandwich 
Five-bladed-P" 
propeller 
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C-type lectins 
C-type lectins are the most diverse members of animal lectins and are 
generally multi-domain proteins, in which C-type homologous CRDs provide Ca^^ 
dependent sugar recognition activity. A variety of other modules initiates a broad 
range of biological activities such as cell adhesion, endocytosis and pathogen 
neutralization. The sugar binding sites in vertebrate C-type CRDs are formed in part 
by a bound Ca^*, which must be present for sugar binding (Dodd and Drickamer, 
2001). The majority of C-type lectins bind either to D-mannose, D-glucose and 
related sugars (mannose type ligands) or to D-galactose and its derivatives (galactose 
type ligands) (Kolatkar and Weis, 1996). C-type lectins with high affinity for glyco-
conjugates bearing terminal galactose residues have been identified on the surfaces of 
KupfFer cells and peritoneal macrophages and appear to mediate tumor cell 
recognition (Sato et al., 1992). However, C-type lectins with lower affinity for 
galactose type ligands are found in proteoglycan core proteins of cartilage and other 
tissues and are presumed to contribute to the organization of the extracellular matrix 
(Drickamer and Taylor, 1993). The genuine C-type lectins are more varied than it has 
been thought to be, and depending upon gene structure and the nature of additional 
non-lectin domain they have been classified into various subgroups like hyalectans, 
coUectins, selectins, asialoglycoprotein receptors, transmembrane receptors, 
macrophage mannose receptor and single domain lectins (Kilpatrick, 2002). A wide 
range of functions are performed by these lectins, including catabolism of partially 
degraded glycoproteins containing terminal galactose or N-acetylgalactosamine 
residues (Schwartz, 1984), clearance of galactose terminal glycoproteins, desialyted 
erythrocytes and other blood cells (Sharon and Lis, 1989), chronic rejection of 
transplanted tissues (Russell et al., 1994) and cell-cell interaction during 
spermatogenesis and fertilization (Goluboff et al., 1995; Crottet et al, 1996). 
P-type lectins (phospho-mannosyl receptors) 
P-type lectins are mannose-6-phosphate (M-6-P) recognizing, calcium 
independent group of lectins which have unique repeating motifs in their 
CRD (Dahms, 1996). These lectins play an essential role in the generation of 
functional lysozomes within higher eukaryotic cells by directing newly synthesized 
lysozomal enzymes bearing the M-6-P signal to lysosomes (Dahms and Hancock, 
2002). 
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The members of the P-type lectin family, the cation-dependent M-6-P receptor 
(CD-MPR) and the insulin-like growth factor II (IGF-II)/MPR are distinguished from 
all other lectins by their ability to recognize phosphorylated mannose residues 
(Drickamer and Taylor, 1993). The reported sub-cellular distribution of P-type lectins 
varies among cell types with about 10% of the MPRs present at the cell surface while 
the remainder are found predominantly in late endosomal compartments and trans 
Golgi network (Waguri et al., 2001). The ability of the IGF-II/MPR to recognize 
functionally distinct ligands illustrates the multifunctional nature of this receptor, its 
involvement in a myriad of important physiological pathways and its crucial role in 
mammalian growth and heart development by influencing fetal cell division and 
differentiation (O'dell and Day, 1998). Over-expression of IGF-II is observed in 
various human cancers (Ellis et al., 1998), overgrowth syndromes (Sperandeo et al., 
2000) and development of atherosclerosis (Zaina et al., 2002), thus suggesting its role 
in various pathological conditions. 
/- type lectins 
I-type lectin is a collective term introduced by Powell and Varki (1995) to 
describe carbohydrate recognizing proteins that belong to the immunoglobulin (Ig) 
super family. I-type proteins recognize sialic acids, glycosaminoglycans and other 
sugars. According to their specificity and binding affinities, these lectins have been 
classified into many subclasses, like Siglecs, CD-83 (Scholler et al., 2001) and cell 
adhesion molecule LI (Kleene et al., 2001). 
Siglecs (sialic acid binding immunoglobulin super family lectins) are I-type 
lectins recognizing sialic acids. Each Siglec has a distinct expression pattern in 
different cell types, indicating that they perform highly specific functions including 
critical roles in neural development, such as neural cell adhesion, positive and/or 
negative regulation of neurite outgrowth and myelin sheath formation (Filbin, 1995). 
CD83 is a 45 kDa glycoprotein expressed on mature dendritic cells, thus suggesting 
its involvement in the interaction between dendritic cells and circulating monocytes as 
well as activated and/or stressed T cells (Zhou and Tedder, 1995). Cell adhesion 
molecule LI is a 200 kDa homophilic and heterophilic adhesion molecule expressed 
in the nervous system, CD4+ T cells, monocytes and B cells, where it plays an 
important role in axon guidance, cell migration and neurogenesis ((Ebeling et al., 
1996; Angataetal., 2002). 
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I-type lectins bearing specificity towards sugars other than sialic acids 
includes neural cell adhesion molecules (NCAM), myelin protein zero (MPO), 
intracellular adhesion molecules (ICAM-1/CD54), CD2 and hemolin. They are 
expressed in a wide array of tissues including nervous system, vascular endothelium, 
and certain lymphocytes and monocytes, where they are involved in T cell 
development and myelination of peripheral neurons (Warner et al, 1996), 
inflammation and wound healing (Angata et al., 2002). I-type lectins interacting with 
sulfated glycosaminoglycans (GAGs) shows selectivity towards the type of GAGs 
they interact favorably with heparin/heparan sulfate. This category includes vertebrate 
fibroblast growth factor receptors (FGFR), perlecan (heparan sulfate proteoglycan-
2/HSPG2) and CD48, and are essential for mammalian embryonic development 
(Arikawa et al., 2001) and CD4+ T cell activation (Hopf et al., 2001). 
Pentraxins 
The term 'pentraxins' was applied to C-reactive proteins (CRP) and its 
homologue, serum amyloid P component (SAP) to reflect their unusual quaternary 
structure in which five identical polypeptide subunits combine to form a ring with a 
central hole, loosely resembling a doughnut. These proteins are complement 
activating molecules with high affinity for phosphorylcholine. However, CRP has also 
been found to bind galactans and galactose phosphate through a different binding site. 
Pentraxins are expressed in vertebrate species, where the division into CRP or SAP is 
not made on the basis of primary structural homology to the human examples, but 
rather on a preference for phosphorylcholine (CRP) or phosphoethanolamine (SAP) 
(Kilpatrick, 2002). 
S-type lectins 
S-type lectins refer to soluble vertebrate tissue lectins which require thiol reducing 
agents to maintain their activity. However, this property is not shared by S-type 
lectins, but specificity towards P-galactosides is a common characteristic among this 
class of lectins. Therefore, a consensus was reached that the term 'p galactoside 
binding lectin' or 'galectin' would be more apt for the nomenclature of these specific 
proteins. 
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Galectins 
Galectin or P-galactoside binding lectin was first discovered in a popular slime 
mould species DictyosteIlium discoidium during the study of eukaryotic development 
and differentiation in 1973. This agglutinin, first named as discoidin and then 
discoidin-1 was inhibited by lactose, galactose and other related sachharides and 
exhibited a 400-fold increase in specific activity during aggregation of amoebae, and 
was originally thought to mediate the adhesive contact between the cells. Within few 
years, several rather similar lectins were discovered in related species (Barondes, 
1986). 
All the isolated lectins were readily inhibited by lactose, but differed in fine 
specificity, including relative affinities for galactose and N-acetylgalactosamine. An 
apparently similar lactose specific lectin was then reported fi^om electric organ of the 
electric eel (Teichberg et al., 1975). The discovery of electrolectin prompted the 
researchers to survey various tissues of higher animals for lactose specific agglutinins. 
Such activity was found to be very widely distributed among numerous rat organs, but 
the highest specific activity was found in pectoral muscle of chicken embryos. All 
these lectins were dimers exhibiting subunit molecular weights around 15 kDa with 
the exception for intestine lectin (14 kDa) which behaved as a monomer and had a 
somewhat different carbohydrate binding site. 
Later, soluble lectins were isolated fi'om several mammalian tissues including 
human heart and muscle (Child and Feizi, 1979) as well as rabbit bone marrow 
(Harrison et al., 1984). Thus, it was apparent that these 'soluble lectins', 'endogenous 
lectins', 'galaptins' or 'P-galactoside binding proteins' occurred universally in 
vertebrate tissue (Harrison, 1991). Since, many of the vertebrate lectins are 
structurally homologous; the term 'galectin' is now preferred to denote members of 
this family (Kilpatrick, 2002). 
The research work on galectins is now no more limited to purification and 
characterization, but has rather spread to wide arrays like artificial synthesis of 
galectins using recombinant DNA techniques (Leffler et al., 2004; Ahmed and Vasta, 
2008; Nagae et al., 2008). Studies on galectins are mainly related to their functional 
roles and their structural changes upon binding to sugar residues (Patnaik et al., 2006; 
Mok et al., 2007). 
Review of literature 
Analysis of Gene Bank databases has led to the identification of more galectin 
like proteins in mammals, invertebrates, plants and microorganisms, confirming that 
these carbohydrate binding proteins are highly conserved throughout the evolution 
(Cooper, 2002; Lefifler et al., 2004). Almost all of them appear in human genomic 
DNA and their mRNA is also expressed, suggesting that they are not pseudogenes 
(Cooper and Barondes, 1999; Leffler et al, 2004). As sequence databases continue to 
explode, many more galectin relatives will be discovered and fill the gaps in the 
galectin family tree. In fact, soon, genomics and proteomics may advance to the point 
that specific interactions of galectin subunits with each other, carbohydrate ligands, or 
other proteins could be accurately predicted from sequence alone. Most galectins have 
been proposed to exert discrete biologic effects, according to their sub-cellular 
compartmentalization, developmentally regulated expression and cell activation status 
(Zuniga et al., 2001). The weahh of new information promises a future scenario in 
which galectins or their antagonists will be targeted in respect to their fine structure 
and detailed mechanism of crucial roles played by them in every aspect of living 
system can be understood. 
Classification of galectins 
All galectins contain conserved CRDs that are responsible for carbohydrate 
binding. Based on differences in the sequence homology of CRDs, 15 different 
mammalian galectins have been identified till date (Ahmad et al., 2004; Ahmed and 
Vasta, 2008; Nagae et al., 2008). The characteristics and functions of all the 15 
mammalian galectins are shown in Table 2. A schematic representation of the overall 
structures of Gal-1, -2, -3 and -4 is shown in Fig. 2. 
Galectin-1 
Galectin-1 (Gal-1) is a homodimer protein composed of two non-covalently 
linked 14 kDa subunits with one CRD of 134 amino acids (Kiss et al., 2007). Since 
each dimeric molecule possesses two galactoside binding sites, Gal-1 can mediate 
either intra-molecular or inter-molecular cross-linking by binding to more than one 
sugar residue (Gabius et al, 2002; Kilpatrick, 2002; Imbe et al, 2003). This protein is 
expressed on the cell surface, in extracellular matrix, in the cytoplasm and the nucleus 
of the cells in various tissues including skin, muscle, lymph node, dorsal root 
ganglion, thymus, lung, spleen and placenta (Imbe et al, 2003; Leffler et al, 2004). 
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Table 2 
Characteristics and functions of galectins 
Galectins (Mol. wt) 
Structural type 
Gal-1 (14 kDa) 
Proto type 
Gal-2 (14 kDa) 
Proto type 
Gal-3 (29-35 kDa) 
Chimera type 
Gal-4 (36 kDa) 
Tandem repeat type 
Gal-5(17kDa) 
Proto type 
Gal-6 (34 kDa) 
Tandem repeat type 
Gal-7 (14.5 kDa) 
Proto type 
Gal-8 (34 kDa) 
Tandem repeat type 
Gal-9 (35 kDa) 
Tandem repeat type 
Gal-10(17kDa) 
Proto type 
Gal-11(10 kDa) 
Proto type 
Gal-12 (37 kDa) 
Tandem repeat type 
Gal-13 (16 kDa) 
Proto type 
Gal-14(18kDa) 
Proto type 
Gal-15(14kDa) 
Proto type 
Localization 
Ubiquitous 
expression 
Small intestine, 
stomach 
epithelial cells 
Ubiquitous 
expression 
Gastrointestinal 
tract 
Erythrocytes 
Gastrointestinal 
tract 
Keratinocytes 
Ubiquitous 
expression 
Immune cells, 
gastrointestinal 
tract, lung 
Eosinophils, 
basophils 
Eye lens 
Adipose tissue 
Placenta 
Eosinophils 
(sheep) 
Sheep stomach 
with parasitic 
infection, 
uterus 
Biochemical and functional properties 
Apoptosis induction in activated T cells and activated 
thymocytes, induction a polarized Th2 immune response, 
cell growth, mRNA splicing, regeneration of nerve axon 
(oxidized Gal-1), aberrant neurite outgrowth of the 
olfactory neuron, inhibition of acute inflammation. 
Expressed at minor level in tumor cells, risk factor of 
myocardial infarction. 
Cell adhesion, mRNA splicing, inhibition of T cell 
apoptosis, macrophage chemotactic factor AGE receptor, 
reduced intra-peritoneal inflammatory response, 
accelerated progression of diabetic nephropathy, anti-
apoptotic and pro-inflammatory functions, induces 
chemotaxis of monocytes, down regulates IL-5 gene 
transcription, inhibition of anoikis. 
Activation of intestinal CD4^ T cells, expressed at sites of 
tumor cell adhesion. 
No function assigned. 
High homology to Gal-4. 
Marker of all subtypes of stratified epithelium, increases 
susceptibility of keratinocytes to UBV induced apoptosis. 
Cell adhesion, regulation of neutrophil function, 
modulation of integrin interaction with the extracellular 
matrix. 
Apoptosis induction in activated T cells, eosinophil 
chemotactic factor, apoptosis induction in cancer cells, 
cell adhesion. 
Charcot-Leyden crystal, affinity for mannose. 
Represents a new lens crystalline, lacks affinity for |3-
galactosides. 
Apoptosis induction in adipocytes, causes cell cycle 
arrest. 
Pregnancy-related protein. 
Possible involvement in allergic reaction 
Endometrial interactions, uterine immune and 
inflammatory responses, placental morphogenesis. 
11 
Review of literature 
' -^ ' '" ' 3. ISI^SSiii 
Galectin-1 
Galectin-2 
Galectin-3 
Galectin-4 
Galcctin-1 Galectin-2 Galcctin-3 Galectin-4 
Figure 1. Schematic representation of the overall structures of GaI-1, -2, -3 & -4: 
The galectins are shown schematically as linear diagrams corresponding to single 
peptide chains (top) and as assembled proteins (bottom). The CRDs of about 130 
amino acid residues are indicated in blue, linker peptide are shown in orange and the 
N-terminal domain of Gal-3 (about 30 residues) is indicated in black (Barondes et al., 
1994). 
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Gal-1 expression has also been reported in immune privileged sites such as 
placenta and cornea, suggesting an important role in generating and maintaining 
immune tolerance (Ilarregui et al., 2005). In vitro, Gal-1 induces cell cycle arrest and 
apoptosis of activated T cells or T cell lines (Ion et al., 2006). However, the in vivo 
functions of Gal-1 are currently unclear because targeted disruption of the Gal-1 gene 
in null mutant mice resulted in the absence of major phenotypic abnormalities, 
probably because of functional compensation by other family members (Kiss et al., 
2007). Moreover, it has also been shown that Gal-1 inhibits chemotaxis and trans-
endothelial migration of polymorphonuclear leukocytes in vitro (La et al., 2003). 
Expression of Gal-1 in bone marrow derived mesenchymal (stromal) cells has 
been implicated in bone marrow cell differentiation (Kadri et al., 2005). Ahhough 
many of these effects were found to depend on the carbohydrate binding activity of 
galectins, some were mediated exclusively by protein interactions. Gal-1 has also 
been shown to be a positive growth regulator towards other cell types, such as 
vascular endothelial cells. It has been speculated that growth inhibitory or stimulatory 
properties of Gal-1 is highly dependent on the cell types, cell activation status and 
concomitant environmental signals. In addition, these effects might be regulated 
alternatively by the relative levels of Gal-1 in the extracellular milieu and the 
equilibrium between its monomeric and dimeric forms, because dimeric Gal-1 is 
required to induce some, but not all of the biological effects mediated by this 
carbohydrate binding protein (Rabinovich et al., 2002). 
Galectin-2 
Gal-2 is closely related to Gal-1 (non-covalent dimer with subunits of about 14 
kDa), but has a distinct and restricted expression profile (Rabinovich et al., 2007). 
Structurally, Gal-2 shares 43% amino acid sequence identity with Gal-1, and the 
analysis of expression in rat tissues and human tumor cell lines had revealed its 
presence to be confined to the gastrointestinal tract (Ahmed and Vasta, 2008). Thus, 
Gal-2 is likely to encounter T cells, especially in inflammatory bowel disease, 
shedding light on its immuno-modulatory capacity. In contrast to Gal-1, it lacks 
reactivity towards CD3 and CD7. However, it is a potent inducer of apoptosis in 
activated T cells, probably mediated by binding to Pi integrin (a closely associated 
glycoprotein) (Lahm et al., 2004). 
A-i 
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Galectin-3 
Gal-3 is a 29-35 kDa member of the galectin family which promotes cell 
growth and proliferation and acts as a mitogenic signal (Ahmed and Vasta, 2008). 
Gal-3 consists of an N-terminal domain (about 130 amino acids) made of tandem 
repeats of short stretches of amino acids connected to a C-terminal CRD (Dumic et 
al., 2006). It is ubiquitously expressed in a wide range of tissues and in inflammatory 
cells like neutrophils, dendritic cells, macrophages and monocytes (Acosta et al., 
2004). In the peripheral and central nervous system, Gal-3 has been reported to be 
expressed in neurons, Schwann cells and astrocytes including gliomas and microglia 
(Yang et al., 2006). 
Gene expression profiling and immuno-histochemical analysis has shown Gal-
3 expression to be highly up-regulated in prion-infected nervous tissues at the mRNA 
and protein level, thus suggesting its role in chronic neuro-degeneration (Mok et al. 
2006, 2007). Moreover, Gal-3 has been implicated in a variety of inflammatory 
conditions mostly involving innate immune reactions (Bernandes et al., 2006). Extra-
cellular Gal-3 can also function as an inducer of T-cell apoptosis through binding to 
CD7 and CD29 on the T cell surface (Fukumori et al., 2004), as well as a positive or a 
negative growth factor, depending on the target cells (Marer, 2000). 
In addition, Gal-3 plays a critical role in host protection against infection 
(Vray et al., 2004), for example, it displays a direct fungicidal activity by inducing 
death of Candida species containing specific P-1—*2 linked oligomannans and also 
binds to wide variety of mammalian pathogens (Levroney et al., 2005). Gal-3 is also 
strongly expressed in wide variety of cancers, thus implicating its role in prognosis 
and malignancy of tumors and also inhibits apoptosis in response to chemotherapeutic 
drugs (Plazk et al., 2004). 
Galectin-4 
Gal-4 was the first mammalian lectin reported with a single polypeptide chain 
having two distinct but homologous CRDs separated by an un-conserved linker 
sequence of up to 70 amino acids (Dumic et al., 2006) and can bind to two individual 
carbohydrate epitopes. This galectin is a monomer with molecular weight of 36 kDa 
and is abundantly present in intestinal epithelium (Barondes et al., 1994). 
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Galectin-5 
Gal-5 was first discovered as a lactose binding protein isolated from rat lung 
(Cerra et al., 1985) and erythrocytes (Rabinovich et al., 2007). It consists of one CRD 
with little additional sequence, and has up to 40% identity with Gal-3 and -4 (Leffler 
et al., 2004; Ahmed and Vasta, 2008), 
Galectin-6 
Gal-6 has two CRDs that are about 80% identical with those of Gal -4, but the 
linker peptide joining them is 24 amino acids shorter than Gal-4 (Gitt et al., 1998). 
Gal-4 and -6 are so similar that they cannot be distinguished in most localization 
assays such as immuno-histochemical and northern blots, but their combined 
expression can be easily detected and distinguished from other proteins. Possibly, 
Gal-6 is also expressed in small intestine of several mammalian species (Leffler et al., 
2004). 
Galectin- 7 
Gal-7 is a 14 kDa member of the lectin family expressed in stratified epithelia, 
inter-follicular epidermis and the outer root sheath of the hair follicle (Leonidas et al., 
1998). Thus, Gal-7 is considered as a marker of all subtypes of keratinocytes and its 
expression does not seem to be influenced by the stages of differentiation (Magnaldo 
and Darmon, 1997). In addition, Gal-7 is also reported to increase the efficacy of 
chemotherapeutic drugs in urothelial cancer mediated via intracellular reactive 
oxygen species (Matsui et al., 2007). 
Galectin-8 
Gal-8, also known as prostate carcinoma tumor antigen-1 (PCTA-1) is a 35 
kDa protein made up of tandem repeat CRDs joined by a linker peptide (Bidon-
Wagner and Le Pennec, 2004), and structurally related to Gal-4 (34% identity). 
However, unlike Gal-4, which is confined to the intestine and stomach, Gal-8 is 
expressed in liver, kidney, cardiac muscle, lung and brain (Hadari et al., 1995, 2000). 
Native Gal-8 exists as a monomer and its two CRDs are structurally different with 
different specificities for sugar residues which do not require complex N-glycans for 
binding (Patnaik et al., 2006). 
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Galectin-9 
Gal-9 is a 40 kDa protein consisting of 353 amino acids and having 35% 
sequence identity between the N- and C-terminal CRDs. Gal-9 is a lactose binding 
protein reported to be expressed in a sub-population of cells present in peripheral 
blood leukocytes, lymphoid tissues (Tureci et al., 1997), kidney, intestine and thymus 
(Wada et al., 1997). It controls wide range of activities like T-cell development (Wada 
and Kanwar, 1997), chemo-attraction of eosinophils, induction of apoptosis and down 
regulation of effector THi responses (Nagae et al., 2008). 
Galectin-10 
Gal-10 has originally been isolated as Charcot-Leyden crystal because of its 
unusual solubility properties and spontaneous crystallization in eosinophil mediated 
inflammatory tissues (Charcot and Robin, 1853; Leyden, 1872; Kilpatrick, 2002). It 
constitutes of less than 7% of the total protein content of a typical 
eosinophils (Ackerman et al., 1993) and displays weak lactose and mannose binding 
specificity in soluble and crystalline state, respectively (Kilpatrick, 2002). 
Galectin-11 
Very little information is available on Gal-11, except that they contain one 
CRD (Kilpatrick, 2002). Gal-11 (also called GRIFIN for 'galectin related inter-fiber 
protein') was found to be expressed in eye lens, suggesting a role for this protein in 
the maintenance of immune privilege in this vulnerable tissue (Rabinovich et al., 
2002, 2007). 
Galectin-12 
Gal-12, a recently identified member of galectin sub-family, contains two 
CRDs and possesses growth inhibitory properties (Hotta, 2001). Expression of Gal-12 
is high in peripheral blood leukocv'tes and adipocytes, but very low or undetectable 
expression has been reported in many tissue and cell lines, except in those of myeloid 
origin with the potential to undergo terminal differentiation (Yang and Liu, 2003). 
Galectin-13 
Except that they contain one CRD (Kilpatrick, 2002), very little information is 
available on Gal-13. 
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Galectin-14 
Gal-14 is a novel sheep galectin specifically expressed in eosinophils, and is 
similar in sequence to the first CRD of Gal-9. It has been shown to possess 
galactoside binding activity and reported to be released into the airway lumen in 
response to allergen challenge suggesting its possible role in immune defense 
(Dunphy et al., 2002). 
Galectin-15 
Gal-15 (also known as OVGALll) a previously uncharacterized member of 
the galectin family containing a conserved CRD and a separate putative integrin 
binding domain, was discovered in sheep uterus. It is concentrated near and on the 
apical surface of the endometrial luminal epithelia and localized within discrete 
cytoplasmic crystalline structures of conceptus trophectoderm (Tr). 
Gal-15 possess affinity for lactose and mannose sugars and is 
immunologically identical to an unnamed 14 kDa protein isolated from the ovine 
uterus, that forms crystalline inclusion bodies in endometrial epithelia and conceptus 
Tr (Gray etal., 2004). 
Architectural types of galectins 
Based on the protein architecture and its ability to function as a cross linker, 
the galectin family has been divided into three sub-groups as shown in Fig. 2 (Vasta et 
al., 2004). 
Prototype 
The proto-type galectins (Gal-1, -2, -5, -7, -10, -11, -13, -14 and -15) consist 
of a single CRD per subunit with a short N-terminal sequence and a single core 
protein domain (Rabinovich et al., 2007; Nagae et al., 2008). Most of these galectins 
are homodimers or multimers but some of them, such as Gal-5, -7 and -10 exists in 
monomeric form (Kopitz et al., 2003). They also show distinct tissue specificity and 
developmentally regulated expression in different sources (Cooper, 2002). 
Dimerization of prototype galectins involves self association of monomer subunits at 
the sides opposite to their CRDs through non-covalent interactions (Rabinovich et al., 
2007). 
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The CRD pockets and bound ligand face away from each other, an 
arrangement unlikely to allow muhivalent binding to closely clustered ligands 
(Brewer, 2002; Dam et al., 2005). However, these dimers can very effectively cross-
link separated ligands and can even form chains or crystalline networks of the 
divalent lectins bound to multivalent ligands (Liu and Rabinovich, 2005). 
Chimera type 
Chimera type galectins are composed of a protein domain joined to a distinct 
N- or C-terminal domain (Rabinovich et al., 2007), which is responsible for 
interaction between subunits, thus facilitating its oligomerization (Liu and 
Rabinovich, 2005). In vertebrates, the only chimeric galectin discovered till date is 
Gal-3, but several other chimeric galectins are apparent in invertebrates. 
Gal-3 is composed of an N-terminal domain with several repeats of a peptide 
sequence rich in proline, glycine and tyrosine residues, followed by a C-terminal 
galectin domain (Dumic et al., 2006). The activity of C-terminal domain remains 
intact, but loses much of its propensity to multimerize (Kuklinski and Probstmeier, 
1998). 
Gal-3 monomers are in equilibrium with higher order oligomers in solution, 
and precipitates as a pentamer with multivalent oligosaccharides. This lectin binds to 
muhi-glycosylated proteins with positive cooperativity, suggesting that Gal-3 
monomers, after ligand binding, recruit additional lectin molecules to form a complex 
of muhivalent interactions (Ahmed et al., 2004). The biological functions attributed to 
Gal-3 are thus, likely to depend upon both ligand cross-linking and oligomerization 
(Stillman et al., 2005; Toscano et al., 2007). 
Tandem repeat type 
Tandem repeat type galectins (Gal-4, -6, -8, -9 and -12) are composed of two 
non identical core galectin domains joined either directly or via a linker peptide of 
variable length (Toscano et al., 2007). Their CRDs are positioned in such a way that 
they can simultaneously bind to muhivalent ligands, greatly enhancing the binding 
avidity (Hirabayashi et al., 2002) as opposed to homo-functional cross-linking by 
dimeric prototype galectins (Cooper, 2002). 
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Figure 2. Architectural types of galectins: The first group consists of prototype 
galectins having one CRD. The second group consists of chimera type galectins 
that have a CRD and a non-CRD domain linked together. The third group consists 
of tandem repeat type galectins with two CRDs. Aldiough prototype and chimera 
type galectins have only one CRD, two molecules bind to each CRD 
(dimerization) so that they can actually bind to two carbohydrate chains, like 
tandem repeat type galectins (Stilhnan et al., 2005). 
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Secretion and biosynthesis of galectins 
Although galectins are often reported to be expressed on cell surfaces or in 
extracellular matrix, they lack recognizable secretion signal sequences and do not pass 
through the standard ER/Golgi pathway (Cooper, 2002), with the possible exception 
of a sponge galectin (Miarons and Fresno, 2000). Instead, most galectins have 
characteristics typical of cytoplasmic proteins, such as an acetylated N-terminus, free 
sulfhydryl groups and lack of glycosylation. Nevertheless, there is strong 
experimental evidence that at least some galectins are indeed secreted, albeit by novel 
non classical mechanisms (Hughes, 1999; Leffler et al., 2004). Galectin secretion 
from cells is tightly controlled during development, and several unrelated factors 
including cytokines as well as adhesive and membrane fiision can modulate secretion 
(Hughes, 1999). Pulse chase experiments also demonstrated that lectins are actively 
secreted from cells, rather than leaked from damaged cells (Cooper, 2002; Hughes, 
2001). Upon secretion, galectins typically bind to and stay associated with 
glycoproteins and glycolipids on the cell surface, or within the surrounding 
extracellular matrix to complete its folding and stability (Stillman et al., 2005). Thus, 
while galectins are abundant in tissues where they are synthesized, only low levels are 
found in serum, which do not reflect the rates of synthesis in tissues (He and Baum, 
2004). 
Detection and identification of galectins 
The detection and identification of galectins has come a long way from the 
time when their ability to bind P-galactosides and their cross-reaction with other 
galectins were exploited (Hirabayashi and Kasai, 1993). Hemagglutination of trypsin 
treated erythrocytes was also widely used as an indicator of their presence but 
suffered from the problem of hemolysis of the cells, even under isotonic conditions 
(Nowak et al., 1977). This drawback was overcome when glutaraldehyde was used to 
strengthen the cells before they were used for galectin detection (Turner and Liener, 
1975). 
With advances in techniques of molecular biology, the methods of detection of 
galectins were also revolutionized. Immunoscreening of cDNA was advancement 
over these primitive methods and resulted in the discovery of Gal-5 and -8 (Hadari et 
al., 1995). Screening the tumor cDNA libraries from sera of afflicted patients 
identified another molecule, Gal-9 (Tureci et al, 1997). 
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RT-PCR was another technique that was used to detect, with much success, 
the differential expression of galectins (Wolff et al., 2005) and its resuhs match well 
with Western blot data (Hittelet et al., 2003). For all its popularity, the method still 
provides only an indirect estimate of galectin levels. 
Recently, search algorithms have been developed to search for sequences that 
encode structures similar to the known galectin domains. The screening of the 
GenBank databases identified seven new putative galectins genes. Similar approaches 
have been applied to other organisms with the result that there has been a massive 
increase in the number of possible galectins. 
Amongst a total of 20,000 genes in C. elegam, 26 have been identified as 
candidate galectin genes. The ubiquitous distribution of galectins is evident from the 
identification of candidate genes in the Mastadenovirus (U25120) (Perillo et al., 1998) 
and lymphocystis disease virus (L63545, 26549-27313=053R), Drosophila 
(LP06039), Zebrafish (AI384777 and G47571) and Arabidopsis (AC000348, 
T7N9.14), with the report \n Arabidopsis being the first in any plant (Cooper, 1999). 
While all these methods are useful in the research laboratory, and have yielded 
15 mammalian galectins till date (Pieters, 2006), advances made in clinical studies of 
galectins and their implication in tumorigenesis has made the need to develop rapid 
and accurate protocols for their accurate detection and estimation very pressing. 
Western blotting using anti-galecfin antibodies has been one of the biggest 
success stories as far as detection is concerned and has been used to confirm the 
increased expression of Gal-1 in pancreatic tumors (Shen et al., 2004). 
Labeled antibodies have also been used in situ to study expression patterns of 
Gal-1 and -3 in lung cancer (Szcke et al., 2005). Membrane based methods have 
utilized the use of a LacNAc conjugated biotinylated polyacrylamide probe to 
demonstrate the increased expression of Gal-3 in Escherichia coli. The detection 
system was based on enzyme-streptavidin conjugates (Kamemura et al., 1998). 
Quantification of galectins was not possible until the advent of ELISA, which 
provided information about the amounts of different galectins (Pieters, 2006). 
Commercially available detection and quantification systems can detect Gal-3 at as 
low a concentrafion as 0.2 ng/ml. With the emphasis on cancer based research in 
galectins, flow cytometry based on the use of Glyc-PAA-fluo probes has been used to 
detect total galectin activity in cancer cells (Moiseeva et al., 2005). The technique has 
proved effectual for Gal-3 with the use of LacNAc and asialoGM-1 (Pieters, 2006). 
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The problem with most of the methods described so far is their dependence on 
specific anti-galectin antibodies. Recently, efforts have been made to devise strategies 
based on chemical approaches. PhotoafFmity based probes are being synthesized 
(Pieters, 2006). In one case, benzophenone was attached on galactose-C3 and 
irradiated to link the galectin captured by the sugar from a mixture of proteins and the 
complex was visualized, in gel, by the use of fluorescent label attached to the other 
end of the probe. While this method annuls the need for antibodies, it is still not 
proven for its efficacy as a diagnostic and prognostic tool. 
Purification strategies of galectins 
Over the years galectins have been isolated and purified to homogeneity by 
various chromatographic methods. The fresh animal tissue is solubilized with suitable 
buffer containing reducing agents and competing sugars in order to dissociate 
galectins from insoluble substances of starting tissues (Kasai and Hirabayashi, 1996). 
Muhiple forms of galectin have also been isolated from human and rat lung by 
employing ion exchange chromatography on DEAE-cellulose or sephadex column 
followed by chromatography on CM-sephadex column (Cerra et al., 1985) in the 
presence of protease inhibitors to minimize the proteolytic degradation of lectin. 
Galectins have also been isolated from crude extract by ammonium sulphate 
fractionation followed by affinity chromatography on asialofetuin or lactosyl-
Sepharose 4B columns (Ola et al., 2001) or gel filtration chromatography on 
Sephadex columns (Rizvi et al., 2007) and bound protein eluted with a suitable ligand. 
Galectin activity is measured by hemagglutination assay using fresh rabbit and human 
erythrocytes treated with trypsin or neuraminidase (Muramoto et al, 1999). 
Physico-chemical properties of galectins 
Galectins are soluble proteins bearing an affinity for P-galactoside containing 
moieties, besides possessing a CRD with conserved sequence elements that require a 
reducing environment for action but no divalent ions (Hasan et al., 2007). They are 
distinguishable from all other lectins by their low molecular weights (ranging from 
14-36 kDa), dimeric nature and their variable sub-cellular location. By virtue of their 
multi-valency, galectins are able to cross-link cell surface glycoconjugates and 
initiates cell biological response (Rabinovich et al., 2007). 
22 
Review of literature 
These lectins binds to N-acetyllactosamine with relatively low affinity 
(dissociation constant, Kd in the range of 90-100 \JM), but they bind to glycoproteins 
containing polylactosamine sequences with a high affinity (Kd-ltiM) (Dam et al., 
2005). While CRDs of all galectins share affinity for N-acetyllactosamine found on 
many cellular glycoproteins, individual galectins can also recognize different 
modifications of this sugar, thus demonstrating the fine specificity of certain galectins 
for tissue specific ligands (Ahmed et al., 2004). 
In the isoelectric focusing experiment, 90% of rat lung galectin moved with 
the isoelectric point (pi) of pH 5.5 (Clerch et al., 1988). Amino acid composition of 
galectins isolated from different mammalian sources has been found to be 
considerably similar, if not identical (Shahwan et al., 2004). The total number of 
acidic amino acid residues is found to be significantly higher than the total number of 
basic amino acid residues. All the galectins studied so far have blocked N-termini, 
and an acetyl group has been demonstrated to be the blocking group (Leffler et al., 
2004; Rabinovich et al., 2007). Galectins occasionally contain cysteine residues, but 
no disulfide bond is formed and all -SH groups are in a free state. Cloning of cDNAs 
revealed that galectins are synthesized without a signal sequence (Kasai and 
Hirabayashi, 1999), strongly suggesting that galectins are designed as intracellular 
proteins (Leffler et al., 2004). 
Ligands for galectins 
Despite the large number of p-galactoside containing glycoconjugates present 
in the cellular milieu, only few glyco-proteins from cell extracts bind to particular 
galectins in vitro (Barondes et al., 1999), suggesting that these may be the interactions 
that are physiologically significant. Among naturally occurring glyco-conjugates, 
glycoproteins that contain polylactosamines are especially good ligands for galectins 
(Liu, 2000; Rabinovich et al., 2007). Of these, laminin, a glycoprotein with many 
polylactosamine chains, has been implicated as a natural ligand for Gal-1 (Hughes, 
2001) and is also bound by Gal-3 (Liu, 2000). 
Gal-1 has also been shown to bind other glycoconjugates, including 
polylactosamine rich lysosome associated membrane proteins that are sometimes 
found on the cell surface (Imbe et al., 2003), a lactosamine containing glycolipid on 
olfactory neurons (Horie and Kadoya, 2004), and integrin avPi on skeletal muscle 
cells (Hadari et al., 2000). 
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Carbohydrate binding domain and specificity 
Galectins have in common a highly conserved CRD with affinity for lactose 
and N-acetyllactosamine (Barondes et al, 1999; Vasta et al., 2004; Ahmed and Vasta, 
2008), formed by part of the six stranded anti-parallel P-pleated sheets that form an 
extended sandwich (Fig. 3) with a typical jellyroll topology and is around 134 amino 
acid long (Liao et al., 1994). The core sequence of this domain lies between the 30"* 
and the 90"' residues and is encoded by a single exon (Cooper and Barondes, 1999). 
The number and arrangement of the CRDs may vary and has been used as a basis of 
their classification. The galectin CRD has a concave side forming a groove long 
enough to hold a linear oligosaccharide made of up to four monosaccharide units 
(Leffler et al., 2004). The fine specificity of the two CRDs may differ (Hirabayashi et 
al., 2002; Ideo et al., 2003) displaying tightest interaction with galactose residues, but 
interaction with glucose is also significant, making the affinity for lactose 50-150 
folds higher compared to galactose for most galectins (Toscano et al., 2007). 
However, the carbohydrate binding cleft can accommodate an additional one to three 
sachharide residues justifying polylactosaminoglycans as good ligands for galectins 
(Sorme et al., 2004). In fact, in addition to the primary site which accommodates 
lactose/ N-acetyllactosamine (Toscano et al., 2007), polylactosaminoglycans are 
bound by the galectins more tightly than lactose/N-acetyllactosamine due to the 
presence of secondary sites for interaction with more extended oligosaccharides 
(Leppanen et al., 2005). Each galectin has a unique specificity, for example, the 
affinity of Gal-1 for blood group A tetrasaccharide is about 100 fold lower than that 
of Gal-3 and certain complex mucin derived saccharide that bind Gal-3 well, do not 
bind Gal-1 at all. Gal-1, -3, and -5 also differ in their affinity for certain disaccharides 
such as Gal-p-1-p GalNAc (Brewer, 2002). The two chicken galectins, C14 and C16, 
were shown to differ in their fine specificity for a panel of synthetic lactose derivative 
(Barboni et al., 2000). 
Multivalency of galectins 
Most galectins are divalent, either by self-association or by including two 
CRDs in one protein (Gabius et al., 2002). All the galectins identified till date can be 
structurally classified into three basic types (Vasta et al., 2004), which achieve 
muhivalency by distinct mechanisms. 
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Multimerization is a common feature across various families of carbohydrate 
binding proteins, perhaps because binding interactions of individual CRDs with even 
their most favored carbohydrate ligands are of relatively low affinity, and 
multimerization can greatly increase binding avidity for multivalent or clustered 
ligands (Rabinovich et al., 2007). However, in studies of a range of multivalent 
galectins, only some show enhanced avidity for multivalent ligands (Hirabayashi et 
al., 2002). This may mean that for some galectins, the significance of di- or 
multivalency is to provide them the ability to cross-link ligands (Cooper, 2002). 
Indeed, there is considerable evidence that some galectins regulate in association with 
their glycoconjugate ligands on cell surfaces, in extracellular matrices, or both 
(Brewer, 2002; Rabinovich et al., 2007). Monovalent galectins might function to 
competitively block such cross-linking activity (Cooper, 2002). 
Crystal structure of galectins 
The refined X-ray model of S-lectin revealed 133 amino acid residues in one 
monomer and 132 amino acid residues in the other monomer, two N-
acetyllactosamine molecules and 154 water molecules. S-lectin dimer forms a 
22-strand anti-parallel P-sandwich, with the N and C termini of each monomer at the 
dimer interface (Fig. 4). The two molecules are related to each other by a 
non-crystallographic two-fold rotation perpendicular to the P-sheets displaying a jelly 
roll topology containing a P-hairpin insertion with the first and second parallel P-
strands omitted. The structure reveals that there is one carbohydrate-binding site per 
monomer, which is located on the same side of the P-sandwich and on the far ends of 
the dimer 46 A apart. The integrity of the dimer is maintained by the P-sheet 
interaction across the monomers and by the formation of a hydrophobic core common 
to both. In S-lectin, the two P-sheets of the monomers extend continuously across the 
dimer interface and all direct protein carbohydrate interactions involve side chains 
located on P-strands (Liao et al., 1994). 
The well-defined electron density of both carbohydrate molecules clearly 
indicates the a-anomeric form for the GlcNAc unit (Liao et al., 1994). Most amino 
acid residues involved in sugar binding are invariant in all sequences of S-lectins. The 
binding-site depression is shaped to complement the galactose moiety with extensive 
van Der Waals contacts and a network of electrostatic interactions (Fig. 5). 
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In addition, a water molecule mediates the interaction of the side chain of Asn-
46 with the 3-OH and 4-OH of galactose. The aromatic side chain of the conserved 
Trp-68 stacks adjacent to the galactose ring. Such van Der Waals interactions between 
sugar and aromatic side chains are quite common in protein-carbohydrate complexes 
(Vyas, 1991). The axial 4-OH of galactose is the main determinant of S-lectin 
specificity which forms two key electrostatic interactions i.e., one with N-atom of 
Arg-48 and the other with N-atom of His-44. The interactions of the GlcNAc moiety 
with the protein are less extensive than those of H-44 of galactose, whereas the 
binding of N-acetyllactosamine to S-lectin is five-fold tighter than the binding of 
lactose which may be attributed to van Der Waals interactions between the N-acetyl 
group and the side chains of Arg-73 and Glu-71 (Ahmed et al., 1990). 
The carbohydrate-protein interactions are supported by exquisite protein-
protein electrostatic interactions, assuring optimal side-chain conformations. Most 
striking is the spatial disposition of the charged residues (Arg-48, Asp-54, Arg-73 and 
Glu-71) which together form a network of three sah bridges unprecedented in other 
sugar binding proteins of known structure. Of these, Asn-46, Glu-71 and Arg-73 have 
been suggested as essential for binding by site-directed mutagenesis (Hirabayashi and 
Kasai, 1991). These structural data explain why those amino acid residues that are 
directly and indirectly associated with the carbohydrate binding are conserved. 
Thiol group environment of galectins 
The crucial role that the oxidation states of S-lectin thiol groups play in 
functional regulation in vivo is still a mystery. According to the refined structure, the 
thiol groups of Cys-42 and Cys-60 are reduced and buried, whereas that of Cys-2 is 
disordered, and those of Cys-16, Cys-88 and Cys-130 are oxidized and solvated. No 
thiol group is directly involved in sugar binding, and all thiol groups bind heavy 
atoms without impairing sugar binding. Cys-60 is the only cysteine residue close to 
the binding site. Its main chain atoms are involved in the formation of the active site 
depression, and its side chain is buried and surrounded by hydrophobic residues (Liao 
et al., 1994). Site-directed mutagenesis studies of the 14 kDa S-lectins by replacing 
Cys-60 and Cys-2 by serine residues did not inhibit sugar binding, consistent with 
earlier reported structural informations (Hiarabayashi and Kasai, 1991). 
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Figure 3. Fine structure of interaction between Gal-2 and lactose: The 
sugar residues are shown in green and oxygen atoms are represented in red 
along with their position numbers. The amino acid side chains interacting 
with the saccharides are shown in light blue. The principal hydrogen 
bonds between amino acid side chains and the sugar residues are shown as 
yellow dotted lines (Barondes et al., 1999). 
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Figure 4. Three dimensional structure of S-lectin: ^strands are shown as 
ribbons and the N-acetyllactosamine molecules are shown as yellow stick models. 
The model was generated by the computer program RASTER 3D written by David 
Bacon (University of Alberta, Canada) (Barondes, et al., 1994). 
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Figure 5. Stereoscopic representation of S-lectin carbohydrate binding site: Bonds 
between carbohydrate atoms are solid and those between protein atoms are open. The 
electrostatic interactions between protein and sugar atoms are shown in thin N-46 lines. 
For clarity, protein-protein electrostatic interactions of residues involved in sugar 
binding are not indicated; these include saU bridges between Arg-48 and Asp-54, Arg-
73 and Asp-54, and Arg-73 and Glu-7 (Liao et al., 1994). 
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Hemolytic and membrane perturbing action of galectins 
The ability of galectins to act as humoral factors in the defense mechanism 
against various pathogenic agents suggests important applications for these proteins. 
Gal-1 preferentially binds to ganglioside GMi on neuroblastoma cells to exert growth 
control (Kopitz et al., 2003) and harbors a site to interact with hydrophobic tails of 
oncogenic H-Ras (Rotblat et al., 2004). The underlying mechanism to carry out this 
role is its glycan binding property present on the cell membranes, thereby causing 
lysis of the cells. 
Lytic action of some galectins have been ascribed to enzymatic activity 
(Hittelet et al., 2003), perturbation of the activities of membrane associated enzymes 
(Lowe and Marth, 2003), and pore formation in the membranes (Yu et al., 2002). The 
galectin dependent association of glycans may affect membrane features such as 
fluidity, permeability and osmofragility. In addition, lectin might also interact with 
hydrophobic membrane patches adding to its impact on membrane characteristics 
(Gupta etal., 2006). 
Role of galectins in cell-cell and cell-matrix interactions 
Galectins plays a pivotal role in the adhesion and migration of cell mediated 
by cross-linking a mosaic of extracellular matrix glycoproteins like laminin, 
fibronectin, lysosome associated membrane proteins and CD45. Despite specific 
binding of galectins to these glycoconjugates, its anti or pro-adhesive role still 
remains obscure. For example, Gal-1 promotes the adhesion of ovarian carcinoma 
cells to extracellular matrix (Rabinovich et al., 2004), whereas it inhibits the adhesion 
of myoblast to laminin by blocking the laminin receptor integrin UTPI from 
recognizing laminin (Matarrese et al., 2000). 
Similarly, Gal-3 preferably mediates adhesion of the neutrophils to laminin in 
comparison to melanoma (Sato et al., 2002). While, Gal-3 contributes to interaction 
between dendritic cells and naive T-lymphocytes in lymph nodes (Rabinovich et al., 
2002, Ilarregui et al., 2005), a recent study revealed that Gal-3 even disrupts 
thymocyte interaction within the thymic microenvironment, thus acting as a de-
adhesion molecule (Villa et al., 2002). 
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Role of galectins in pre-mRNA splicing 
The process of deletion and reconstitution of splicing activity, assayed in cell 
free system suggested that galectins are major factors involved in pre-mRNA splicing 
(Park et al., 2001). Other techniques such as co-localization studies (Wang et al., 
2007) and immuno-fluorescence microscopy (Liu et al., 2002) also revealed nuclear 
speckled structures containing galectins and known splicing factors, thus providing 
additional evidence confirming the role of galectins in mRNA splicing. The domain 
structure for GaI-1 and Gal-3 suggested that homologous CRD is necessary and 
sufficient for splicing activity, which thereby interacts with various functional 
proteins constituting the spliceosome assembly (Park et al., 2001). 
Role of galectins in cell growth and apoptosis 
Several studies provide correlative evidence for an association between 
galectin expression and cell proliferation. Gal-3 is expressed at high levels in a wide 
range of neoplasms, including spontaneous, viral, uhraviolet and chemically induced 
tumors, thus suggesting the possibility of galectins having a role in cell growth 
regulation (Plazk et al., 2004; Dumic et al, 2006). Some pro-apototic galectins, such 
as Gal-1 and Gal-9 directly initiate apoptosis by cross-linking cell surface receptors, 
whereas intracellular expression of other galectins, such as Gal-7 potentiates other 
death signals (Rabinovich et al., 2004). Galectins affect cell fate decisions in a variety 
of tissues and cell types. For example, Gal-1 kills T-cells, B-cells and prostate and 
breast cancer cell lines, suggesting that Gal-1 may recognize a common carbohydrate 
ligand on diverse cell surface receptors to initiate a common intracellular death 
pathway (Stillman et al., 2005). 
Muhiple galectins have also been shown to influence viability in a single cell 
type. Complex expression patterns of galectins and their carbohydrate ligands may 
allow temporal regulation of cell viability during development, tissue remodeling and 
inflammation (Leffler et al., 2004). In addition, some galectins can act extracellularly 
to induce apoptosis in concert with other stimuli. For example, addition of exogenous 
Gal-8 induced apoptosis of serum-starved carcinoma cells in a carbohydrate 
dependent manner (Hadari et al., 2000). Furthermore, Gal-1 also induces apoptosis of 
breast and prostate cancer cell lines (Yang and Liu, 2003) and melanoma cells 
(Stillman et al., 2005). 
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Role of galectins in cell cycle regulation 
Galectins play important role in cell growth and apoptosis, and also contribute 
significantly in cell cycle regulation. For example, Gal-1 has been shown to inhibit 
growth of mouse embryonic fibroblast at relatively low concentrations and induce cell 
cycle arrest during S to G2 transition of mammary cell lines (Yang and Liu, 2003). It 
also inhibits IL-2 induced proliferation of phytohemagglutinin activated T 
lymphocytes, IL-independent proliferation of T lymphoma cells. Con-A stimulated rat 
T-cells (Rabinovich, et al. 2004), human neuroblastoma cells (Rubinstein et al., 
2004), human leukemia T cells and murine fibroblasts (Nakahara et al., 2005). 
Role of galectins in cancer and metastasis 
The myriad critical roles played by galectins ranging from cell signaling to 
apoptosis make them potent tumirogenic molecules. Galectins are often over-
expressed in cancerous cells and cancer associated stromal cells (Lahm et al., 2004). 
In general, this altered expression correlates with the aggressiveness of tumors and the 
acquisition of metastatic phenotype, indicating that galectins might modulate tumor 
progression and influence disease outcome (Greco et al., 2004). There is increasing 
evidence that galectins have important functions in several aspects of cancer biology 
(Rabinovich et al., 2005; Liu and Rabinovich, 2005), including tumor transformation 
(Paz et al., 2001), apoptosis (Rabinovich et al., 2002) and cell growth regulation 
(Yamaoka et al., 2000). 
In addition, galectins are also involved in various steps of tumor metastasis, 
including tumor cell adhesion (Levy et al., 2001), homotypic cell aggregation 
(Glinsky et al., 2003), invasiveness (Hittelet et al., 2002) and angiogenesis (Nangia-
Makker et al., 2000). Gal-3 could be used as a prognostic marker for thyroid cancer, 
colon cancer and cancers of pancreas, bladders, stomach, kidneys, and head and neck 
squamous epithelial cells (Hasan et al., 2007). Gal-1 is also involved in cancer 
development as it anchors the molecule Ras, which is involved in cellular 
transformation (Paz et al., 2001). Increased malignant potential of human thyroid 
tumors (Xu et al., 1995), glioma (Rorive et al., 2001,) and prostate adeno-carcinoma 
(Rabinovich et al., 2004) has been correlated with enhanced expression of Gal-1, both 
on the surface of tumor cells and the stromal tissue surrounding the tumors (He and 
Baum, 2004; Stillman et al., 2005). 
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Role of galectins in inflammatory and immunomodulatory responses 
Among the various functions of galectins, its role in modulation of the 
immune response has been very well documented. Recent research indicates that Gal-
1 ameliorates phospholipase A2 induced edema (Rabinovich et al., 2002), regulates 
the release of soluble mediators from lipopolysaccharide stimulated macrophages, 
blocks neutrophil extravasation (Elola et al., 2005), induces mast cell degranulation 
(Rubenstein et al., 2004) and stimulates nitric oxide synthesis (Rabinovich et al., 
2004). Moreover, presence of Gal-1 in bone marrow derived mesenchymal (stromal) 
cells suggests its implications in bone marrow derived cell differentiation and 
mobilization (Kadri et al., 2005; Kiss et al., 2007). In addition, Gal-1 displays 
pleiotropic immunomodulatory functions, including regulation of lymphocyte survival 
and cytokine secretion in autoimmune system, transplant diseases, and parasitic and 
viral infection models (Santucci et al., 2000, 2003; Rabinovich et al., 2004; Levroney 
et al, 2005). 
Therapeutic applications of galectins 
Research over the past decade indicated that the local administration of Gal-1 
prevented clinical and histo-pathological manifestations of many well known diseases 
such as Mysthania Gravis, experimental encephalomyelitis, (Santucci et al., 2000; 
Wada and Makino, 2001; Rabinovich et al, 2004), auto-immnune encephalitis 
(Kilpatrick, 2002), collagen induced arthritis (Wada and Makino, 2001), colitis 
(Santucci et al, 2000), hepatitis (Santucci et al, 2003), autoimmune uveitis (Toscano 
et al, 2007) and anti-glomerular basement membrane (anti-GBM) glomerulonephritis 
(Tsuchiyama et al, 2000). In anti-GBM glomerulonephritis in experimental rats, the 
administration of Gal-9 induced apoptosis of activated CD 8+ cells and ameliorated 
proteinuria and renal tissue injuries (Tsuchiyama et al, 2000). The ability of Gal-1 to 
suppress the allogeneic T-cell response through apoptotic and non-apoptotic 
mechanisms suggests its potential use for immuno-suppression in organ 
transplantation and graft versus host diseases (Rabinovich et al, 2002; Stillman et al, 
2005). For example, Gal-1 treatment significantly improved reconstitution of normal 
splenic architecture following hematopoietic stem cell transplantation and, similar to 
its effects on autoimmune settings, this P-galactoside binding protein reduced the 
production of Tl-type cytokines (Toscano et al, 2007). 
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Possible usage of galectins in the therapy of atherosclerosis and diabetic 
vascular complications by modulating macrophage function and advanced end 
glycation product clearance is suggested by several studies (Stillman et al., 2005). 
Gal-7 is also reported to increase the chemotherapeutic efficacy of cisplatin in 
treatment of urothelial cancer through the accumulation of intracellular reactive 
oxygen species (Matsui et al., 2007). Furthermore, galectins display antimicrobial 
activity by acting as immunosuppressant during various infections caused by 
Trypanosoma cruzi (Zuniga et al., 2001), Leismania major (Pelletier et al, 2003), 
HIV (Lanteri et al., 2003) and Nipah virus (Levroney et al., 2005). 
Interestingly, the discovery of anti-galectin antibodies in pathological sera and 
autoimmune disorders like Chagas' cardiomiopathy (Giordanengo et al., 2001), 
non-endemic loiasis (Rabinovich et al., 2002, 2004) and Hodgkin's disease 
(Kilpatrick, 2002) opens new diagnostic and potentially therapeutic avenues for 
researchers in application of galectins as suitable target for novel drugs and 
pharmacological molecules. Detection of altered galectin expression also serves as 
excellent diagnostic markers in various carcinomas (Stillman et al., 2005; Hasan et al., 
2007) and inflammatory cells (Rabinovich et al., 2005). Direct administration of 
oxidized galectin has implication in axonal regeneration and functional recovery after 
peripheral nerve injury (Kadoya et al., 2005). 
Role of galectins in heart tissue and cardiovascular diseases 
Gal-1 has nearly ubiquitous distribution in animal tissues including heart of 
mammals. In mammalian heart, Gal-1 is localized mainly in endocardial tissue, 
myocardial cell constituents, connective-tissue elements and vascular structures. In 
the heart of heahhy individuals, Gal-1 is involved in basic physiological functions like 
adhesion, transportation and apoptosis (Bardosi et al., 1990). Though galectin activity 
in mammalian heart was first reported from calf heart almost four decades ago 
(Waard et al, 1976), only few mammalian heart galectins, like those from porcine 
heart and bovine heart (Southan et al, 1987) have been thoroughly characterized till 
date. Till the end of the last century, functional aspect of mammalian heart galectins 
was limited to basic physiological functions like adhesion, transportation and 
apoptosis in the heart of healthy individuals. However, some breakthrough studies in 
the last decade have implicated significant Gal-1 involvement in various 
cardiovascular disorders. 
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Giordanengo et al. (2001) demonstrated the occurrence of anti-Gal-1 
autoantibodies in sera from patients in the acute and chronic stages of Chaga's 
disease, caused by Trypanosoma cruzi infection of heart and other tissues. A marked 
increase in the level and frequency of IgE anti-Gal-1 antibodies was found in the sera 
from patients of acute Chaga's disease, but a low frequency of IgM anti-Gal-1 
immunoreactivity was observed. Moreover, Ig G immunoreactivity to Gal-1 was 
found to be correlated with the severity of cardiac damage in chronic Chaga's disease. 
A couple of years later, Gal-1 was shown be involved in the vascular extracellular 
matrix (ECM) assembly by affecting the incorporation of some ECM components 
(Moiseeva et al., 2003). Over-expression of the Gal-1 gene, parallel to the other genes 
encoding ECM proteins and genes involved in ECM turnover has been reported in 
aneurysmal dilation of brain blood vessels. These data also indicate the role of Gal-1 
in the ECM assembly during wound healing and tissue matrix remodeling, and in the 
developmental stages of atherosclerosis and restenosis. Further studies suggested 
remarkable involvement of Gal-1 in hypoxia-induced pulmonary hypertension (Case 
et al., 2007) and atherogenesis (Chellan et al., 2007). 
The involvement of Gal-1 in such potentially life threatening cardiovascular 
diseases strongly demand detailed exploration of mammalian heart galectins. Thus, 
we decided to carry out purification and extensive characterization of buffalo heart 
galectin, so as to provide an impetus regarding the easy availability of mammalian 
heart galectins to help understand the basic molecular mechanism behind these deadly 
diseases. 
Role of glycosylation in galectin functioning 
Glycosylation is an event known to be of paramount importance to cellular 
functioning and interactions. Its aberrations have been found in all types of cancers 
and several glycosyl epitopes fimction as tumor associated antigens (Hakomori, 
2002). Yet, the information available concerning its role in carcinogenesis is quite 
nebulous, primarily because of the lack of attention given to this field of investigation 
in comparison with more attractive and rewarding avenues like genetic studies. 
However, the implications of abnormal glycosylation in cancer development are being 
recognized. The specific steps involved in the development of cancer because of 
incorrect glycosylation are not known. 
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One molecule that has been studied in much detail is cell surface GM3 
(Kojima et al., 1991). Its interaction with CD9 and CD82 bestows anti-metastatic 
potential on the cell (Miura et al., 2004). GM3 and CD9 have even been found to be 
co-expressed in several colorectal (Ono et al., 2001) and bladder cell lines (Satoh et 
al., 2001). A reduction in the expression of this ganglioside may correlate with 
increased chances of metastasis (Hakomori, 2002). 
Though there is a shortage of unambiguous data, but the close analogy 
between the expression patterns of glycoconjugates and their binding to galectins 
cannot be ruled out. GM3 has been found to be a ligand for Gal-8 (Ideo et al., 2003). 
This galectin has two CRDs (Hadari et al., 1995) and is involved in cross-linking of 
its ligands. Extracellularly, it can organize cell adhesion molecules on the same cell as 
well as on different cells and the matrix. A change in the ligands of such a cellular 
anchor may be very important, if not tantamount, to metastasis. This could also be the 
missing link in the elucidation of galectin functioning and further studies to explore 
similar interactions between other galectins and their ligands should direct the course 
of research in the future. 
Despite such a significance of galectin glycosylation, only few galectins like 
sponge galectin (Miarons and Fresno, 2000) have been found to be glycosylated. This 
can be attributed to the lack of attention given to this aspect of galectin biology, as 
compared with more attractive and rewarding avenues like genetic studies. In an 
attempt to elucidate the role of glycosylation in galectin functioning, we carried out 
the glycosylation and deglycosylation studies of purified buffalo heart galectin. 
Role of galectins in activation of oxidative burst and degranulation of 
neutrophils by neutrophil activators 
Various functions have been demonstrated for galectins that appear to be 
multifunctional proteins with particular relevance in the physiology of the immune 
response. Gal-3 has been found to activate mast cells, neutrophils and eosinophils in 
an IgE-mediated fashion, playing a role in allergic inflammation and host defense 
against bacterial and parasitic infections (Truong et al., 1994). In relation to 
superoxide production, human Gal-3 induces the formation of oxygen radical in the 
presence of cytochalasin B (CB) by human neutrophils and monocytes in a dose-
dependent manner (Yamaoka et al., 1995). 
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Karlsson et al. (1998) and Almkvist et al. (2002) demonstrated that 
recombinant human Gal-3 induced NADPH-oxidase activity in exudated but not in 
peripheral blood PMN. Gal-1 from human placenta also induces superoxide release by 
human PMN of patients with certain tumors (Timoshenko et al., 1993) and Gal-1 
from human spleen induces superoxide formation by homologous neutrophils in the 
presence of CB (Elola and Fink, 1999). More recently it has been also shown that 
recombinant Gal-1 had the same effect (Almkvist et al., 2002). During phagocytosis, 
phagocytes destroy invading microorganisms through the generation of oxidizing 
radicals derived from partial reduction of oxygen to superoxide anion (O ). The 
enzyme responsible for O^ " production is NADPH-oxidase which uses NADPH as 
substrate, and consists of a membrane flavocytochrome b and three cytosolic proteins-
p47phox, p67phox and p40phox (Babior, 1999). 
Bacterial killing also involves another event called degranulation, the process 
of fusion between the primary phagosome and the granules present in the phagocyte 
cytoplasm. Some of the enzymes contained inside these granules are elastase, 
myeloperoxidase and lysozyme. A chicken galectin (16 kDa) produces a significant 
release of lysozyme from human neutrophils in the presence of CB (Timoshenko et 
al., 1995). In the present work, we compared the level of activation of NADPH-
oxidase in buffalo PMNs under the stimulation with N-formyl-l-methionyl-l-leucyl-1-
phenylalanine (fMLP), phorbol 12-myristate 13-acetate (PMA) and Gal-1 purified 
from buffalo {Bubalus bubalis) heart. For PMN degranulation studies, we evaluated 
lysozyme release under similar experimental procedures. 
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METHODS 
Preparation of buffalo heart homogenate 
Fresh buffalo heart tissue (100 gm) collected from local slaughter house was 
removed from its pericardium, minced into small pieces and suspended in 200 ml ice-
chilled PBS 'A' (75 mM sodium phosphate buffer pH 7.2, containing 0.15 M NaCl, 
10 mM EDTA, 5 mM P-ME, 200 mM lactose and 0.02 % (w/v) sodium azide). 
Homogenization was carried out at 4°C in a stainless steel vessel using mixer table 
homogenizer. The homogenate was centrifuged in a Beckman C-24 BL cooling 
centrifuge (JA-20 rotor) for 30 min at 10,000 rpm at 4°C and the supernatant collected 
was centrifuged twice for 30 min at 15,000 rpm at 4°C. 
Ammonium sulphate fractionation 
The supernatant was then subjected to 0-30% ammonium sulphate 
fractionation. The fractionated solution was centrifuged again for 30 min at 15,000 
rpm at 4°C, and the supernatant thus obtained was subjected to 30-70% ammonium 
sulphate fractionation. The precipitate obtained was dissolved in PBS 'B' (75 mM 
sodium phosphate buffer pH 7.2, containing 0.15 M NaCl, 5 mM |3-ME and 0.02 % 
(w/v) sodium azide). After extensive dialysis against PBS 'B', the samples were 
centrifuged for 30 min at 15,000 rpm at 4°C to remove any aggregate formed and the 
clear supernatant was applied to Sephadex G50 gel fihration column chromatography. 
Purification of buffalo heart lectin 
The buffalo heart lectin was purified on Sephadex G50 gel filtration column 
packed according to the method of Laurent and Killander (1964). Sephadex G50 
powder (10 g) was allowed to swell in sufficient amount of distilled water and left 
overnight. The gel formed was boiled for 6 h in boiling water bath, suspended in PBS 
'B' and allowed to settle down. The superfine particles in the supernatant were 
removed by decanting. A previously cleaned glass column (2 x 60 cm) mounted on a 
vertical support was filled with distilled water; glass wool was fitted at the outlet of 
the column and checked for leaks and air bubbles. The de-aerated gel slurry was 
gently poured with the help of a glass rod into the column with care to avoid 
generation of air bubbles. The column was then left standing overnight. 
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After checking for a bubble free packing of the column, its flow rate was 
increased gradually and after accomplishing a constant flow rate higher than that 
required for final elution the column was adjusted to the required flow rate (10 ml/h). 
The packed column was thoroughly washed with two bed volumes of PBS 'B'. In 
order to check the uniform packing and to determine the void volume of the column, 
0.2% (w/v) solution of blue dextran in PBS 'B' was passed through the column. The 
volume of blue dextran or lectin solution applied on the column was not more than 2-
3% of the total bed volume. The column was thoroughly washed and equilibrated with 
PBS 'B' prior to application of the sample. The dialyzed sample obtained after 30-
70% ammonium sulphate fractionation was applied to the gel filtration column at 
room temperature. The column was then eluted with PBS 'B' at a flow rate of 10 
ml/h, 3 ml fractions were collected and protein concentration was determined in each 
fraction by the method of Lowry et al. (1951). The fractions of protein peak were 
dialyzed against PBS 'B' to remove lactose and tested for hemagglutination activity 
and used for further studies. 
Determination of protein concentration 
Protein concentration was estimated by the method of Lowry et al. (1951). 
Aliquots of protein solution were taken in a set of tubes and the volume was made up 
to 1 ml with PBS 'B'. Five milliliter alkaline copper reagent was then added, 
incubated for 10 min and finally 0.5 ml of 6 N Folin-Ciocaheau's phenol reagent was 
added. The tubes were instantly vortexed and incubated for 30 min at room 
temperature. The color developed was read at 660 nm against a reagent blank. A 
calibration curve was prepared using BSA standard. 
Determination of lectin activity 
• Preparation of untrypsinized erythrocytes 
A fresh blood sample from the vein of a heahhy rabbit was collected in an 
anticoagulant (heparin). The erythrocytes were isolated by centriftjging the blood 
sample at 2000 rpm for 5 min at room temperature and washed three to four times 
with PBS 'B' (5 ml per ml packed cells). Washed erythrocytes were then made 4% 
(v/v) by adding PBS'B' . 
1 Q 
Purification and characterization of buffalo heart lectin 
• Preparation of trypsinized erythrocytes 
An 8% (v/v) suspension of washed erythrocytes was prepared in PBS 'B'. A 
trypsin solution (100 mg%) was then added to the erythrocyte suspension (0.1 ml of 
trypsin solution per ml of erythrocytes suspension) and incubated for 1 h at 37°C. The 
trypsinized erythrocytes were washed four to five times with PBS 'B' and 4% (v/v) 
suspension was prepared for further use. 
• Hemagglutination assay 
Hemagglutination activity of the purified buffalo heart lectin was determined 
using trypsinized rabbit erythrocytes according to the method of Lis et al. (1994) on 
microtiter V-shaped plates (Laxbro, India). Starting from the second row, all the wells 
of microtiter plate were filled with 50 ^1 PBS 'B'. Two 50 ^l aliquots of the purified 
lectin solution to be tested for activity was added into the first and second well and 
mixed by shaking the plate manually. Fifty microliter of lectin dilution was then 
removed from the second well and mixed with buffer of third well, then from third to 
fourth well and so on. This protocol produced two fold serial dilutions of the lectin 
solution to be tested. Fifty microliter of the 4% (v/v) erythrocyte suspension was then 
added to each well and mixed properly. The plate was incubated for 1 h at room 
temperature and examined for visible agglutination. Agglutinating unit (titer) is 
defined as the reciprocal of the highest dilution giving a visible agglutination. The 
specific activity is defined as the ratio of titer to protein concentration. 
Slab gel electrophoresis 
• Polyacrylamide gel electrophoresis (PAGE) 
Native PAGE was performed by Tris-glycine buffer system of Laemmli 
(1970), using slab gel apparatus manufactured by Genei Pvt. Ltd., Bangalore, India. 
Routinely 12.5% and 15% acrylamide gels were run. Stock solutions of 30% 
acrylamide, containing 0.8% bisacrylmide, 1.0 M Tris-HCl (pH 6.8), 37 ^1 TEMED 
and a pinch of ammonium persulphate were mixed in specific proportion to give 
desired percentage of acrylamide gel. The gel solution was then poured in the mould 
formed between the two glass plates (8.5 x 10 cm) separated by 1.5 mm thick spacers 
and checked for bubbles and leaks. A comb providing template for 7 wells was then 
inserted into the glass mould as soon as the polymerization began. 
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The comb was removed after polymerization and the wells were overlaid with 
Tris-glycine buffer (0.025 M Tris + 0.2 M glycine). The lectin samples to be loaded 
on the native PAGE were mixed with 10 mM Tris-HCl buffer (pH 8.0), containing 1 
mM EDTA, 10% glycerol, 2.5% (v/v) 2-mercaptoethanol and traces of bromophenol 
blue as a tracking dye. Electrophoresis was carried out in Tris-glycine buffer at 100 V 
till the tracking dye reached the gel bottom. 
• Sodium dodecyl sulphate (SDS)-PAGE 
SDS-PAGE was also performed by the method of Laemmli (1970). Stock 
solutions of 30% acrylamide, containing 0.8% bisacrylmide, 1.0 M Tris-HCl (pH 6.8), 
37 ]i\ TEMED, a pinch of ammonium persulphate and 10% of SDS were mixed in 
specific proportion to give desired percentage of acrylamide gel. The lectin samples to 
be loaded on the SDS-PAGE were mixed with 10 mM Tris-HCl buffer (pH 8.0), 
containing 1 mM EDTA, 2% SDS, 10% glycerol and 2.5% (v/v) 2-mercaptoethanol 
and traces of bromophenol blue as a tracking dye. Samples were then boiled for 5 min 
in a boiling water bath and electrophoresis was carried out in Tris-glycine buffer 
(0.025 M Tris + 0.2 M glycine + 0.02% SDS) at 100 V till the tracking dye reached 
the gel bottom. 
• Staining of the gels 
After electrophoresis, the gels were stained with five gel volumes of 0.25% 
CBB R-250 in 5% methanol and 10% acetic acid for at least 4 hours. For destaining, 
the gels were incubated in S% methanol and 7.5% acetic acid at room temperature. 
Molecular weight determination 
• Gel filtration chromatography 
The molecular weight of the purified buffalo heart lectin was determined using 
Sephadex Gioo gel filtration column under native (without P-ME) as well as reduced 
(with p-ME) conditions. The lectin along with standard molecular weight markers 
were loaded on the column pre-calibrated by determining the elution volume of the 
following molecular weight markers: PB, Phosphorylase b (97.4 kDa); BSA, Bovine 
Serum Albumin (68 kDa); OA, Ovalbumin (45 kDa); CA, Carbonic Anhydrase (29 
kDa); STI, Soyabean Trypsin Inhibitor (20.1 kDa); Lys, Lysozyme (14.4 kDa). 
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The column then was then eluted with PBS 'B' at a flow rate of 10 ml/h, 3 ml 
fractions were collected and protein concentration was determined in each fraction by 
the method of Lowry et al. (1951). The data were analyzed according to the 
theoretical treatment of Andrews (1965). The linear plot between 'elution volume 
(Ve)/void volume (Vo)' and 'log M' was used for calculating the molecular weight of 
the purified lectin. 
•SDS-PAGE 
The subunit molecular weight of the purified buffalo heart lectin was 
calculated by the procedure of Weber and Osborn (1969) using its mobility on SDS-
PAGE. The mobility of marker proteins determined under identical conditions was 
plotted against the logarithm of molecular weight. The analysis of data indicated a 
linear relationship between log M and relative mobility (Rm) and the plot was used 
for calculating the molecular weight of the purified lectin. 
Stokes radius determination 
Stokes radius of the purified buffalo heart lectin was determined using the gel 
filtration data. The partition coefficient (Kav) value of each marker protein was 
calculated from the formula [Kav = (Ve-Vo)/(Vt-Vo)], where 'Ve' stands for elution 
volume, 'Vo' stands for void volume and 'Vt' designates total volume of the column. 
A linear plot between the square root of the negative logarithm of Kav and Stokes 
radii of the marker proteins was used for calculating Stokes radius of the purified 
lectin. 
Determination of diffusion coefficient 
Diffusion coefficient (D) of the purified buffalo heart lectin was computed 
using the equation, D=KT/67nir, where, 'K' is the Boltzman constant (1.38x610''^  
erg/deg), 'T' is the absolute temperature (303 k), 'n' is the coefficient of viscosity of 
the medium (0.0100 P for water and dilute aqueous sah solutions at 20° C) and 'r' is 
Stokes radius. 
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Carbohydrate binding specificity 
Saccharide specificity of the purified buffalo heart lectin was determined by 
sugar inhibition tests using two fold serial dilutions of the sugar solutions. To assess 
inhibition tests, standard solution (100 mM) of following saccharides were prepared 
in 0.15 M NaCl: P-D-lactose, D-galactose, methyl-P-D-galactopyranoside, p-
nitrophenyl-P-D-galactopyranoside, D-galactosamine, methyl-a-D-galactopyranoside, 
p-nitrophenyl-a-D-galactopyranoside, D-glucose, D-mannose, D-fiacose, D-sucrose 
(Glc-a-l,2-Fuc), D-melibiose, D-glucosamine, D-cellobiose and D-fructose. 
To determine the minimum concentration required for inhibition of 
hemagglutination by saccharides, 25 i^l serially diluted test saccharides were added to 
each well containing 25 nl purified lectin containing four agglutinating units. Fifty 
microliters of trypsinized erythrocytes was added into each well and contents were 
mixed by gentle shaking and incubated for an hour at room temperature. Highest 
dilution of the test saccharides required for complete inhibition was noted. 
Sequencing of tryptic and chymotryptic peptides: enzymatic digestion and 
purification 
Purified buffalo heart lectin (2 mg in 3 ml of PBS containing 5 mM P-ME and 
0.5 M NaCl) was dialyzed against 0.01 .M ammonium hydrocarbonate and 
lyophilized. The lyophilized lectin was dissolved in 400 ^1 of 8 M deionized urea/0.05 
M Tris-HCl pH 8.3, reduced with 0.045 M dithiothreitol (40 nl) at 50°C for 30 min, 
and then carboxamidomethylated with 0.1 M iodoacetamide (80 \i\) under nitrogen 
atmosphere at room temperature for 2 h. The carboxamidomethylated lectin was 
diluted to 2 ml with distilled water and digested with trypsin and high specificity 
chymotrypsin at 37°C for 20 h using 1:20 enzyme/substrate ratio. 
The tryptic and chymotryptic peptides were separated by reverse phase HPLC 
(Pharmacia LKB, Sweden) on a Vydac C18 column (4.7x250 mm) equilibrated with 
0.1% trifluoroacetic acid in water (v/v). The column was eluted at a flow rate of 1.0 
ml/min with 0-60% acetonitrile linear gradient in 0.1% trifluoroacetic acid (v/v) 
during 10 min. 
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Amino acid sequencing and computerized sequence comparison 
The peptide fragments were then appUed to a polybrene coated glass filter and 
sequenced in an Applied Biosystems model 477A automatic sequencer run according 
to the manufacturer's instructions. Searches for similarities to the determined 
sequence were performed with the aid of the Swiss-Prot protein sequence data bank 
and ExPASy tools. The peptides were then aligned by their similarities 
Effect of divalent metal ions 
To examine the effect of divalent metal cations on the activity of the purified 
lectin, demetallization of lectin (100 ng/ml) was carried out using 0.1 M EDTA 
followed by remetallization of the sample with 0.1 M CaCb, MnCh, [Sr(CH3COO)2], 
MgCh and NiCb in PBS 'B'. Hemagglutination activity of each sample was tested by 
using a microtitre plate assay. 
Human blood group specificity 
Hemagglutination ability of the purified buffalo heart lectin was also scanned 
using trypsinized as well as untrypsinized preparations of human erythrocytes (blood 
groups A, B, AB and O) by two fold serial dilution method 
Determination of sulfhydryl groups 
The exposed thiol (-SH) groups were determined according to the procedure 
of Ellman (1959). For the determination of exposed -SH groups, appropriate amount 
of the purified buffalo heart lectin was added in 100 mM Tris-EDTA buffer (pH 8.0) 
to give a total volume of 3 ml, followed by the addition of 0 1 ml DTNB solution 
(40 mg DTNB in 10 ml of 0.1 M Tris HCl, pH 8.0). After 15 min, the color developed 
was read at 412 nm The number of free thiol groups was calculated in 'milli-moles' 
using cysteine (0.125 M) as standard. 
Effect of thiol blocking reagents, denaturants and detergents 
The rate of reaction of the purified buffalo heart lectin (100 \xg/m\) with 70 
mM each of iodoacetamide, iodoacetate, p-hydroxymercuricbenzoate (pHMB) and N-
ethylmaleimide (NEM) in PBS 'B' was determined at room temperature 
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The effect of denaturants on the purified lectin (100 \igjml) was determined by 
incubating lectin samples with increasing concentrations (0-8 M) of urea, guanidine 
HCl (GdnHCl) and thiourea in PBS 'B' at 37°C for one hour. 
The effect of different detergents was monitored by incubating the purified 
buffalo heart lectin (100 ng/ml) with increasing concentrations (1-5 M) of SDS, 
Tween-20 and Triton X-100 in PBS 'B' at 37°C for one hour. After designated time, 
hemagglutination activity of each sample was tested using microtitre plate assay. 
Thermal stability 
Thermal stability of the purified buffalo heart lectin (100 \ig/m\) was 
determined by incubating the samples in PBS 'B' at various temperatures (30-80°C) 
for 30 min. The samples were then cooled on ice and hemagglutination activity of 
each sample was tested using microtitre plate assay. 
pH stability 
For determining the pH stability, the purified buffalo heart lectin (100 |xg/ml) 
in 50 \xl of normal saline containing 5 mM P-ME was incubated for 24 h at 4°C with 
50 ml of the following buffers: 0.1 M sodium acetate buffer (pH 3.5-5.5), 0.1 M 
sodium phosphate buffer (pH 6,5-7.5), 0.1 M Tris-HCl buffer (pH 8.5-9.5) and 0.1 M 
glycine-NaOH buffer (pH 10.5-11.5). Hemagglutination activity of each sample was 
tested using microtitre plate assay. 
Equilibrium dialysis 
The binding of lactose to the purified buffalo heart lectin was quantitatively 
studied in PBS 'B' by equilibrium dialysis in a dialysis bag (3.0 ml capacity) made 
from Sigma cellulose membrane. The dialysis bag containing 100 [igjml of the lectin 
solution was placed in plastic vials containing 1 ml lactose solution in the range of 40-
400 \iM. After equilibrating for 24 h at 37°C, a portion was taken from the lectin free 
compartment and its carbohydrate content was estimated (Dubois et al., 1956). The 
amount of lactose bound per mole lectin was calculated according to the Scatchard 
analysis. 
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UV-VIS spectroscopy 
The requirement of reducing agent for maintenance of the lectin activity was 
further investigated by measuring the time-course effect of an oxidizing agent on the 
purified buffalo heart lectin by adding 5mM H2O2 in PBS 'B ' without p-ME. The UV 
spectra of the native lectin (100 ng/ml in PBS 'B' containing P-ME) and the oxidized 
lectin (100 ng/ml in PBS 'B' containing 5 mM H2O2 in the absence of P-ME) were 
measured on UV-1700 Pharmaspec UV-VIS double beam spectrophotometer 
(Shimadzu Corp., Kyoto, Japan) in the wavelength range of 220-320nm. 
Fluorescence spectroscopy 
Intrinsic fluorescence of the purified buffalo heart lectin (100 ^g/ml) was 
measured at 25°C in a Hitachi F-200 spectrofluorometer (Hitachi, Tokyo, Japan) 
equipped with a DR3 recorder. The solutions were selectively irradiated using an 
excitation wavelength of 280 nm with 10 nm band pass. Emission spectra were 
measured in the range of 300-400 nm. Changes in the fluorescence spectra in the 
presence of 5 mM H2O2, 0.1 M lactose, 8 M urea and 5 M SDS solutions were also 
recorded. Appropriate controls containing the substances used for treatment were also 
taken. Each spectrum was an average of five scans. 
Circular dichroism (CD) spectroscopy 
CD measurements were carried out on a Jasco spectrophotometer model J-810 
using a SEKONIC XY plotter (model SPL-4301A) with a thermostatically controlled 
(25°C) cell holder attached to a NESLAB model RTE-210 water bath with an 
accuracy of ±0.10°C. The instrument was equipped with a microcomputer and pre-
calibrated with (+)-10-camphorsulfonic acid. CD measurements were taken in the far 
UV region (200-250 nm) as well as the near UV region (250-350 nm) using purified 
buffalo heart lectin concentration of 250 ng/ml and 1 mg/ml, respectively. Original 
spectrum of the purified lectin was recorded with a scan speed of 100 nm/min with a 
response time of 1 sec. Changes in the CD spectra in the presence of 5 mM H2O2, 0.1 
M lactose, 8 M urea and 5 M SDS solutions were also recorded. Appropriate controls 
containing the substances used for treatment were also taken. Each spectrum was an 
average of five scans. 
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Fourier transform infra red (FTIR) spectroscopy 
All FTIR measurements were carried out on a NICOLET (ESP) 560 
spectrophotometer (USA) equipped with a transmission OMNIC ESP 5.1 software 
and a DIGS detector. Original spectrum of the purified buffalo heart lectin (150 
\ig/ml) at 37°C was recorded with a resolution of 4 cm'' and 128 scans. Changes in 
the FTIR spectra in the presence of 5 mM H2O2, 0.1 M lactose, 8 M urea and 5 M 
SDS solutions were also recorded. The changes in the peak frequency and intensity 
were then assigned to conformational change within the protein. Appropriate controls 
containing the substances used for treatment were also taken. Each spectrum was an 
average of five scans. 
Bioinformatics studies 
The amino acid sequence of the purified buffalo heart lectin was formatted 
using DNA tools (http;//biology.semo.edu/cgi-bin/dnatools.pl). BLAST-P 
(http://www.ncbi.nlm.nih.gov/BLAST; Altschul et al., 1990) and CLUSTALW 
(www.ebi.ac.uk/clustalw) were used to further corroborate the amino acid sequence. 
The peptide cutter program of ExPASy tools (http://ca.expasy.org/) was used to 
predict the digestion of the purified lectin by trypsin and high specificity 
chymotrypsin in reverse phase HPLC. The theoretical average mass and monoisotopic 
mass of the purified lectin were predicted using ExPASy tools and compared with 
findings of the wet lab. Probable secondary structure of the purified lectin was 
explored using 3D-JIGSAW Comparative Modelling Server program of ExPASy 
tools. 
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RESULTS AND DISCUSSION 
Purification of buffalo heart lectin 
About 70% of total active protein was precipitated between 30-70% 
ammonium sulphate saturation, resulting in 3.95 fold purification. After extensive 
dialysis against PBS 'B', the salt fractionated protein was chromatographed on 
Sephadex Gjo gel filtration column equilibrated with PBS 'B' . Table 3 shows the 
purification of lectin from 100 g buffalo heart tissue. The purified lectin yield of 0.97 
mg represented 63% recovery with 1715.3 fold purification. The purified buffalo 
heart lectin moved as a single band on native PAGE (Fig. 6a) as well as SDS-PAGE 
(Fig. 6b), suggesting homogeneity of the purified lectin with respect to charge and 
mass. Figure 7 shows the elution profile of the purified buffalo heart lectin. 
Molecular weight determination 
On Sephadex Gioo gel fihration column, the purified buffalo heart lectin eluted 
as a monomer of 14.5 kDa under reducing conditions, whereas it eluted as a dimer of 
29 kDa under non-reducing conditions (Fig. 8), thus revealing their homo-dimeric 
nature. SDS-PAGE also demonstrated the molecular weight of the purified lectin as 
14.5 kDa (Fig. 6b). 
The Stokes radii of the monomeric and dimeric forms of the buffalo heart 
lectin were found to be 17.8 A and 26.3 A respectively, and the diffusion coefficients 
corresponding to the respective Stokes radii were computed to be 12.5x10' cm /s 
and 8.47x10"'^ cmVs, respectively. 
These findings fiirther confirmed the homo-dimeric nature of the purified 
lectin. The dimeric nature of P-galactoside binding lectins provides them the potential 
to bind to glycoconjugates. The positive and negative effects of Gal-1 on cell growth 
might be influenced by both the dose and the relative distribution of monomeric 
versus dimeric form (Stillman at al., 2006). 
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Table 3. Purification table of buffalo heart lectin 
Step fraction 
Crude homogenate 
Ammonium sulphate 
fraction 
Chromatography 
Total 
protein 
2730 
586 
0.97 
Total 
activity 
(Titer)'' 
19888 
13952 
12544 
Specific activity 
(titer/mg 
protein) 
7.03 
27.75 
12058.8 
Purification 
fold 
1.0 
3.95 
1715.3 
% 
yield 
100 
70 
63 
Values are means of three different preparations from 100 g fresh buffalo heart 
tissue. 
* Determined by the method of Lowry et al. (1951). 
The titer of the tested galectin is expressed as reciprocal of the highest 
dilution showing agglutination of trypsinized rabbit erythrocytes. 
% yield of the fraction = Total activity of the fi-action x 100 
Total activity of crude homogenate 
a 
PB(<»7.4ll)a» 
BS.\<6Sll>i) 
OA(4Skt)a) 
CA(2«>kr)a» 
Sn(3u . l lDa l 
L}Sll4.4kl)a) 
£ 
BrfKi-l 
(14.5 kDa) 
lt,IK>-l 
ll4.5klXi) 
(») (b) 
Figure 6. Polyacrylamide gel electrophoresis of the purified buffalo heart lectin: 
Panel 'a'. Native PAGE of the purified buffalo heart lectin (35pg). Panel 'b'. SDS-
PAGE: Lane 'a ' contains molecular weight maricers (35pg) m descending order of 
their molecular weights and lane 'b ' contains purified buffalo heart lectin (35^g). The 
molecular weight markers used were: PB, Phosphorylase b (97.4 kDa); BSA, Bovine 
Serum Albumin (68 kDa); OA, Ovalbumin (45 kDa); CA, Carbonic Anhydrase (29 
kDa); STl, Soyabean Trypsin Inhibitor (20.1kDa) and Lys, Lysozyme (14.4 kDa). The 
relative mobility (Rm) of the marker proteins were plotted against their molecular 
weight using least square analysis of the data. 
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Figure 7. Elution profile of the purified buffalo heart lectin 
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Figure 8. Molecular weight determination of the purified buffalo heart lectin: 
Molecular weight of the purified buffalo heart lectin was determined by gel filtration 
chromatography under native (without (3-ME) as well as reduced (with P-ME) 
conditions. The elution position of monomeric and dimeric forms of the purified 
lectin has been indicated by arrows A and B, respectively. 
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Carbohydrate binding specificity 
Most P-galactoside binding lectins display affinity towards lactose and N-
acetyllactosamine with subtle differences in their carbohydrate specificities (Leffler et 
al., 2004; Vasta et al., 2004; Rabinovich et al., 2007). Therefore, a number of simple 
sugars and complex saccharides were screened for sugar specificity of the purified 
buffalo heart lectin by hemagglutination inhibition assay. Structural variations in the 
CRD topology of lectins has been reported to contribute to their extraordinary 
sensitivity towards corresponding sugar residues (Reuter and Gabius, 1999), and 
formed the basis of our studies regarding their specificity towards various saccharides. 
Hemagglutination inhibition studies using a number of saccharides led to the 
conclusion that the purified buffalo heart lectin is specific for saccharides bearing 
non-reducing terminal D-galactose linked in a P-configuration (Table 4). This is 
further supported by the observation that methyl-a-D-galactopyranoside and p-
nitrophenyl-a-D-galactopyranoside are weak inhibitors as compared to methyUP-D-
galactopyranoside and p-nitrophenyl-P-D-galactopyranoside (Ola et al., 2001). The 
affinity for P-galactosides satisfied the first criterion for inclusion of the purified 
buffalo heart lectin in Gal-1 subfamily. 
The inhibition of the lectin activity by D-galactose and D-galactosamine 
indicates that a free hydroxyl or a free amino group at C2 is required for 
monosaccharide to cause inhibition of lectin binding to erythrocytes (Ola et al., 2001; 
Shahwan et al., 2004). Moreover, the configuration at C4 is also important, since 
neither D-glucose nor D-glucosamine caused inhibition. The fact that lactose is far 
more potent inhibitor for hemagglutination activity of the purified lectin suggests that 
carbohydrate binding site of the purified lectin could have extended geometry, which 
is only partially occupied by the galactose molecule (Rabinovich et al., 2004). This 
finding is consistent with the X-ray crystallographic studies using small disaccharides 
which predicted the 4-OH and 6-OH groups of galactose and 3-OH group of glucose 
comprising lactose structure are critically important for high affinity binding (Liao et 
al., 1994). An ammonium group on C2 (D-galactosamine, D-glucosamine) decreases 
the inhibitory properties, likely because of its positive charge. Unlike human brain 
Gal-1, which required low concentrations of p-D-galactose, p-nitrophenyl-P-D-
galactoside and D-fucose (1.4, 0.4, and 25 mM, respectively) for complete 
hemagglutination inhibition (Bladier et al, 1989), the purified lectin required higher 
concentrations of these saccharides, suggesting its own unique specificity. 
<;i 
Purification and characterization of buffalo heart lectin 
Table 4. Effect of saccharides on hemagglutination activity of the purified 
buffalo heart lectin: Standard solution of various saccharides (100 mM) were 
prepared in 0.15 M NaCl and four agglutinating units of the purified lectin was used 
in two fold serial dilution method to determine the minimum concentration required 
for inhibition of hemagglutination by various sugars. 
Saccharides 
P-D-lactose 
D-galactose 
Methyl-|3-D-galactopyranoside 
p-nitrophenyl-P-D-galactopyranoside 
D-Galactosamine 
Methyl-a-D-galactopyranoside 
p-nitrophenyl-a-D-galactopyranoside 
D-Glucose 
Minimum inhibitory concentration 
(mM) 
0.5 
3.0 
5.4 
5.6 
27.0 
>100 
>100 
>100 
Note: The following sachharides showed no inhibitory activity at 100 mM: D-
mannose, D-fucose, D-sucrose (Glc-a-l,2-Fuc), D-melibiose, D-glucosamine, D-
cellobiose, D-fructose. 
'm-
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Amino acid sequencing 
For determining the amino acid sequence, the tryptic and chymotryptic 
fragments of the purified buffalo heart lectin were separated by reversed phase HPLC 
(Fig. 9). The peaks T1-T9 representing pure peptides were subjected to amino acid 
analysis and automated sequencing (Fig. 10), except for T6. The presence of an acetyl 
group was deduced from its blocked N-terminus as reported for other Gal-1 (Shahwan 
et al., 2004). 
The T6 sequence not established by tryptic digestion was subjected to Edman 
degradation and the resuUing fragments were designated as C1-C3. The sequence 
alignment of the purified lectin with other Gal-1 characterized from cattle myelin 
sheath (Abbott et al, 1989), bovine heart (Southan et al, 1987), human brain (Bladier 
et al, 1991), rat lung (Clerch et al, 1988) and sheep brain (Shahwan et al, 2004) 
showed more than 87% identity, in agreement with its high conservation throughout 
evolution. These results suggest that the 14.5 kDa lectin is species specific rather than 
organ specific protein (Bladier et al, 1991). 
The analysis of amino acid sequence of the purified buffalo heart lectin 
indicated that the aromatic side chain of the conserved Trp68 stacks adjacent to the 
galactose ring. Such van Der Waal interactions between sugar and aromatic side 
chains are quite common in protein-carbohydrate complexes (Kasai and Hirabayashi, 
1996). The axial 4-OH of galactose, a main determinant of the lectin specificity, 
forms two key electrostatic interactions; one with the N-atom of Arg48 and the other 
with the N-atom of His44 (Shahwan et al, 2004). Both are invariant residues in the 
sequences of various galectins (Fig. 10). In addition, the conservation of amino acid 
residues that interact with carbohydrate ligands (His44, Asn46, Arg48, His52, Asp54, 
Asn61, Trp68, Glu71, and Arg73) allowed us to classify it as 'prototype' according to 
its molecular architecture as it neither has a link peptide joining two CRDs nor has the 
CRD joined to different types of domain as found in 'tandem repeat' and 'chimera' 
topologies, respectively. Besides, they show the characteristics of cytoplasmic 
proteins, such as an acetylated N-terminal amino group and the lack of hydrophobic 
trans-membrane segment and secretion signal peptide similar to other Gal-1 
(Barondes et al, 1994). The conserved 134 amino acid CRD satisfied the second 
criterion for inclusion of the purified buffalo heart lectin in Gal-1 subfamily, and thus 
we designated the purified protein as buffalo heart galectin-1 (BfHG-1). 
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Figure 9. HPLC profile of peptides obtained by tryptic (a) and chymotryptic (b) 
digestion of the purified buffalo heart lectin: Peptides were separated by reversed-
phase HPLC on a Vydac C18 column equilibrated with 0.1% (v/v) trifluoroacetic acid 
in water. Elution was performed at a flow rate of 1.0 ml/min with 0-60% acetonitrile 
linear gradient in 0.1% (v/v) trifluoroacetic acid for 10 min, and the elution was 
monitored at 220 nm. Peaks T1-T9 represents tryptic peptides and C1-C3 represent 
chymotryptic peptides, whose sequence was determined by Edman degradation and 
established from amino acid sequence. 
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BfHG-l ACGLVASNLNLKPGECLRVRGEVAPDAKSFLLNLGKDDNNLCLHFNPRFNAHGDINTIVC 60 
I -16 11 Tl 11 -T7 11 -T5 
I-C2-I l-Cl- I I—C3 1 
CMG-1 ACGLVASNLNLKPGECLRVRGEVAADAKSFLLNLGKDDNNLCLHFNPRFNAHGDVNTIVC 60 
BHG-1 ACGLVASNLNLKPGECLRVRGEVAADAKSFLLNLGKDDNNLCLHFNPRFNAHGDVNTIVC 60 
SBG-1 ACGLVASNLNLKPGECLRVRGEVAADAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVC 60 
HBG-1 ACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVC 60 
RLG-1 ACGLVASNLNLKPGECLKVRGELAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVC 60 
BfHG-l NSKDGGAWGAEQREVAFPFQPGSWEVCISFNQADLTVKLPDGHEFKFPNRLNLEAINYM120 
— I I -12 11 -T9 11 -T3 11 - T 8 — 
CMG-1 NSKDAGAWGAEQRESAFPFQPGSWEVCISFNQTDLTIKLPDGYEFKFPNRLNLEAINYL120 
BHG-1 NSKDAGAWGAEQRESAFPFQPGSWEVCISFNQTDLTIKLPDGYEFKFPNRLNLEAINYL120 
SBG-1 NSKDGGAWGAEQREVAFPFQPGSVAEVCISFNQTDLTVKLPDGYEFKFPNRLNLEAINYM120 
HBG-1 NSKDGGAWGTEQREVAFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYM120 
RLG-1 NSKDDGTWGTEQRETAFPFQPGSITEVCITFDQADLTIKLPDGHEFKFPNRLNMEAINYM120 
BfHG-l SAGGDFKIKCVAFD 134 
1 |„T4-| 
CMG-1 SAGGDFKIKCVAFE 134 
BHG-1 SAGGDFKIKCVAFE 134 
SBG-1 SADGDFKIKCVAFE 134 
HBG-1 AADGDFKIKCVAFD 134 
RLG-1 AADGDFKIKCVAFE 134 
Figure 10. Comparison of the amino acid sequences of BfHG-l with other Gal-1: 
BfHG-l sequence was compared with cattle myelin Gal-1 (CMG-1), bovine heart Gal-
1 (BHG-1), sheep brain galectin (SBG-1), human brain Gal-1 (HBG-1) and rat lung 
Gal-1 (RLG-1). Amino acids conserved in all Gal-1 are designated with asterisks (*). 
Amino acids from other Gal-1 which differ from those present at the same position in 
BfHG-l are indicated in bold (•). 
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Effect of divalent metal ions 
Divalent metal ions did not affect the activity of BfHG-1, similar to other Gal-
1 (Ola et al., 2007). 
Human blood group specificity 
The concentration of BfHG-1 required for hemagglutination varied markedly 
with the type of human erythrocytes. BfHG-1 agglutinated native human erythrocytes 
with marked preference for the blood group A, probably mediated by the 
polylactosaminoglycans found on the surface of human erythrocytes (Ola et al, 
2001). The overall order of preference was A>0>AB>B. However, the trypsinized 
erythrocyte suspension was found to be more specific in hemagglutination than the 
untrypsinized erythrocyte suspension. 
Determination of sulfhydryl groups 
It is a well established fact that almost all the known p-galactoside binding 
lectins require reducing agents for the hemagglutination activity and stability (Cerra et 
al., 1985; Southan et al., 1987). BfHG-1 also strictly requires reducing agents such as 
P-ME to show activity for longer period of time. Exposed thiol group analysis of 
BfHG-1 indicated a molar ratio of 2.9, suggesting the presence of approximately three 
moles of sulfhydryl group per mole of galectin. 
Thermal and pH stability 
As can be seen in Fig. 11, BfHG-1 retained full hemagglutination activity up 
to 48°C with a gradual drop of activity beyond this temperature and a complete loss at 
68°C. Thus, BflG-l exhibited high thermal stability, similar to a bovine galectin 
characterized by Ahmed et al. (1996). In relation to pH stability BfHG-1 was found to 
be stable in the pH range of 4.5-10.5 (Fig. 12). 
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Figure 11. Thermal stability of BfHG-1: B{HG-1 (100 ^g/ml) was incubated in PBS 
'B' at various temperatures (30-80°C) for 30 min. The samples were cooled on ice and 
hemagglutination activity of each sample was tested using microtitre plate assay. 
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Figure 12. pH stability of BfHG-1: BfHG-1 (100 ng/ml) in 50 i^l of normal saline 
containing 5 mM P-ME was incubated for 24 h at 4°C with 50 ml of the following 
buffers: 0.1 M sodium acetate buffer (pH 3.5-5.5), 0.1 M sodium phosphate buffer 
(pH 6.5-7.5), 0.1 M Tris-HCl buffer (pH 8.5-9.5) and 0.1 M glycine-NaOH buffer (pH 
10.5-11.5). Hemagglutination activity of each sample was tested using microtitre plate 
assay. 
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Effect of thiol blocking reagents 
The requirement of reduced form of cysteine for the maintenance of BfHG-1 
in its active form (Shahwan et al., 2004; Ola et al., 2007) was further confirmed by its 
differential inhibition in the presence of various thiol blocking reagents. The loss of 
galectin activity in the presence of thiol blocking reagents can be due to possible 
conformational changes that occurred during modification of cysteine residues (Liao 
et al., 1994; Clerch et al., 1988). However, relatively slower rate of inactivation points 
towards the possibility of cysteine molecules being partially buried inside the galectin, 
and possibly not involved directly in carbohydrate binding, rather being present at a 
relatively distant site (Whitney et al., 1986; Ali and Salahuddin, 1989; Shahwan et al., 
2004). This easily explains the effectiveness of pHMB, the most hydrophobic 
blocking reagent, in most readily inhibiting the hemagglutination activity of BfHG-1 
followed by lesser hydrophobic NEM, iodoacetate and iodoacetamide (Fig. 13). 
Effect of denaturants 
As per the chaotropic denaturants, urea caused maximum loss in BfHG-1 
activity, followed by GdnHCl and thiourea (Fig. 14). These findings indicate that the 
secondary structure of BfHG-1 is stabilized mainly by hydrogen bonding and 
hydrophobic interactions (Nelson and Cox, 2001), suggesting a denaturant induced 
alteration in the environment of the Trp residues. 
Effect of detergents 
Among the detergents, SDS, a well known ionic detergent denatured BfHG-1 
even at very low concentrations, possibly by changing the order of protein water 
molecules and also by intercalating into hydrophobic clefts of the lectin with its long 
hydrocarbon chain (Lanio et al., 2003). Tween-20 and Triton X-100 being neutral 
detergents showed less inhibition on the lectin activity (Fig. 14) for they did not bind 
to BfHG-1 in detectable amount and were found not very efficient in breaking non-
covalent bonds, which are responsible for the quaternary structure of muhimeric 
proteins (Helenius and Simons, 1972). 
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Figure 13. Effect of thiol blocking reagents on BfHG-1 activity: BfHG-1 (100 
|ag/ml) was incubated with 70 mM each of iodoacetamide, iodoacetate, pHMB and 
NEM in PBS 'B' at room temperature. After designated time, hemagglutination 
activity of each sample was tested using microtitre plate assay. 
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Figure 14. Effect of denaturants and detergents on BfHG-1 activity: BfHG-1 (lOu 
^g/ml) was incubated with increasing concentrations of denaturants (0-8 M) and 
detergents (1-5 M) in PBS 'B' at 37°C for one hour. After designated time, 
hemagglutination activity of each sample was tested using microtitre plate assay. 
S9 
Purification and characterization of buffalo heart lectin 
Equilibrium dialysis 
BfHG-1 readily reacted with lactose as follows 
BfHG-1 + n(Lac) -^ BfHG-1 (Lac)n (1) 
Ka ^  [BfHG-1 Lacnl (2) 
[B^G-l] [Lacln 
V —>• JlKalLac] (3) 
l+Ka[Lac] 
where 'n' is the number of carbohydrate binding sites in BfHG-1 dimer, 'Lac' 
designates lactose, 'u' stands for the amount of lactose bound per mole of BfHG-1, 
and 'Ka' is the association constant for interaction of Lac with BfHG-1 'D' was 
determined in triplicate and plotted according to Eq (3) The linear Scatchard plot of 
equilibrium dialysis data of native BfHG-1 in PBS 'B' with lactose at 37°C was drawn 
(Fig 15) The slope of the plot gave binding constant value (Ka) for BfHG-1 as 
7 08x10^ M'' The number of binding sites calculated from the X intercept was found 
to be 2 1 per BfHG-1 dimer 
UV-VIS spectroscopy 
Cerra et al (1985) reported that a reducing agent is necessary for initial 
purification of galectins, but is not required for their continued activity Like other p-
galactoside binding lectins (Southan et al, 1987, Ola et al, 2001, Kadoya et al, 2005, 
Rabinovich et al, 2007), BfHG-1 also showed hemagglutination activity only in the 
presence of reducing agents such as p-mercaptoethanol BfHG-1 showed no detectable 
loss of activity when kept for up to 4 months in PBS containing 0 3 M lactose at 4°C, 
thus suggesting that lactose maintains BfHG-1 in an active form even in the absence 
of a reducing agent, possibly by preventing oxidative inactivation due to formation of 
intra-molecular disulphide linkages (Cho and Cummings, 1995) 
Since galectins remain in active conformation in the presence of reducing 
agents, we speculate that they contain an oxidizable residue whose integrity is crucial 
for their activity BfHG-1 presents a UV spectrum maximum at 280 nm (Fig 16), 
corresponding to the presence of single Trp residue and a large number of other 
aromatic residues However, oxidation of BfHG-1 in the presence of 5 mM H2O2 
(without P-ME) resuhed in the shift of absorption peak to 250 nm suggesting 
oxidation of Trp residue to an oxindole moiety, which absorbs maximally at 250 nm 
(Levi and Teichberg, 1981) This result suggested that reducing agents not only 
prevent oxidation of Cys residues in galectins but also protect Trp from oxidation 
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Binding coefficient 
Figure 15. Scatchard plot for the binding of lactose to BfHG-1: BjHG-l solution 
(100 |ag/ml) was placed in plastic vials containing 1 ml lactose solution in the range of 
40-400 \M.. After equilibrating for 24 h at 37°C, a portion was taken from the galectin 
free compartment and its carbohydrate content was estimated. The amount of lactose 
bound per mole BfHG-1 was calculated according to Scatchard analysis. 
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Figure 16. UV-VIS spectroscopy of BfHG-1: The UV spectrum of BfHG-1 (100 
^g/ml in PBS 'B ' containing p-ME) and that of oxidized BfHG-1 (100 ^g/ml in PBS 
'B' containing 5 mM H2O2 in the absence of P-ME) were measured in the wavelength 
region of 220-320nm. 
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Fluorescence spectroscopy 
When excited at 280 nm, BfHG-1 exhibited maximum fluorescence emission 
at 332 nm (Fig. 17), typical of Trp residue in a hydrophobic environment. The 
fluorescence profile of the oxidized BfHG-1 showed remarkable quenching in the 
fluorescence intensity accompanied with a blue shift from 320 to 342 nm for oxidized 
BfHG-1. Oxidized BfHG-1 also exhibited a decreased activity, thus implicating intra-
molecular disulphide bonding as the basis of active conformation of BfHG-1 
(Whitney et al., 1986). However, the presence of lactose prevented the oxidation of 
Trp which is supported by a slight decrease in the fluorescence of protein-
carbohydrate complex. These findings stress upon the significance of reducing 
environment which is probably needed to reduce molecular oxygen normally present 
in the solutions to prevent it from oxidizing Trp residues. It also indicates that the 
fluorophore is present within or in the vicinity of lactose binding site and may be 
readily accessible to lactose (Levi and Teichberg, 1981). 
The involvement of Trp68 aromatic ring (a highly conserved amino acid) in 
interaction with hydrophobic part of the side chain of the conserved Lys63 assures its 
optimal orientation for interaction with lactose residues (Shahwan et al., 2004). 
Although, there is no direct evidence that Trp is crucial for hemagglutination activity 
of heart lectins, it may have some possible role in the maintenance of the 
carbohydrate binding site of the lectin molecules as several research groups, based on 
X ray studies on bovine spleen galectin have shown that Trp 68, a highly conserved 
amino acid in P-galactoside binding lectins form stacking interaction with galactose 
moiety (Vasta et al., 2004). 
The fluorescence emission spectra of BfHG-1 were also recorded after 
treatment with urea, pHMB and SDS. The resuUing decrease in the fluorescence 
intensity indicates that the Trp residue in the native BflG-1 is located near an intra-
molecular quenching group and BfHG-1 denaturation increases this interaction. The 
effect of oxidant was also monitored by CD and FTIR analysis. A shift in far UV-CD 
(Fig. 18), near UV-CD (Fig. 19) and FTIR (Fig. 21) spectra showed a major transition 
of native secondary structure of BfHG-1 from P-pleated form to a more open and 
enriched a-helix conformation, thus clarifying the reason for the loss of activity upon 
oxidation (Kadoya et al., 2005). 
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Figure 17. Fluorescence spectra of BfHG-1: Fluorescence spectrum of BfHG-1 (100 
Hg/ml) was measured in the range of 300-400 nm. Changes in the fluorescence spectra 
in the presence of 5 mM H2O2, 0.1 M lactose, 8 M urea and 5 M SDS solutions were 
also recorded. Appropriate controls containing the substances used for treatment were 
also taken. 
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CD and FTIR spectroscopy 
The far UV-CD spectra of BfHG-1 showed a low intensity spectrum with 
minimum at 218 nm (Fig. 18), consistent with a predominantly P-sheet structure 
profile as reported for other Gal-1 (Shahwan et al., 2004). The near UV-CD spectra of 
BfHG-1 (Fig. 19) were also recorded. The FTIR spectra also correlates with CD 
analysis, consistent with the presence of a large percentage of p-sheet structure in the 
native galectin as suggested by maximum absorbance peak at 1630 cm" for BfHG-1 
(Fig. 20). The FTIR spectrum of native BfHG-1 was found to be truncated between 
1652 and 1576 cm'\ The presence of lactose did not resuh in any significant change 
in secondary structure of BfHG-1. However, treatment of BfHG-1 to H2O2, urea, 
pHMB and SDS caused very marked changes in far UV-CD (Fig. 19), near UV-CD 
(Fig. 20) and FTIR spectra (Fig. 21), concomitant with the loss of P-sheet structure. 
The spectral change is consistent with the disruption of regular secondary structures 
(25-50% a-helix and 35-60% p-sheet) to random coil structures. It is possible that the 
formation of disulfide bonds locks the purified lectin into a new inactive 
conformation, that neither can form the usual secondary structure nor can bind 
saccharides (Clerch et ai., 1988; Horie and Kadoya, 2004). This strongly emphasizes 
the requirement of the regular secondary structure for maintaining the active 
conformation of BfHG-1. 
Bioinformatics studies 
The predictions of bioinformatics studies were strongly in agreement with the 
results obtained in wet lab. BLAST-P and CLUSTALW established BfHG-1 amino 
acid sequence similarity with other Gal-1. The predictions for trypsin and high 
specificity chymotrypsin digestion of BfHG-1 using the peptide cutter program of 
ExPASy tools were in accordance with the result obtained for reverse phase HPLC 
(Table 5). ExPASy tools predicted average mass as well as monoisotopic mass of the 
purified lectin as 14.5 kDa, thus corroborating our findings. Secondary structure 
predictions of BfHG-1 using 3D-JIGSAW Comparative Modelling Server of ExPASy 
tools were in accordance with known secondary structures of other Gal-1 (Fig. 21). 
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Figure 18. Far UV-CD spectra of BfHG-1: CD measurements were taken in the far 
UV region (200-250 nm) using BfHG-1 concentration of 250 ng/ml. Original 
spectrum of BfHG-1 was recorded with a scan speed of 100 nm/min with a response 
time of 1 sec. Changes in the CD spectra in the presence of 5 mM H2O2, 0.1 M 
lactose, 8 M urea and 5 M SDS solutions were also recorded. Appropriate controls 
containing the substances used for treatment were also taken. 
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Figure 19. Near UV-CD spectra of BfHG-1: CD measurements were taken in the 
near UV region (250-350 nm) using BfHG-1 concentration of 1 mg/ml. Original 
spectrum of BfHG-1 was recorded with a scan speed of 100 nm/min with a response 
time of 1 sec. Changes in the CD spectra in the presence of 5 mM H2O2, 0.1 M 
lactose, 8 M urea and 5 M SDS solutions were also recorded. Appropriate controls 
containing the substances used for treatment were also taken. 
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Figure 20. FTIR spectra of BfHG-1: Original spectrum of BfHG-1 (150 ng/ml) was 
recorded at 37°C with a resolution of 4 cm'^  and 128 scans. Changes in the FTIR 
spectra in the presence of 5 mM H2O2, 0.1 M lactose, 8 M urea and 5 M SDS 
solutions were also recorded. Appropriate controls containing the substances used for 
treatment were also taken. 
Table 5. Prediction of chymotryptic and tryptic digestion of BfHG-1 using the peptide 
cutter program of ExPASy tools. 
Name of enzyme 
Chvmotrvpsin-high specificity 
CC-term to TFYWl. not before P) 
Trypsin 
No. of 
cleavages 
10 
11 
Positions of cleavage sites 
30 45 49 68 79 91 106 119 126 133 
20 28 36 48 63 73 99 107 HI 127 
129 
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REMAR?C ACCI: Relative solvent accessibility for each residue of the template; 
from low to high -^,1,2,3,4,5,6,7,8,9,? 
REMARK SS_QP: Predicted secondary structure of query (PSIPRED; Jones 
D.T.(1999)J.Mol.Biol. 92,195-202) 
REMARK SS_TP: Predicted secondary structure of template 
REMARK SS: Known secondary structure of template 
REMARK SCORE: Accuracy of query to template sequence alignment (95 percent of 
alignments over 2 are accurate) 
REMARK EVALUE: Parent confidence (expected number of random sequence? with the 
same similarity in our database) 
REMARK BfHG-1 ACGLVASNLNLKPGECLKVRGEVAPDAKSFLLNLGKDDNNLCLHFNPRFNAHGDINTIYCNSKDGGA 
REMARK lslc_D ACGLVASNLNLKPGECLRVRGEVAADAXSFLLNLGKDDNHLCLHFNPRFNAHGDVIMTIVCNSKDAGA 
REMARK ACCI 786553782515594 1*314*4128724212111 *53642**n^ini72S#265in ni2e755 
REMARK SS_QP CCCCEEECCCCCCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEEEECCCCCCCEEEEEEEECCC 
REMARK SS_TP CCCEEEECCCCCCCCEEEEEEEECCCCCEEEEEECCCCCCEEEEECCCCCCCCCCCEEEEEEEECCE 
REMARK SS CCCCEEEEEEECCCCEEEEEEEECCCCCCEEEEEEEECCEEEEEEEEEEEECCEEEEEEEEEEECCE 
REMARK BfHG-1 WGAEQREVAFPFQPGSVVEVCISraQADLTVKLPDGHEFKFPNRLMLEAINYMSAGGDFKIKCVAFD 
REMAJ<K lslc_D WGAEQRESAFPFQPGSVVEVCISFNQTDLTIKLPDGYEFKFPMRLNLEAIMYLSAGGE'FKIKCVAFE 
REMARK ACCI 5575352842416544413111214373*2*4169#4415*41426173142111163143653356 
REMARK SS_QP CCCCEEECCCCCCCCCCEEEEEEECCCEEEEEECCEEEEEEECCCCHHHEEEEEEECCEEEEEEEEC 
REMARK SS_TP ECCEEEECCCCCCCCCCEEEEEEECCCEEEEEECCCEEEEECCCCCHHHEEEEEEECCEEEEEEEEC 
REMARK SS ECCCEEECCCCCCCCCEEEEEEEECCCEEEEECCCCCEEEEECCCCCCCEEEEEEEECEEEEEEEEC 
REMARK BfHG-1 92.54 
REMARK SS ID 91.79 N(134) EE(66) HH(3) CC(54) EH(0) EC(ll) HCCO) 
Figure 21. Secondary structure prediction of BfHG-1 using 3D-JIGSAW 
Comparative Modelling Server program of ExPASy tools. 
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Deglycosylation studies 
METHODS 
Carbohydrate content determination 
The carbohydrate content of BfHG-1 was determined using the phenol 
sulphuric acid method (Dubois et al., 1956). Standard glucose solution (20 mg%) 
ranging from 50-500 \i\ was pipetted in different test tubes and the volume was made 
up to 1000 \i\ by adding distilled water. This was followed by the addition of 1 ml of 
5% phenol in all the test tubes. Five milliliter concentrated H2SO4 was then added and 
the tubes were vortexed instantly, kept at room temperature for 10 min and kept 
further at 30°C for 20 min. Finally, the absorbance of the characteristic yellow orange 
color was measured at 490 nm. 
Deglycosylation of BfHGM 
Deglycosylation of BfHG-1 was carried out according to the method of 
Rasheedi et al. (2003). BfHG-1 (1 mg/ml) in PBS 'B' was treated with 10 mM sodium 
periodate solution in a molar ratio of 5:1. Reaction mixture was then incubated for 15 
min at room temperature in dark. The oxidation process was stopped by adding 0.5 ml 
ethylene glycol per ml lectin sample. The quenched sample was then dialyzed at room 
temperature overnight against PBS 'B'. The carbohydrate content determination by 
phenol-sulphuric acid method and relative mobility of the native and deglycosylated 
BfHG-1 on SDS-PAGE was monitored to confirm deglycosylation of the galectin. 
Effect of deglycosylation on the properties of BfHG-1 
The effect of deglycosylation on the properties of BfHG-1 was studied in 
terms of 
• Electrophoretic pattern and molecular weight 
• Stokes radius and diffusion coefficient 
• Thermal and pH stability 
• Reaction pattern of thiol blocking reagents, denaturants and detergents 
• UV-VIS, fluorescence, CD and FTIR spectroscopy 
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RESULTS AND DISCUSSION 
Determination of carbohydrate content in BfHG-1 
Although galectins are often reported to be present on cell surfaces or in 
extracellular matrix, they lack recognizable secretion signal sequences and do not pass 
through the standard endoplasmic reticulum/Golgi bodies' pathway. Whereby, most 
of the isolated galectins have characteristics typical of cytoplasmic proteins, such as 
having an acetylated N-terminus, free sulfhydryl groups, and lack of glycosylation 
(Hughes, 1999). Thus, galectins are usually non-glycosylated proteins. Interestingly, 
carbohydrate analysis has revealed the presence of 3.55% sugar moiety of the total 
mass of BfHG-1, suggesting it to be the first glycosylated galectin to have been 
purified from mammalian heart tissues. 
The addition of large glycan structures to the protein backbone can 
dramatically alter the structure, and consequently the function of the polypeptide 
architecture to which they are attached. Linked glycans can affect protein structure in 
two capacities (Sinha and Surolia, 2007): 
1. The addition of carbohydrate to the partially folded nascent polypeptide 
can have an impact and/or facilitate the protein-folding process. 
2. The carbohydrates can stabilize the mature protein. 
Deglycosylation of BfHG-1 
The elution of profiles of native and deglycosylated BfHG-1 on Sephadex G50 
is shown in Fig. 22. In order to investigate the role of carbohydrate residues on 
soluble BfHG-1, we removed the sugar residues using periodate oxidation method. 
This method completely removed the sugar moieties; as confirmed by Dubois 
analysis, the difference in mobility of the native and deglycosylated BfHG-1 on SDS-
PAGE and varying elution profiles on Sephadex Gioo gel fihration column (Fig. 23), 
The unique and startling revelation of BfHG-1 being glycosylated in nature 
prompted us to fiirther investigate the role of glycosylation on the structure and 
ftmctions of BfHG-1 by a cooperative analysis of its activity and structural stability in 
both native and deglycosylated forms over a wide range of temperature and pH, and 
in the presence of oxidizing agent, thiol blocking reagents, denaturants and detergents. 
For convenience, we designated the deglycosylated buffalo heart galectin as dBfHG-1. 
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Figure 22. Elution profile and SDS-PAGE of native and deglycosylated BfHG-1: 
On Sephadex G50 gel filtration column, dB(HG-l eluted later than the native 
glycosylated B(HG-1. The relative mobilities (Rm) were plotted against their 
molecular weight using least square analysis of the data. The molecular weight 
markers used were: Phosphorylase b (97.4 kDa), Bovine Serum Albumin (68 kDa), 
Ovalbumin (45 kDa), Carbonic Anhydrase (29 kDa), Soyabean Trypsin Inhibitor 
(20.1 kDa), Lysozyme (14.4 kDa). Inset shows the electrophoretic pattern of native 
and deglycosylated BfHG-1: Lane 'a ' contains molecular weight markers (35 ng) in 
descending order of their molecular weight, lane 'b ' contains 35ng of purified native 
protein and lane 'c ' contains 35 ng of deglycosylated protein. Gel was stained using 
coommassie brilliant blue R 250 dye. 
71 
Deglycosylation studies 
Reladvj mobilily (Rm) 
Figure 23. Molecular weight determination: Sephadex Gioo gel filtration column 
used for molecular weight determination. The elution position of dimer, monomer and 
deglycosylated BfHG-1 are indicated by arrows A, B and C respectively. 
72 
Deglycosylation studies 
Effect of deglycosylation on the electrophoretic pattern of BfHG-1 
Deglycosylated BfHG-1 eluted later than the native glycosylated BfHG-1, 
which corresponded to its enhanced mobility on SDS-PAGE (Fig. 22). On Sephadex 
Gioo gel filtration column, the dBfHG-1 eluted as a monomer of 14 kDa under 
reducing conditions while as a dimer of 28 kDa under non-reducing conditions. The 
reduced molecular weight of dB{HG-I compared to the native BfHG-1 (14.5 kDa 
under reducing conditions and 29 kDa under non-reducing conditions) can thus be 
attributed to the effect of deglycosylation. These findings showed that deglycosylation 
does not disturb dimerization of the galectin, suggesting that the sugar moieties 
removed in deglycosylation do not play any role in BfHG-1 dimerization. 
Effect of deglycosylation on Stokes radius and diffusion coefficient of BfHG-1 
Deglycosylation resuhed in the decrease in Stokes radii and a corresponding 
increase in diffusion coefficients of the native and deglycosylated BfHG-1. As a result 
of deglycosylation, Stokes radius of the monomeric form of BfHG-1 decreased from 
17.8 A to 17.5 A and that of the dimeric form of BfHG-1 decreased from 26.3 A to 26 
A. Correspondingly, diffusion coefficient of the monomeric form of BfHG-1 increased 
from 12.5 x 10'^ ^ to 12.7 x 10"'^  cm^/s and that of the dimeric form of BfHG-1 
increased fi-om 8.47 x 10"*^  cm^/s to 8.57 x 10"'^  cmVs. 
Effect of deglycosylation on thermal stability of BfHG-1 
The thermal stability of BfHG-1 (100% activity up to 48°C) was found to be 
higher than dBfHG-1 (100% activity up to 44°C) as depicted in Fig. 24. Thus, the 
presence of carbohydrate residues in the galectin backbone clearly indicates its role in 
thermal mehing of proteins (Arnold and Hoffman, 1997). These results have been 
found to be consistent with previous findings (Koster and Robertson, 1997). 
Effect of deglycosylation on pH stability of BfHG-1 
The pH stability range of dBfHG-1 (pH 5.5-9.5) was found to be lesser than 
the pH stability range of BfHG-1 (pH 4.5-10.5) as depicted in Fig. 25. Both native and 
deglycosylated forms exhibited maximum activity at pH 7.4. However, a decreased 
activity profile was observed for dBfHG-1. Hence, the presence of carbohydrate 
moiety protected the purified galectin from extreme pH conditions (Rasheedi et al., 
2003). 
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Figure 24. Effect of deglycosylation on the thermal stability of BfHG-1. 
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Figure 25. Effect of deglycosylation on pH stability of BfHG-1. 
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Effect of deglycosylation on the reaction pattern of BfHG-1 with thiol blocking 
agents, denaturants and detergents 
Deglycosylation did not lead to in any changes in the preferential action of 
thiol blocking reagents, denaturants and detergents on the inhibition of BfHG-1 
activity. 
Among the thiol blocking reagents, the more hydrophobic pHMB most readily 
abolished the hemagglutination activity of BfHG-1 (Fig. 26) followed by lesser 
hydrophobic NEM and iodoacetamide. 
As for denaturants, urea most readily inhibited the hemagglutination activity 
of BfHG-1 (Fig. 27) followed by GdnHCl and iodoacetamide. 
Among the detergents, SDS most readily inhibited the hemagglutination 
activity of BfHG-1 (Fig. 28) followed by Tween 20 and Triton X-100. 
The deglycosylated form, however, exhibited reduced activity profile 
compared to the native galectin that are consistent with earlier reports reflecting the 
prominent role of glycosylation in imparting resistance to denaturant mediated 
inactivation of lectins (Rasheedi et al., 2003; Fatima and Hussain, 2007). 
Effect of deglycosylation on UV spectra 
The UV spectra of native and deglycosylated BfHG-1 showed absorbance 
maxima at 280 nm, while slightly higher absorbance was observed for the dBfHG-1 
(Fig. 29). Oxidation of BfHG-1 in the presence of 5mM H2O2 (without P-ME) resulted 
in the shift of absorption peak to 250nm due to oxidation of Trp residue to oxindole 
moiety (Levi and Teichberg, 1981). 
Although dBfHG-1 exhibited a reduced activity profile both before and after 
oxidation, the effect of H2O2 as oxidant was much more pronounced on dBfHG-1. 
These findings suggest that glycosylation protect the lectins from oxidant mediated 
inactivation. 
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Figure 26. Effect of deglycosylation on reaction pattern of BfHG-l with thiol 
blocking agents. 
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Figure 27. Effect of deglycosylation on reaction pattern of BfHG-1 with denaturants. 
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Figure 29. Effect of deglycosylation on UV-VIS spectra of BfHG-1. 
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Effect of deglycosylation on fluorescence spectra 
Both B^G-1 and dBfHG-1 showed fluorescence emission maximum around 
332 nm when excited at 280 nm; dBfHG-1 exhibited higher fluorescence intensity 
compared to B^G-1 (Fig. 30). This is probably because of the removal of 
carbohydrate residues facilitating enhanced exposure of the fluorophore. This 
observation holds true with earlier reported studies relating to fluorescent behavior of 
glycosylated and non-glycosylated proteins (Fatima and Hussain, 2007). When treated 
with increasing concentrations of urea, pHMB and SDS, dBfHG-1 exhibited higher 
fluorescence intensity and a greater red shift compared to BfHG-1. These findings 
suggest that carbohydrate moieties causing steric hindrances play a significant role in 
shielding the Trp residues of native lectin from more polar microenvironment (Fatima 
and Hussain, 2007). This emphasizes on the importance of the glycan residues 
attached to the native protein which stabilize its structure and protect the unfolding of 
the protein. Glycosylation has been reported to increase the stability of a number of 
molecules against different denaturating agents (Rasheedi et al., 2003; Sinha and 
Surolia, 2007), and increased resistance against protease degradation (Berkel et al., 
1995). Thus, there may be overall change in the structure of both the native as well as 
deglycosylated forms and the reorientation of Trp residues in the presence of different 
denaturants which was more obvious in the deglycosylated form. Based on these 
studies, it can be predicted that glycosylation influences the conformational dynamics 
of nascent polypeptides and confers their biological activity. 
Effect of deglycosylation on UV-CD spectra 
The far UV-CD (Fig. 31) and the near UV-CD (Fig. 32) maxima of BfHG-1 
and dBfHG-1 showed no change. However, dBfHG-1 exhibited decreased circular 
dichroism than BflG-1. When treated with urea, pHMB and SDS, dBfHG-1 exhibited 
decreased circular dichroism than dBfHG-1. 
Effect of deglycosylation on FTIR spectra 
Both BfHG-1 and dBfHG-1 exhibited the FTIR spectra maximum around 1630 
cm'\ but dBfHG-1 exhibited lesser optical density than BfHG-1 (Fig. 33). Upon 
treatment with urea, pHMB and SDS, dBfHG-1 exhibited decrement in absorbance 
than BfHG-1, thus stressing the role of carbohydrate residues in preventing the lectins 
from inactivation caused by denaturing agents. 
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Immunological, oxidative burst and degranulation studies 
METHODS 
Immunization of rabbits with BrHG-1 
Antibodies against BfHG-1 were raised in healthy adult male albino rabbits. 
Serum collected prior to immunization served as control. Primary immunization was 
done by administering BfHG-1 (300 |ag) emulsified in equal volume of Freund's 
complete adjuvant through subcutaneous injection at several sites on the back of 
rabbit. After two weeks, secondary immunization (booster dose) was done by 
administering BfHG-1 (150 i^g) in Freund's incomplete adjuvant. A similar second 
and third booster dose was given after third and fourth week, respectively. The blood 
sample was collected after five weeks and allowed to coagulate for 3 h at 20°C. The 
antiserum was then de-complemented for 30 min at 37°C, collected in small aliquots 
and kept frozen at -20°C till further use. 
Double immunodiffusion 
Double immunodiffusion was performed according to the method of 
Ouchterlony (1962). One percent molten agarose was prepared in normal saline 
containing 0.1% sodium azide and allowed to solidify at room temperature. Lactose 
solution (30 mM) was then poured on the petri plate to prevent interaction of the 
BfHG-1 with agarose or serum glycoproteins. Required numbers of wells were cut 
from agarose, antiserum (40 ^1) was applied to the central well and antigen (BfHG-1) 
was added in the peripheral wells. The petri-plate was incubated for 4 h at 37°C and 
then at 4°C overnight in order to get a clear precipitin band. The petri plate was then 
photographed under proper illumination (Fotodyne, New Berlin, USA). 
Direct binding ELISA 
Direct binding ELISA was performed by the method of Aotsuka et al. (1979). 
Polystyrene microtitre plate (96 wells) was coated with 100 nl BfHG-1 (250 ^g/ml) in 
TBS (10 mM Tris, 150 mM NaCl, pH 7.4), incubated for 2 h and then stored 
overnight at 4°C. The antigen coated wells were washed three times with TBS-T (20 
mM Tris, 144 mM NaCl, 2.68 mM KCl, pH 7.4 with 500 |il Tween-20) to remove 
unbound antigen. Unoccupied sites were blocked with 150 |xl of 1.5% BSA in TBS at 
room temperature for 3 h. The serially diluted antiserum (100 i^l) was then added to 
each well and plates were incubated at room temperature for 2 h. 
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The bound antibodies were assayed by an appropriate anti-rabbit IgG labeled 
with horse radish peroxidase using hydrogen peroxide and tetramethylbenzidine as 
substrate. The plates were then incubated for 1 h, the absorbance (A) was read at 450 
nm and the results were expressed as a mean of (Atest-Acontroi). 
Competition ELISA 
The antigenic specificity of anti-BfHG-1 antibodies was determined by 
competition inhibition experiments (Hasan et al, 1991). Varying amounts (0-20 
)ag/ml) of BfHG-1 and GHG-1 (goat heart galectin-1) were mixed with a fixed amount 
of anti-BjHG-1 antibodies (1:100 dilution), incubated at room temperature for 2 h and 
left overnight at 4°C. The immune complex thus formed was coated in the microtitre 
wells. The remaining steps were same as that of direct binding ELISA. 
The results obtained were expressed as percent inhibition. 
Percent inhibition = 1-A (inhibited) x 100 
A (uninhibited) 
where, A (inhibited) = absorbance at 450 nm in the presence of inhibitors. 
A (uninhibited) = absorbance at 450 nm in the absence of inhibitors. 
Dot blot analysis 
The specificity and immunological cross reactivity of anti-BfHG-1 antiserum 
with tissue homogenates of heart, liver, brain and lung was demonstrated by standard 
dot blot assay. BfHG-1 (2 ^1) was spotted on nitrocellulose paper and the blots were 
blocked by overnight incubation with 5% BSA solution. The nitrocellulose membrane 
was then exposed to anti-BfHG-1 antiserum (1:50 dilution) followed by treatment 
with peroxidase coated anti-rabbit antibodies (1:1000 dilution) at 37°C for 2 h in a 
moist chamber. At every step, nitrocellulose membrane was washed with 0.05% 
Tween-PBS to remove excess reagents and the blots were developed with a mixture 
of 0.1% H2O2 containing diaminobenzidine (1 mg/ml). 
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Isolation of polymorphonuclear neutrophils (PMNs) from buffalo blood 
Fresh heparinized buffalo blood (300 ml) diluted 1:2 in saline was layered on 
the top of Histopaque-1077 and centrifuged at 2000 rpm for 5 min. PMNs were 
collected from the layer above the erythrocyte pellet and separated in a dextran 
gradient (6% w/v) in saline (Boyum, 1976). Supernatant rich in PMNs was then 
submitted to a hypotonic shock in distilled water for 45 s to induce erythrocyte lyses, 
and immediately suspended in Hanks' balanced salt solution (HBSS). These cells 
were more than 95% viable (ascertained by Trypan blue exclusion) and contained 
more than 95% neutrophils, as judged by morphology (Giemsa staining). 
Effect of BfHG-1 on the oxidative burst of buffalo PMNs 
Oxidative burst refers to the production of superoxide radicals (O "^) by the 
enzyme NADPH-oxidase. In the present study, superoxide forming activity was 
monitored using cytochrome C assay (Mayo and Curnutte, 1990). The effects of the 
well known PMN activators, N-formyl-L-methionyl-L-leucyl-L-phenylalanine 
(fMLP) and phorbol-12-myristate-13-acetate (PMA) on superoxide production were 
evaluated at concentrations ranging from 0.01 ^M to 100 \M. At similar 
concentration range, BfHG-1 was then tested as probable stimulus for O "^ formation 
by buffalo neutrophils. Dimethyl sulfoxide (DMSO) was used as solvent for 
Cytochalasin B (CB), fMLP and PMA. 
The reactions were performed at 37°C in UV-1700 Pharmaspec UV-VIS 
double beam spectrophotometer (Shimadzu Corp., Kyoto, Japan). The final volume of 
each reaction mixture was 1 ml, containing a final concentration of 2.9x10 PMNs/ml. 
For each stimulant to be tested, two cuvettes were employed, the experimental and the 
reference one, both containing cytochrome C from horse heart at a final concentration 
of 80 \iM. CB was then employed in a final concentration of 6 |ig/ml, and the 
mixtures were incubated for 5 min before adding 25 nl BiHG-I and/or PMN 
activators in multiple combinations. Each reference cuvette contained 60 \x$/m\ of the 
enzyme superoxide dismutase (SOD). In this method, cytochrome C reduction by 
agents other than superoxide was subtracted by measurement of the sample against a 
reference of identical composition, except for the addition of SOD (Curnutte et al., 
1975). The values were expressed as the rate of nanomoles O^7min/10^ PMNs at 550 
nm, using an extinction coefficient of 29.5 mM" cm" . 
83 
Immunological, oxidative burst and degranulation studies 
The effects of neutrophil activators on the superoxide forming capability of 
the buffalo neutrophils pre-treated with HBSS (control) and BfHG-1 (100 |iM) were 
also monitored. The pre-treatments were performed at 37°C for 30 min, followed by 
treatment with PMA and fMLP at concentration range of 0.01-100 i^M. Superoxide 
production was then evaluated and values were expressed as the rate of nanomoles O '^ 
/min/lO'^PMNs. 
We then carried out thermal inhibition of superoxide production to check 
whether BfHG-1 induced superoxide release from buffalo neutrophils involve the 
activation of cytosolic NADPH-oxidase. The inhibition experiments were performed 
by blocking the binding of BfHG-1 (100 nM) with lactose (100 mM) at room 
temperature for 30 min. For the inhibition of NADPH-oxidase activity, PMNs were 
heated for 0, 2, 4, 6, 8 and 10 min at 46°C followed by treatment with or without 
PMA (200 ng/ml) (Erickson et al., 1992). 
Effect of BfHG-l on the degranulation of buffalo PMNs 
Degranulation refers to the release of lysozyme, which in the present study 
was evaluated by the rate of lysis of Escherichia coli. The effects of the well known 
PMN activators on neutrophil degranulation were evaluated at concentrations ranging 
from 0.01 ^M to 100 JAM. At similar concentration range, BfHG-1 was then tested as 
probable stimulus for lysozyme release by buffalo neutrophils. Buffalo PMN 
suspension (100 jil) containing 8.0x10' cells/ml was pre-incubated with 25 ^1 of CB 
(6 |.ig/ml) at 37°C for 5 min, followed by addition of 25 ^1 BfHG-1 and/or neutrophil 
activators in multiple combinations. Mixtures were then incubated at 37°C for 20 min 
and reactions were stopped by cooling and centrifuging. Supernatant collected was 
frozen at -20°C and assayed for enzyme activity. One milliliter of £. coli suspension 
(A450nm = 0.5) was incubated with 50 ^1 supernatant at 25°C. The decrease in 
absorbance was determined with time at 450 nm. The enzyme release was expressed 
as the percentage of total enzyme activity. 
The effects of neutrophil activators on lysozyme releasing ability of the 
buffalo neutrophils pre-treated with HBSS (control) and BfHG-1 (100 ^M) were also 
monitored. The pre-treatments were performed at 37°C for 30 min, followed by 
treatment with PMA and fMLP at concentration range of O.OI-IOO ^M. Lysozyme 
release was then evaluated and values were expressed as lysozyme percent. 
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RESULTS AND DISCUSSION 
Ouchterlony double immunodiffusion 
In view of the possible role of heart lectins, it was of interest to see whether 
the purified buffalo heart lectin is phylogenetically/structurally related to other heart 
lectins or are distinct proteins sharing only a similar saccharide binding specificity. 
Double immunodiffusion revealed high immunogenicity of BfHG-1 in rabbits as 
they readily gave a single line of identity indicating homogeneity of the protein 
preparation (Fig. 34). Immunodiffusion studies also revealed that anti-BfHG-1 
antibodies were quite specific for BjHG-l. 
Direct binding ELISA 
Direct binding ELISA was performed to characterize the immune response in 
rabbits using BfHG-1 as antigens (Fig. 35). The antiserum showed high titre value 
(>128000), suggesting high immunogenic nature of BfHG-1. Pre-immunized serum 
served as negative control and did not show any appreciable binding to BfHG-1. 
Competition ELISA 
The specificity of the induced anti-BfHG-1 antibodies and sharing of 
common antigenic determinants between the BfHG-1 and GHG-1 (goat heart 
gaIectin-1) was further ascertained by competition ELISA, using BfHG-1 and GHG-
1 as competitors (Fig. 36). The induced antibodies showed higher specificity for 
BfHG-1 (the immunogen) than GHG-1. BfHG-1 (20 ng/ml) inhibited the anti-BfHG-
1 antibodies binding to solid phase bound antigen by 86%, while GHG-1 (20 |Ag/ml) 
inhibited the anti-BfHG-1 antibodies binding by 81%. The antibodies were quite 
specific for the immunogen (BfHG-1), since only 5 [ig/ml of BfHG-1 was required 
for achieving 50% inhibition (Table 6). Anti-BfHG-1 antibodies displayed full cross-
reactivity with GHG-1, with a concentration of 7 |ag/ml required to achieve 50% 
inhibition and the relative affinity for GHG-1 was found to be 94 %. 
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Figure 34. Ouchteriony double immnnodiflusion. 
Well 'a' contains rabbit antiserum raised against 
BflG-l, well 'b, c and d' contains BfHG-1 
(250ng/ml). 
Table 6. Relative binding affinity of anti- B,HG-1 antibodies to B<HG-1 and GHG-1 
Inhibitor 
BfHG-l 
GHG-1 
Cone, for 50% 
inhibition (i^ml) 
5 
7 
Maximum percent 
inhibition at 20 |ig/ml 
86 
81 
Percent relative 
affinity 
100 
94 
86 
o 
in 
o 
0 . 5 -
0 . 4 -
0 . 3 -
0 . 2 -
0.1 -
BjHG-l immunized 
BHG-I preimmunized 
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-Log semm dilution 
Figure 35. Direct binding ELISA of anti-BfHG-1 antibodies: Polystyrene 
microtitre plate was coated with 100 [i\ BtHG-1 (250 ng/ml) in TBS, incubated for 2 h 
and then stored overnight at 4°C. The antigen coated wells were washed with TBS-T 
to remove unbound antigen. Unoccupied sites were blocked with 150 ^1 of 1.5% BSA 
in TBS at room temperature for 3 h. The serially diluted antiserum (100 |il) was then 
added to each well and plates were incubated at room temperature for 2 h. The bound 
antibodies were assayed by an appropriate anti-rabbit IgG labeled with horse radish 
peroxidase using hydrogen peroxide and tetramethylbenzidine as substrate. The plates 
were then incubated for 1 h, the absorbance was read at 450 nm and the resuhs were 
expressed as a mean of (Atest~Acontroi)-
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Figure 36. Competition ELISA of anti-BfHG-1 antibodies by BfHG-1 and GHG-
1: Varying amounts of BfHG-1 and GHG-1 (0-20 |ig/ml) was mixed with a fixed 
amount of anti-BfHG-l antibodies (1:100 dilution), incubated at room temperature for 
2 h and left overnight at 4°C. The immune complex formed was then coated in the 
microtitre wells. The remaining steps were same as that of direct binding ELISA. The 
results obtained were expressed as percent inhibition. 
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Dot blot analysis 
The antiserum was also tested against homogenates of heart, liver, brain and 
lung by dot blot analysis (Fig. 37). It was observed that antibodies reacted strongly 
with all of them, thus establishing immunological cross reactivity of BfHG-1 with 
other lectins that might be present in these tissue homogenates. Antigenic reactivity 
between the BfHG-1 and other heart lectins corroborate with the earlier findings and 
are consistent with the resuhs for phylogenetically related species (Waard et al., 
1976), These observations on the cross reactivity between heart lectins of different 
species suggest a taxonomic relation in the structure and function of these lectins. 
Our results showing antigenic cross-reactivity between lectins from different 
tissues of different species are certainly in line with the idea that all the P-
galactoside binding lectins in animal tissues have a common flmdamental biological 
role that has been preserved during evolution (Levi and Teichberg, 1981; Ola et al., 
2001). 
Effect of BfHG-1 on the oxidative burst of buffalo PMNs 
This study was undertaken to gain some useful insights regarding the 
dependence of lectin induced superoxide formation on the carbohydrate recognizing 
domains (CRD) of lectins and to understand the role of protein-carbohydrate 
interaction in oxidative burst. In relation to control tests, cytochalasin B (CB) and 
DMSO by themselves did not induce any release of superoxide radicals (O^) in 
purified buffalo neutrophils. The effect of fMLP, PMA and BfHG-1 (at concentration 
range of 0.01-100 |aM) on the activation of NADPH-oxidase was evaluated in the 
absence as well as presence of CB. 
The O '^ formation with fMLP analyzed by linear regression indicates a dose-
dependent relation (y=6.9560+2.935Ix; p<0.06) (Fig. 38). The O^ " formation with 
PMA analyzed by linear regression indicates a dose-independent relation 
(y=7.2361+0.1916x; p>0.09) (Fig. 38). At all the concentrations ranging from 0.01 
i^M to 100 ]xM, BfHG-1 induced a significantly higher O^ " formation as compared to 
fMLP and PMA. The O '^ formation with BtHG-1 analyzed by linear regression 
indicates a significant dose-dependent relation (y=3.174+3.5924x; p<0.008) (Fig. 39). 
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Figure 37. Dot blot analysis using anti-BiHG-l antibodies. Tissue homogenates (2 
\ig) from heart, liver, brain and lung were loaded on nitrocellulose membrane, which 
was then treated with anti-BfHG-1 antibodies raised against (1:50 dilution). The labels 
a, b, c, d and e correspond to control (PBS 'B'), heart, liver, brain and lung tissue 
homogenates, respectively. 
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Figure 38. PMA/fMLP induced superoxide production by buffalo neutrophils in 
the absence and presence of CB: For each reaction mixture to be tested, two 
cuvettes were employed- the experimental and the reference one, both containing 
horse cytochrome C (80 ^M). CB (6 \ig/m\) was then added and the mixtures were 
incubated for 5 min followed by the addition of 25 nl fMLP/PMA at concentration 
range of 0.01-100 ^M. Cytochrome C reduction by agents other than superoxide was 
subtracted by measurement of the sample against a reference of identical composition, 
except for the addition of SOD (60 jig/ml). The final volume of each reaction mixture 
was 1 ml containing a fmal concentration of 2.9x1 o' PMNs/ml. The values were 
expressed as the rate of nanomoles O^Vmin/lO^ PMNs at 550 ran. Values shown are 
the mean ± S.E.M obtained from three observations. 
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Figure 39. BfHG-l induced superoxkie production by buffalo neutropiiils in the 
absence and presence of CB: For each reaction mixture to be tested, two cuvettes 
were employed- the experimental and the reference one, both containing horse 
cytochrome C (80 \iM). CB (6 fig/ml) was then added and the mixtures were 
incubated for 5 min, followed by the addition of 25 jil BfHG-l at concentration range 
of 0.01-100 nM. Cytochrome C reduction by ^ents other than superoxide was 
subtracted by measurement of the sample against a reference of identical composition, 
except for the addition of SOD (60 ^g/ml). The final volume of each reaction mixture 
was 1 ml containing a final concentration of 2.9x10^ PMNs/ml. The values were 
expressed as the rate of nanomoles CrVmin/lO PMNs at 550 nm. Values shown are 
the mean ± S.E.M obtained fi"om three observations. 
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In the presence of Cytochalasin B (CB), an enhanced activation of NADPH-
oxidase by fMLP, PMA and BfHG-1 was observed, thus producing a significant 
response of O^ " formation. A gradual increase in the production of superoxide radical 
was observed when the neutrophils were treated with various agents, and the results 
can be summarized as. (B/HG-l + CB + fMLP) < (B,HG-] + CB + PMA) < (BfHG-1 
+ CB + fMLP + PMA) (Fig. 40). Thus, BfHG-1 significantly stimulated superoxide 
production by neutrophils which were further enhanced by the presence of neutrophil 
activators and CB. 
Relevant roles of galectins are described in adaptive immune response, innate 
immunity and modulation of the acute inflammatory response. In relation to these 
functions, our study demonstrated that in mammals, superoxide formation by BfHG-1 
in the presence of CB is dependent, at least partially, on the CRD of BfHG-1. 
Interestingly, although it is not clear how CB acts on neutrophils, a correlation 
between the inhibition of actin polymerization and enhancement of NADPH-oxidase 
activity in stimulated cells has been previously demonstrated by Cohen et al. (1982). 
Moreover, superoxide production through protein-carbohydrate interactions 
had been demonstrated for different vegetable lectins. Twelve lectins were compared 
for their capacity to affect O^ " production in human neutrophils. P-galactoside specific 
lectins from V. album and Con-A proved to be the strongest inducers, followed by 
ricin and wheat germ agglutinin. In these experiments, Gal-1 from human placenta 
and the lactoside specific Erythrina cristagalli agglutinin elicited a considerably 
smaller response (Timoshenko and Gabius, 1993). Two other galactose-specific 
lectins, namely Halocynthia roretzi haemolymp lectin (Yukosawa et al., 1986) and 
type 2 fimbrial lectin of Actinomyces viscosus T14 (Sandberg et al., 1988) were also 
reported to stimulate respiratory burst. 
Therefore, the association of certain cell surface glycoligands with suitable 
lectins may result in precise post-receptor signal pathways that probably depend on 
the fine carbohydrate binding specificity and on some other factors such as number or 
spatial localization of receptors and mobility of lectin-ligand complexes (Timoshenko 
and Gabius, 1993). 
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Figure 40. Superoxide production by bufTaio neutrophils in the presence of 
(BfHG-l^CB+fMLP), (BflG-l+ CB+PMA) and (BflG-l+CB+IMLP+PMA): For 
each reaction mixture to be tested, two cuvettes were employed- the experimental and 
the reference one, both containing horse cytochrome C (80 jiM). CB (6 fig/ml) was 
then added and the mixtures were incubated for 5 min, followed by the addition of 25 
^l BfHG-1/fMLP/PMA at concentration range of 0.01-100 fiM. Cytochrome C 
reduction by agents other than superoxide was subtracted by measurement of the 
sample against a reference of identical composition, except for the addition of SOD 
(60 ng/ml). The final volume of each reaction mixture was 1 ml containing a final 
concentration of 2.9x10^ PMNs/ml. The values were expressed as the rate of 
nanomoles O^7min/10' PMNs at 550 nm. Values shown are the mean ± S.E.M 
obtained from three observations. 
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With reference to superoxide production, our results revealed that the sole 
action of BiHG-l in the same order of concentration as fMLP or PMA resulted in 
higher O '^ production than both the activators The concentrations of BfHG-1 capable 
of superoxide production under our working conditions were found to be 
approximately similar to Gal-3 concentration reported to cause activation of human 
mast cells (Frigeri et al, 1993), human neutrophils (Yamaoka et al, 1995), human 
monocytes (Liu, 1993) and porcine neutrophils (Elola et al, 2005) At any rate, under 
the effect of certain stimuli or as a result of cell injury, an increased secretion of 
cytosolic lectin might occur, producing a transient local high concentration of lectin 
(Yamaoka et al, 1995) Increased secretion of Gal-3 from human monocytes was 
observed after stimulation with calcium ionophore A23187 (Liu, 1993) This is 
consistent with the finding that at concentration of about 100 ng/ml, Gal-3 might 
occur in the broncho-alveolar lavage fluid from mice with induced airway 
inflammation (Liu, 1993), which represents a dose three times lower than the one 
causing maximal activation in the present work A concentration of 10 ^M Gal-1 has 
been reported to be necessary to induce apoptosis of MOLT-4 lymphoblastoid cells, 
which was reversed by the addition of lactose up to 10 min after lectin exposure 
(Perillo et al, 1995) However, it remains to be determined whether the 
concentrations of BfHG-1 employed to cause neutrophil activation in this work could 
also trigger neutrophil apoptosis 
The neutrophil activators exerted significant differences on the superoxide 
forming capability of the buffalo neutrophils pre-treated with HBSS (control) and 
BiHG-1 (Tables 7, 8) At all the concentrations, PMNs treated with BfHG-1 induced 
maximum superoxide formation, thus corroborating the results obtained without pre-
treatment 
Inhibition of superoxide formation 
The thermal inhibition of superoxide production was performed in an attempt 
to check the role of cytosolic NADPH-oxidase in Gal-1 induced superoxide release 
from buffalo neutrophils Complete inhibition of NADPH-oxidase induced superoxide 
formation was observed after 10 min, which was partially overcome by the addition of 
3 ^M BiHG-1 (Fig. 41). 
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Table 7. Effect of PMA stimulus on superoxide production by NADPH-oxidase in 
PMNs pre-incubated with HBSS and BfHG-1 
PMA 
concentration 
(HM) 
0.01 
0.1 
1.0 
10 
100 
Superoxide production by 
PMNs pre-incubated 
with HBSS 
11,57±2.34 
12.78±2.09 
11.79±1.68 
12.46±1.98 
9.53±1.74 
PMNs pre-incubated 
with BfHG-1 
28.47±2.82 
33.09±3.01 
32.86±2.85 
35.71±3.21 
37.22±3.19 
Table 8. Effect of fMLP stimulus on superoxide production by NADPH-oxidase in 
PMNs pre-incubated with HBSS and B,HG-1 
fMLP 
concentration 
0.01 
0.1 
1.0 
10 
100 
Superoxide production by 
PMNs pre-incubated 
with HBSS 
11.67±2.01 
12.59±1.88 
12,33±1.83 
13.3±2.14 
13.98±1.90 
PMNs pre-incubated 
with BfHG-1 
29.51±2.73 
34.23±2.93 
33.60±2.07 
37.32±2.77 
38.27±3.16 
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Figure 41. Inhibition of superoxide production: The inhibition experiments were 
performed by blocking the binding of B^G-1 (100 fiM) widi lactose (100 mM) at 
room temperature for 30 min. For die inhibition of NADPH-oxidase activity, PMNs 
were heated for 0,2,4, 6, 8 and 10 min at 46°C followed by treatment with or without 
PMA (200 ng/ml). Values shown are the mean ± S.E.M obtained from three 
observations. 
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Erickson et al. (1992) had previously demonstrated that mild heating 
inactivated the respiratory burst oxidase from human neutrophil through a mechanism 
involving the specific thermolability of p67phox cytosoHc component. Specific 
thermolability of p67phox was directly demonstrated by the heat treatment of purified 
recombinant cytosolic factor (p47phox and p67phox), and also supported by the 
experiments in which each recombinant cytosoHc factor was used to reconstitute the 
activity of heat treated normal cytosol. In our experiments with the intact buffalo 
neutrophils, NADPH-oxidase thermolability was maximal after a controlled heat 
treatment of 10 min, while 8 min were enough to almost completely block the 
capacity of O '^ production by buffalo neutrophils. Treatment of heat inactivated 
buffalo neutrophils with BfHG-1 (up to 100 |iM) was unable to induce significant O'^ " 
production, which confirms that Gal-1 induced superoxide release from buffalo 
neutrophils involves the activation of cytosolic NADPH-oxidase (Erickson et al, 
1992). 
Effect of BfHG-1 on the degranulation of buffalo PMNs 
Amid reported role of Gal-1 in exerting pro- or anti-inflammatory effects 
(Rubinstein et al., 2004), this study was carried out to understand the role of BfHG-1 
in various inflammatory conditions. CB and DMSO by themselves did not induce any 
lysozyme release from purified buffalo neutrophils. The effect of fMLP and PMA on 
lysozyme release was also evaluated in the presence and absence of CB. Both fMLP 
and PMA induced higher lysozyme release in the presence of CB (Fig. 42). 
Neutrophils were then treated with the BfHG-1 at concentration range of 0.01-10 |iM, 
in the presence of fMLP, PMA and CB to test their effect on lysozyme release. A 
gradual increase in lysozyme release was observed when the neutrophils were treated 
with various agents, and the results can be summarized as: BfHG-1 < (BfHG-l + CB) 
< (B,HG-1 + CB + fMLP) < (BfHG-1 + CB + PMA) < (BfHG-1 + CB + flMLP + 
PMA) (Fig. 43, 44). 
For similar concentration range, lysozyme release followed the same order of 
increment as that exhibited by superoxide production. However, lysozyme release was 
found to be approximately three times higher than superoxide production. This can be 
attributed to contrasting differences emerging at the molecular signal levels, which 
rest to be investigated. 
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Figure 42. PMA/fMLP induced lysozyme release by buffalo neutrophils in the 
absence and presence of CB: Neutrophil suspension (100 fil) was pre-incubated with 
25 ^l of CB (6 ^g/ml) at 37°C for 5 min followed by the addition of 25 fil of 
fMLP/PMA at concentration range of 0.01-100 \iM. Mixtures were then incubated at 
37°C for 20 min and the reactions were stopped by cooling and centrifiiging. 
Supematants collected were frozen at -20°C and assayed for lysozyme activity. One 
milliliter of £. coli suspension (A450nni = 0.5) was incubated witii 50 jil of supernatant 
individually at 25°C. The decrease in absoibance was determined with time at 450 
nm. The enzyme release was expressed as the percentage of total enzyme activity. 
Values shown are the mean ± S.E.M obtained from three observations. 
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Figure 43. BfHG-l induced lysozyme release by buffalo neutrophils in the 
absence and presence of CB: Neutrophil suspension (100 ^1) was pre-incubated with 
25 nl of CB (6 ^g/ml) at 37°C for 5 min followed by the addition of 25 ^l of BfHG-l 
at concentrations ranging from 0.01-100 jiM. Mixtures were then incubated at 37°C 
for 20 min and the reactions were stopped by cooling and centrifiiging. Supematants 
collected were frozen at -20°C and assayed for lysozyme activity. One milliliter of £. 
coli suspension (A450nni = 0.5) was incubated with 50 ^l of supernatant individually at 
25°C. The decrease in absorbance was determined with time at 450 nm. The enzyme 
release was expressed as the percentage of total enzyme activity. Values shown are 
the mean ± S.E.M obtained from three observations. 
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Figure 44. Lysozyme release by bnfTalo neutrophils in the presence of (B|HG-1 + 
CB + fMLP), (BfHG-1 + CB + PMA) and (B(HG-1 + CB + CMLP + PMA): 
Neutrophil suspension (100 ^l) was pre-incubated with 25 \il of CB (6 ^g/ml) at 37°C 
for 5 min foUowed by the addition of 25 \il of qwB,HG-l/£MLP/PMA at 
concentrations ranging from 0.01-100 ^iM. Mixtures were then incubated at 37°C for 
20 min and the reactions were stopped by cooling and centriiliging. Supematants 
collected were frozen at -20°C and assayed for lysozyme activity. One milliliter ofE. 
coli suspension (A4so,m = 0.5) was incubated with 50 fil of supernatant individually at 
25°C. The decrease in absorbance was determined with time at 450 nm. The enzyme 
release was expressed as the percentage of total enzyme activity. Values shown are 
the mean ± S.E.M obtained from three observations. 
100 
Immunological oxidative burst and degranulation studies 
Relative to lysozyme release, degranulation studies with different stimuli have 
been reported in the presence of CB. Lysozyme release from CB treated neutrophils 
exposed to Con-A has been reported to be selectively blocked by a-methyl-D-
mannoside (Goldstein et al., 1977). Also, a 16 kDa chicken galectin produced 
significant degranulation (lysozyme release) from human neutrophils in the presence 
of CB (Timoshenko et al., 1995). Rubinstein et al. (2004) then demonstrated that the 
same galectin might exert pro- or anti-inflammatory effects depending on muhiple 
factors such as sub-cellular compartmentalization, activation state of target cells and 
concentration used. Recently, Elola et al. (2005) also reported spleen Gal-1 induced 
lysozyme release from porcine neutrophils. 
Pre-treatment of buffalo neutrophils with HBSS and BfHG-1 followed by 
stimulation with varying concentrations of fMLP (Table 9) and PMA (Table 10) did 
not produced significant differences in lysozyme release from lectin pre-treated and 
control neutrophils. Regarding pre-treatment experiments, responses of BfHG-1 to 
pre-activation of oxidative burst and degranulation were different. While these pre-
treatments induced an enhancement of the superoxide production, the lysozyme 
release was decreased. Available literature suggests that when exposed to neutrophil 
activators, pre-treated neutrophils produces reactive oxygen radicals including 0 ' and 
H2O2 at a greater rate than untreated neutrophils. Synergistic activation of O " 
production by lectins with different sugar specificities such as Con-A and mistletoe 
lectin (ML I) in the presence of dihydro-CB is also documented. Treatment with 
either ML I (30 ^g/ml) or Con-A (100 \ig/m\), or both plus dihydro-CB induced a 
small extent of O '^ generation, but when neutrophils were pre-treated with Con-A 
followed by treatment with ML I, an enhanced stimulatory effect of 576% was 
observed (Timoshenko and Gabius, 1993). Almkvist et al. (2001) demonstrated that 
galectin-3 is a potent agonist of LPS pre-treated neutrophils, but not of untreated 
peripheral blood cells, and degranulation of gelatinase granules (little mobilization of 
specific granules) is a major event induced by LPS in PMN. Besides, galectin-1 at 
higher concentration produces similar effects (Almkvist et al., 2002). 
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Table 9. Effect of PMA stimulus on lysozyme release in neutrophils pre-incubated 
with HBSS and B^G-1 
PMA 
concentration 
(HM) 
0.01 
0.1 
1.0 
10 
100 
Lysozyme release by 
PMNs pre-incubated 
with HBSS 
16.76±2.10 
17.78±2.09 
21.79±1.68 
23.46±1.98 
23.53±1.74 
PMNs pre-incubated 
with B,HG-1 
19.59±2.26 
20.07±3.42 
25.45±2.95 
26.09±3.39 
28.66±3.02 
Table 10. Effect of fMLP stimulus on lysozyme release in neutrophils pre-incubated 
with HBSS and BfHG-1 
fMLP 
concentration 
(HM) 
0.01 
0.1 
1.0 
10 
100 
Lysozyme release by 
PMNs pre-incubated 
with HBSS 
28.67±2.72 
32.59±1.39 
36.33±1.92 
33.3±2.59 
33.98±2.94 
PMNs pre-incubated 
withBfHG-1 
33.29±2.83 
37.01±2.73 
40.56±3.67 
38.56±2.92 
44.34±3.45 
m ? 
Immunological oxidative burst and degranulation studies 
Although in our experiments, pre-treatment with BfHG-1 followed by 
stimulation with varying concentrations of fMLP and PMA did not produced 
significant differences on degranulation, we cannot discard the possibility that some 
other combination of stimuli might (i.e. LPS priming) have produced different 
physiological effect. Therefore, further pre-treatments would be necessary to elucidate 
if any pre-treatment could produce mobilization of granule receptors as suggested for 
Gal-3 and fMLP (Almkvist et al., 2001). At present, a growing body of evidence 
indicates that Gal-1 has opposite effects on neutrophils, which modulates their roles 
on innate immune response and inflammation process. Rubinstein et al. (2004) 
demonstrated that lectin induces a decrease of extravasation and transendothelial 
migration, and enhances NADPH-oxidase activity. We confirm the later activity and 
add new information on BfHG-1 induced degranulation (lysozyme release). 
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Erythrocyte membrane studies 
METHODS 
Effect of BfHG-1 mediated agglutination on the osmofragility of trypsinized 
rabbit erythrocytes 
The osmofragility of trypsinized rabbit erythrocytes (described in the text on 
page 40) in the presence of BfHG-1 was determined by the method of Raghuramulu et 
al. (1983). An 8% trypsinized rabbit erythrocyte suspension (200 nO was mixed with 
100 ^1 BfHG-1 (100 fig/ml) and incubated for one hour at room temperature for 
agglutination. This was followed by addition of 1.5 ml hypotonic NaCl solution with 
concentrations ranging from 0.3-0.8%. The cells were then incubated for 4 h at 37°C 
with intermittent gentle shaking and centrifoged at 2000 rpm for 5 min and the 
supernatant was collected. The extent of hemolysis was obtained by measuring the 
absorbance at 540 nm and the results were reported as percent hemolysis. The lysis of 
erythrocytes with an equal volume of distilled water was taken as 100%. 
Effect of sachharides on erythrocyte hemolysis in the presence and absence of 
BfHG-1 
The B(HG-1 agglutinated trypsinized erythrocyte suspensions (300 nl) were 
mixed with 1.5 ml PBS 'B' (75 mM sodium phosphate pH 7.2, containing 0.15 M 
NaCl, 5 mM P-ME and 0.02 % (w/v) sodium azide) and then treated with 30 mM 
each of galactose, glucose, sucrose and lactose. The respective suspension was then 
incubated for 4 h at 37°C with gentle shaking and the percent hemolysis was 
determined as given above. Erythrocytes incubated with various sachharides in the 
absence of BtHG-1 were taken as respective controls for corresponding sachharides. 
The effects of variations in BfHG-1 concentration (10-100 ^g/ml), temperature 
(10-50°C), pH (3.5-11.5) and incubation time (0.5-5.0 h) on the hemolysis of 
trypsinized rabbit erythrocytes were also monitored. Erythrocyte suspension devoid of 
BfHG-1 was incubated under similar conditions and served as control. 
Effect of BfHG-1 on pyragallol induced free radical damage to erythrocyte 
membrane 
The BfHG-1 agglutinated trypsinized erythrocyte suspensions (300 ^1) were 
exposed to superoxide radicals (O '^) generated by incubation with pyrogallol auto-
oxidation system (10 ^1 of 0.02 M pyrogallol solution freshly prepared in H2O2). The 
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incubation was carried out for a period of 20 min at 37°C. The treated erythrocytes 
were recovered by centritugation at 3000 rpm for 5 min. The cells were then washed 
thrice and centrifuged with PBS 'B' and the supernatants were pooled for determining 
the concentration of oxyhemoglobin (OxyHb) by the equation of Winterbourn (1990). 
[OxyHb] = (119A577)-(39A63o)-(89A56o) 
Effect of hypochlorous acid (HOCl) on BfHG-1 induced hemolysis of trypsinized 
rabbit erythrocytes 
The BfHG-1 agglutinated trypsinized erythrocyte suspensions (300 ^1) were 
treated with varying concentrations of HOCl (50-350 |iM) at 22°C for 20 min. The 
erythrocytes were then washed thrice with excess of cold PBS 'B' and 10% 
suspension was made in the same buffer (Vissers et al., 1998). HOCl was added as a 
single bolus of 25 mM f' stock solution of sodium hypochlorite (NaOCl) in PBS 'B' 
to RBC suspension and mixed by vortexing. At pH 7.4 this solution contains a 
mixture of HOCl and OCl" at approximately 1:1 ratio and is subsequently referred to 
as HOCl (Vissers et al., 1998). The concentrations of OCl' were determined 
spectrophotometrically using an absorbance coefficient of 350 M" 1 cm' at 292 nm 
(Morris, 1996). The susceptibility of erythrocytes to HOCl induced oxidative damage 
was measured in terms of percent hemolysis as discussed above. 
Differential hemolytic action of BfHG-1 towards erythrocytes of breast and 
prostate cancer patients 
Pre-operated and post-operated (7 days after surgery) heparinised venous 
blood samples from breast and prostate cancer patients (age > 45 years) were 
procured from the surgery outpatient department and the male surgical wards of 
Department of Surgery, J. N. Medical College, Aligarh. Plasma from the samples was 
separated by centriftjgation at 3000 rpm for 5 min. Pre- and post operated erythrocytes 
were separated by centrifuging the blood samples at 3000 rpm for 5 min. An 8% 
trypsinized erythrocyte suspension was then prepared and incubated for 4 h at 37 °C in 
the absence and presence of 100 |nl BfHG-1 (100 |ag/ml). The samples were then 
centrifuged at 2000 rpm for 5 min and percent hemolysis was measured in the 
supernatants by taking the absorbance at 540 nm. 
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RESULTS AND DISCUSSION 
Proteins with cytolytic activities in general and hemolytic activhies in 
particular, have been of great interest to membrane biologists, mainly because the 
study of the mode of action of such agents has contributed considerably to the 
understanding of complexities of biomembrane organization and function. 
Interestingly, the purified buffalo heart lectin also exhibited hemolytic activity 
towards rabbit and human erythrocytes. Lytic actions of some proteins have been 
ascribed to their enzymatic activity (Hittelet et al, 2002), induced perturbation of the 
activities of membrane associated enzymes (Lowe and Marth, 2003), or induction of 
pore formation in the membranes (Yu et al., 2002). Thus, we examined the interaction 
of BfHG-1 with erythrocyte membrane in order to elucidate the mechanism of 
hemolysis by BiHG-1 using rabbit erythrocytes as a model system. 
Effect of BfHG-1 on hemolysis of trypsinized erythrocytes at varying 
concentrations of NaCl solution 
The extent of NaCl mediated hemolysis of trypsinized rabbit erythrocytes in 
the presence and absence of BfHG-1 is depicted in Fig. 45. Erythrocytes exhibited a 
variable hemolytic pattern when treated with varying concentrations (0.3-0.8%) of 
hypotonic NaCl solution. At 0.6% NaCl concentration, BfHG-1 agglutinated 
erythrocytes displayed a significant (P<0.001) 74% hemolysis compared to 55% 
hemolysis of unagglutinated erythrocytes at the same concentration. The study 
showed that BfHG-1 agglutinated erythrocytes were significantly hemolysed in 
comparison to unagglutinated erythrocytes, suggesting that BfHG-1 by virtue of its 
glycan binding property might have created pores or leaks in the cellular membranes 
leading to loss of its function as the selective cell barrier (Devticke et al., 1986). 
Hence, due to an imbalanced colloid-osmotic pressure of intracellular solutes, uptake 
of water and salts rises resulting in increased hemolysis of lectin agglutinated cells 
(Devticke et al., 1986). Some plant and animal lectins have been reported to perturb 
membrane integrity and fluidity, probably by interacting with membrane 
glycoconjugates and consequently penetrating the lipid bilayer (Gupta et al., 2006). 
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Figure 45. Effect of BfHG-1 on hemolysis of trypsinized erythrocytes at varying 
concentrations of NaCl solution: Ti^psinized 8% rabbit erythrocytes agglutinated 
with 100 \x\ of BfHG-1 (100 |ig/ml) and non-agglutinated 8% trypsinized rabbit 
erythrocytes (200 ^1) were incubated for 4 h at 37 °C with varying concentrations of 
1.5 ml NaCl (0.3-0.8%). The samples were then centrifoged at 2000 rpm for 5 min 
and the percent hemolysis was measured in the supernatants by taking the absorbance 
at 540 nm. 
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Lectins oligomerize into dynamic complexes on interacting with cell surface 
glycans like laminin, fibronectin and lysozyme associated proteins and also with the 
lipid bilayer resulting in substantial reorganization of membrane components (Surolia 
et al, 1997). Although the lipid bilayer and the membrane integrated proteins are 
closely packed structures, any displacement of membrane proteins due to the lectin 
binding may disturb the sealed barrier consequently forming an aqueous pore 
(Israelachivilli, 1977). Moreover, aqueous trans-membrane channels in conjugation 
with hydrophobic protein domains have been reported to form a cluster of aggregated 
and displaced proteins (Gupta et al., 2006). 
Effect of carbohydrates on erythrocyte hemolysis in the presence and absence of 
BfHG-1 
Presuming the fact that the increased hemolysis of lectin agglutinated 
erythrocytes is due to the formation of ion permeable leaks formed in the membrane 
(Hatakeyama et al., 1995), many attempts have been made to prevent the colloid 
osmotic lyses by addition of carbohydrates to the extra cellular medium, which may 
counterbalance the osmotic pressure exerted by intracellular macromolecules 
(Hoekstra and Duzgunes, 1989). Moreover, hemolytic activity of lectins has been 
attributed to the formation of ion-permeable pores in the membrane, as with some 
cytolytic proteins (Hatakeyama et al., 1995). Therefore, we examined this possibility 
by performing the osmotic protection experiment using several carbohydrates as 
protectants. The ability of carbohydrates to protect BfHG-1 induced erythrocytes lysis 
was assessed by incubation with different sugar solutions for 4 h at 37 °C. 
As shown in Fig. 46, when rabbit erythrocytes were incubated with BfHG-1 in 
the presence of several carbohydrates with varying molecular masses, lysis was 
inhibited increasingly as the size of the carbohydrates increased; lactose (10% 
hemolysis) and sucrose (20% hemolysis) provided greater protection against lysis of 
rabbit erythrocytes, whereas glucose (70% hemolysis) and galactose (50% hemolysis) 
provided relatively lesser protection against erythrocyte lysis. These resuhs suggest 
that the erythrocytes were ruptured by colloid-osmotic shock after BfHG-1 had 
formed ion-permeable pores in the membrane. Since galactose or GalNAc-containing 
carbohydrates effectively inhibited the hemolysis, it was suggested that BfHG-l 
exerted lytic action by damaging the erythrocyte membrane, after binding to the 
specific carbohydrates on the cell surface. 
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Figure 46. Effect of carbohydrates on erythrocyte hemolysis in the absence and 
presence of BfHG-1: An 8% trypsinized rabbit erythrocyte suspension (200 \x\) was 
incubated for 4 h at 37 T in PBS 'B' alone (control) and with 30 mM each of 
galactose, glucose, sucrose and lactose in the absence and presence of 100 |al of 
BfHG-1 (100 |ig/ml) Samples were then centrifuged at 2000 rpm for 5 min and the 
percent hemolysis was measured in the supernatants by taking the absorbance at 540 
nm Values shown are the mean ± S E M obtained from three observations 
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Effect of variations in BfHG-1 concentration, temperature, pH and incubation 
time on erythrocyte hemolysis 
To obtain information regarding the interaction between BfHG-1 and the 
erythrocyte membrane, we examined the hemolytic activity under different 
conditions. As shown in Fig. 47, a concentration dependent rise in the hemolysis of 
trypsinized rabbit erythrocytes was observed in the presence of BtHG-1. At 100 |ig/ml 
concentration, BfHG-1 showed significant (P<0.001) 84% hemolysis as compared to 
11% hemolysis observed in the absence of BfHG-1 (control). 
When the hemolytic activity of BfHG-1 was measured at various temperatures 
using rabbit erythrocytes, a temperature dependent gradual increase in percent 
hemolysis was also observed (Fig. 48). BfHG-l treated erythrocytes displayed a 
significant (P<0.001) 87% hemolysis at 50°C with respect to 13% hemolysis observed 
in the control (in the absence of BfHG-1). The decreased hemolysis at low 
temperatures might be related to decreased membrane fluidity at these temperatures. 
These findings suggest that the hemolysis is not an enzymatic reaction and might 
depend largely on the binding of BfHG-1 to the specific carbohydrates on the surface 
of the erythrocyte. 
Fig. 49 shows the pH dependence profile of the hemolytic activity and 
stability of BfHG-1. The hemolytic activity of BfHG-1 increased with increasing pH, 
while reduced hemolytic activity was observed at lower pH. However, after 
pretreatment at different pH values for 4 h, a decrease in hemolytic activity was 
observed only in the acidic region, indicating that the low activity in the acidic region 
was not due to irreversible inactivation of the protein. This might reflect the presence 
of some ionizable group of amino acid residue with a pKa around pH 7.5-9.5, which 
is involved in the hemolytic activity. 
As shown in Fig. 50, the hemolytic activity of BfHG-1 increased with 
increasing incubation time. BfHG-1 treated erythrocytes showed a significant 
(P<0.001) 88% hemolysis after 4 h incubation, as compared to 11% hemolysis in the 
absence of BfHG-1 (control). The increase in incubation time probably enhanced the 
lectin-glycan interaction, thus increasing the number and size of the erythrocyte 
membrane pores. This in turn resulted in an increased rate of electrolyte diffusion 
through the pores justifying the reason for increased percent hemolysis observed. 
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Figure 47. Effect of varying concentrations of BfHG-1 on erythrocyte hemolysis: 
A suspension of 8% trypsinized rabbit erythrocytes (200 i^l) in 1,5 ml PBS 'B' was 
incubated for 4 h at 37°C in the presence of increasing concentration of 100 ^1 BfHG-
1 (10-100 ng/ml) and also in the absence of BtHG-1 (control). The samples were then 
centrifuged at 2000 rpm for 5 min and the percent hemolysis was measured in the 
supernatants by taking the absorbance at 540 nm. 
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Figure 48. Hemolysis of BfHG-l agglutinated erythrocytes as a function of 
increasing temperature: A trypsinized 8% rabbit erythrocytes suspension (200 ^1) 
was incubated with 100 ^1 of BfHG-l (100 ^g/ml) for 4 h at 37 °C at various 
temperatures (10-50°C). The samples were then centrifiaged at 2000 rpm for 5 min 
and percent hemolysis was measured in the supernatants by taking the absorbance at 
540 nm. Erythrocyte suspensions incubated at the same temperatures in the absence of 
lectin served as controls. 
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Figure 49. Effect of pH on hemolysis of BfHG-1 agglutinated erythrocytes: A 
tiypsinized 8% rabbit eiythrocytes suspension (200 |il) was incubated with 100 ^1 of 
BfHG-1 (100 ng/ml) for 4 h at 37 °C with following buffers: 0.1 M sodium acetate 
buffer (pH 3.5-5,5), 0.1 M sodium phosphate buffer (pH 6.5-7.5), 0.1 M Tris-HCl 
buffer (pH 8.5-9.5) and 0.1 M glycine-NaOH buffer (pH 10.5-11.5). The samples 
were then centrifuged at 2000 rpm for 5 min and the percent hemolysis was measured 
in the supernatants by taking the absorbance at 540 nm. Erythrocyte suspensions 
incubated at corresponding pH values in the absence of lectin served as controls. 
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Figure 50. Hemolysis of BfHG-1 agglutinated erythrocytes as a function of 
incubation period: Trypsinized 8% rabbit erythrocytes suspensions (200 |il) were 
incubated with 100 ^1 of BfHG-1 (100 t^g/ml) for 4 h at 37 °C at different time 
intervals (0.5-5 h). The samples were then centrifuged at 2000 rpm for 5 min and the 
percent hemolysis was measured in the supernatants by taking the absorbance at 540 
nm. Erythrocyte suspensions incubated for same duration in the absence of lectin 
served as controls. 
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Effect of BfHG-1 on pyrogallol induced damage to etythrocyte membrane 
The effect of pyragallol on trypsinized rabbit erythrocyte membrane was 
studied to investigate the possible role of pyragallol induced oxidative damage to the 
erythrocyte membrane. 
A trypsinized rabbit erythrocyte suspension (8%) pre-treated with BfHG-1 for 
1 and 4 h and then exposed to superoxide radicals (O '^) generated from a pyrogallol 
auto-oxidation system, released 28 and 36 i^M oxyhemoglobin (oxyHb) respectively, 
while only 6 |aM oxyHb was released by unagglutinated erythrocytes (Fig. 51). 
However, oxyHb was not released by BfHG-1 agglutinated or non-agglutinated 
erythrocytes which were not exposed to oxidative stress (pyragallol). Thus, 
agglutination of erythrocytes by BfHG-1 was not responsible for any oxidative 
damage per se. But the agglutination thus caused might have induced perturbations in 
erythrocyte membranes making it more vulnerable to the oxidative attack by 
pyragallol (Lowe and Marth, 2003). The leaks or pores formed in the lipid bilayer 
probably facilitated the superoxide ions to penetrate through the hydrophobic cellular 
membranes which were earlier impervious to these ions (Yu et al, 2002). 
Gal-1 expression has been reported to be enhanced in human thyroid tumors, 
glioma and prostate adenocarcinoma which can be attributed to superoxide radical 
induced oxidative stress (Timoshenko et al., 1993; Stillman et al, 2005), as 
substantial increase in oxyHb concentration has been reported in malignancies 
(Ichalalene et al., 2006). Thus, enhanced Gal-1 expression as observed in cancer 
patients may be responsible for increase in oxidative stress in general, as the 
susceptibility to oxidative damage of Gal-1 treated erythrocytes has been found 
elevated in the present study in terms of oxyHb content. 
Gal-1 has been reported to be over expressed in some cardiovascular disorders 
as well. Giordanengo et al. (2001) reported enhanced Gal-1 expression in chronic 
Chaga's disease and the associated cardiac damage was attributed to superoxide 
radical induced oxidative stress. Moreover, IgG immunoreactivity to Gal-1 was found 
to be correlated with the severity of cardiac damage in chronic Chaga's disease. 
Moreover, Gal-1 was also shown be involved in the vascular extracellular 
matrix (ECM) assembly by affecting the incorporation of some ECM com.ponents 
(Moiseeva et al., 2003). Gal-1 has also been shown to be involved in adhesion, 
migration, and proliferation of vascular smooth muscle cells (SMC), the key steps in 
the development of atherosclerosis and restenosis (Moiseeva et al, 2003). 
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Figure 51. Effect of BfHG-1 on pyragallol induced free radical damage to 
erythrocyte membrane: OxyHb concentration was measured in the hemolysates of 
erythrocyte suspensions exposed to superoxide radicals generated by pyragallol auto-
oxidation system in the absence (a) and in the presence of BfHG-1 after 1 h (b) and 4 
h (c) respectively. Samples were then centrifuged at 3000 rpm at 5 min, erythrocytes 
were washed thrice with PBS 'B' and the percent hemolysis was measured in the 
pooled supernatants by taking the absorbance at 540 nm. Values shown are the mean 
± S.E.M obtained from three observations. 
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Over-expression of the Gal-1 gene, parallel to the other genes encoding ECM 
proteins and genes involved in ECM turnover has been reported in superoxide radical 
induced aneurysmal dilation of brain blood vessels. These data also indicated the role 
of Gal-1 in the ECM assembly during wound healing and tissue matrix remodeling, 
and in the developmental stages of atherosclerosis and restenosis (Chellan at al., 
2007). 
Free radical induced hypoxia has been reported to cause Gal-1 over production 
by vascular, interstitial, epithelial and immune cells (Case et al. 2007). Gal-1 has also 
been shown to regulate SMC differentiation, proliferation and apoptosis via 
interactions with the ECM as well as immune system function, and thus plays an 
important role in the pathogenesis of pulmonary hypertension (PH) (Case et al. 2007). 
In vivo, deletion of Gal-1 gene resulted in the reduction on the magnitude of the PH 
response to chronic hypoxia. In vitro, acute hypoxia increased expression of Gal-1 
mRNA in isolated pulmonary mesenchymal cells. Therefore, Gal-1 over expression 
probably influenced the contractile response to hypoxia and subsequent remodeling of 
ECM during hypoxia-induced PH, which in turn influences disease progression. 
Thus, enhanced Gal-1 expression in the above mentioned diseases may be 
responsible for increase in oxidative stress in terms of increased oxyHb content. 
Effect of hypochlorous acid (HOCl) on BfHG-1 induced hemolysis of trypsinized 
rabbit erythrocytes 
To study the role of BfHG-l induced neutrophil mediated damage to 
erythrocyte membrane and to investigate the role BtHG-1 as membrane perturbing 
tool, the oxidizing action of HOCl was monitored in the presence of BjHG-l in terms 
of percent erythrocyte hemolysis. The extent of erythrocyte hemolysis was found to 
be directly proportional to HOCl concentrations (Fig. 52). Prior agglutination of 
erythrocytes with BfHG-1 resulted in significant (P<0.001) enhancement of hemolysis 
as compared to untreated cells in the presence of varying concentration of HOCl. At 
the concentration of 350 |iM HOCl, BtHG-1 agglutinated erythrocytes showed 52% 
hemolysis compared to 28% hemolysis by non-agglutinated erythrocytes. It is well 
established fact that HOCl is an extremely toxic oxidant to variety of cellular 
components (Vissers and Winterbourn, 1995). It has also been confirmed that HOCl 
causes red blood cell lysis through lipid modification, membrane cross linking, K" 
leakage and cell swelling(Zavodnick et al., 2002). 
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Figure 52. Effect of hypochlorous acid on BfHG-1 induced hemolysis of 
trypsinized rabbit erythrocytes: Agglutinated with 100 ^1 of BiHG-1 (100 [ig/ml) 
and non-agglutinated 8% trypsinized rabbit erythrocytes (200 ^1) were incubated for 
20 min at 22 °C with varying concentrations of HOCl (50-350 ^M). The samples were 
then centrifiiged at 2000 rpm for 5 min and the percent hemolysis was measured in 
the supernatants by taking the absorbance at 540 nm. 
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An additive effect on the increase in percent hemolysis of erythrocytes was 
observed by lectin mediated HOCl induced cell damage suggesting that together with 
hypochlorite, lectins might have acted as an active pore forming agent and hence 
made the membrane components more susceptible to oxidative insult (Yu et al., 
2002). Galectins are homodimeric proteins with two binding sites which can cross-
link identical ligands on the cell surface or to the extracellular matrix thus inducing 
conformational changes in membrane proteins and altering lipid fluidity. These 
properties of galectins might have increased the accessibility of HOCl to erythrocyte 
components (Zavodnick et al., 2002). 
As the average number of pores formed by HOCl per cell has been reported to 
be less than one (Zavodnick et al., 2002), prior agglutination with the lectin possibly 
increased the number of transient pores in plasma membrane. This suggests the 
possibility of the role of Gal-1 in HOCl induced neutrophil mediated cellular damage 
that may have direct implications in various inflammatory conditions, where 
increased expression of galectins has been reported (Rorive et al., 2001). Hence, lectin 
interaction with membranes acts as a perturbing tool causing a change in membrane 
topology and assembly which may play an important role under physiological 
demands or pathological conditions in mammalian system. 
Differential hemolytic action of BfHG-1 towards trypsinized erythrocytes of 
cancerous patients 
Owing to their multivalent sugar binding property, lectins have served as an 
excellent tool for detection of aberrant glycosylation related to various carcinomas 
and may provide useful diagnostic or prognostic information, thus contributing 
directly to cancer biology (Hernandez et al., 2006), as a number of glycoconjugates 
expressed on the erythrocyte membranes have been reported to be altered in primary 
cancerous and metastatic conditions (Baxi et al, 1991). Moreover, the alteration in 
glycoconjugates has been reported to be excellent indicator for diagnosis, staging, 
prognosis and treatment monitoring, and detecting early recurrence of cancer in 
patients with malignant neoplasm (Hernandez et al., 2006). Hence, P-galactoside 
binding lectin purified from the buffalo heart was used to detect the changes in the P-
galactoside expression pattern in erythrocyte membranes of prostate and breast cancer 
patients in terms of their percent hemolysis in the presence of the purified lectin. 
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Further, changes in the galactoside expression patterns were also monitored 
post-therapy in both the cancers in terms of susceptibility to hemolysis by lectin. A 
comparison in the hemolytic pattern was made between BfHG-1 agglutinated and 
non-agglutinated erythrocytes obtained from normal healthy individuals with pre- and 
post-operated breast and prostate cancer patients. 
As can be seen in Fig. 53, a significant (P<0.001) increase (90%) in the 
hemolysis of BfHG-1 agglutinated erythrocytes was observed as compared to the non-
agglutinated erythrocytes obtained from normal healthy females (controls for breast 
cancer patients). A significant (P<0.001) increase (82%) in the hemolysis of BfHG-1 
non-agglutinated pre-operated erythrocytes obtained from breast cancer patients was 
observed as compared to the control erythrocytes. 
The percent hemolysis of lectin agglutinated pre-operated erythrocytes from 
breast cancer patients was found to be significantly (P<0.001) decreased by 36% as 
compared to the control erythrocytes, which might be due to the decrease in the 
expression of P(l—»4) linked glycans on erythrocyte membrane surface in breast 
cancer patients. The percent hemolysis of lectin agglutinated post-operated 
erythrocytes was however found to be enhanced by 27% (P<0.001) as compared to 
pre-operated erythrocytes, as there occurs a re-expression of P(l—*4) linked glycans 
after surgery (Abou-Seif et al., 2000), thus enhancing the binding of lectin and 
thereby increasing in the pore formation and hemolysis. A significant (P<0.001) 12% 
decrease in the hemolysis of lectin agglutinated post-operated erythrocytes was 
observed when compared with the control erythrocytes. 
Fig. 54 shows a significant (P<0.001) increase (90%) in the hemolysis of 
BfHG-1 agglutinated control erythrocytes as compared to the non-agglutinated control 
erythrocytes collected from normal healthy males (control for prostate cancer 
patients). A significant (P<0.001) increase (93%) in the hemolysis of non-
agglutinated pre-operated erythrocytes was observed as compared to the control 
erythrocytes. Lectin induced 78% hemolysis of the erythrocytes obtained from pre-
operated prostate cancer patients. While, only 56% hemolysis was observed in post-
operated prostate cancer patients. Thus, a significant (P<0.001) decrease of 29% was 
observed in the hemolysis of post-operated erythrocytes as compared to pre-operated 
erythrocytes. However, a significant (P<0.001) increase (28%) in the hemolysis of 
lectin agglutinated post-operated erythrocytes was observed when compared with the 
control erythrocytes treated with lectin. 
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The increase in the percent hemolysis of control erythrocytes in the presence 
of lectin is due to hemagglutination induced perturbations in erythrocyte membranes 
(Lowe and Marth, 2003) resulting in enhanced hemolysis. The difference in the 
percent hemolysis between normal healthy males and females may be attributed to the 
difference in their hormones (Abbott et al., 1989). 
The differences in the percent hemolysis of what may be due to the changes in 
the binding properties of blood group substances with glyco-moieties of the 
glycoproteins in cancerous conditions (Hernandez et al., 2006) and thus is further 
strengthened by the fact that the changes in cell surface carbohydrates during 
malignancy development involve blood antigens (Baxi et al., 1991). The lectins have 
also been reported to bind to the D-galactose moieties of the erythrocyte glycoproteins 
(Garber et al., 1994), thus supporting the observed differential hemolysis. 
Lectins can be used as an excellent tool to detect the changes in the 
glycosylation pattern of cells during malignancies as they bind specifically to 
carbohydrate moieties of glycoproteins or glycolipids on the cell surface without the 
involvement of chemical modification (Nagae et al., 2008), v/hich can be a more 
convenient method than examining the biopsy sample in certain cases (Hasija, 2002). 
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Figure 53. Hemolysis of erythrocytes collected from breast cancer patients in the 
absence and presence of BfHG-1: An 8% trypsinized erythrocyte suspension (200 
HI) of the normal healthy females (controls) and pre- and post operated breast cancer 
patients was incubated for 4 h at 37 °C in the absence and presence of 100 ^1 BfHG-l 
(100 pg/ml). The samples were then centrifuged at 2000 rpm for 5 min and the 
percent hemolysis was measured in the supernatants by taking the absorbance at 540 
nm. Values shown are the mean ± S.E.M obtained from fifty observations. 
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Figure 54. Hemolysis of erythrocytes collected from prostate cancer patients in 
the absence and presence of BfHG-1: An 8% trypsinized erythrocyte suspension 
(200 \x\) of normal healthy males (controls) and pre- and post operated prostate cancer 
patients was incubated for 4 h at 37 °C in the absence and presence of 100 |il BfHG-1 
(100 p-g/ml). The samples were then centrifliged at 2000 rpm for 5 min and the 
percent hemolysis was measured in the supernatants by taking the absorbance at 540 
nm. Values shown are the mean ± S.E.M obtained from fifty observations. 
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Summary 
Galectins are the family of proteins defined by at least one characteristic 
carbohydrate recognition domain (CRD) with affinity for p-galactosides, sharing 
certain conserved sequence elements and requiring a reducing environment but not 
divalent cations for their binding activity. In the present study a buffalo heart lectin 
was purified and extensively characterized and the effect of deglycosylation on the 
properties of the purified galectin was studied. The immunological properties of the 
purified galectin were studied; its role in oxidative burst and degranulation was 
investigated, and erythrocyte membrane studies were performed. 
Purification and characterization of buffalo heart galectin 
The purified buffalo heart galectin (BfHG-1) was found to be a metal-
independent 14.5 kDa protein. Stokes radius and diffiision coefficient determination 
revealed its homo-dimeric nature. BfHG-1 retained 100% activity up to 48°C and 
showed pH stability in the range of 4.5-10.5. 
BfHG-1 agglutinated native human erythrocytes showed marked preference 
for the blood group A and the overall order of preference was A>0>AB>B. Exposed 
thiol group analysis of BfHG-1 indicated a molar ratio of 2.9, thus indicating the 
presence of at least three moles of sulfhydryl group per mole of BfHG-1. 
Conformational changes were induced by the interaction of the BfHG-1 with 
thiol blocking reagents, denaturants and detergents. Among thiol blocking reagents, 
the most hydrophobic pHMB maximally inhibited the activity of BfHG-1 followed by 
lesser hydrophobic NEM, iodoacetate and iodoacetamide. The inhibitory effect of 
various chaotropic denaturants showed that urea caused maximum loss in BfHG-1 
activity, followed by GdnHCl and thiourea. SDS, a well known ionic detergent 
denatured BfHG-1 even at a very small concentration, while, Tween-20 and Triton X-
100 being neutral detergents were less inhibitory in nature. 
The slope of linear Scatchard plot drawn using equilibrium dialysis data of 
BfHG-1 with lactose was used to calculate binding constant value, which suggested 
the presence of two binding sites per BfHG-1 molecule. 
BfHG-1 exhibited an UV maximum at 280 nm, corresponding to the presence 
of single Trp residue and a large number of other aromatic residues. However, 
oxidation of BfHG-1 in the presence of 5mM H2O2 (without P-ME) resulted in the 
shift of absorption peak to 250nm, suggesting oxidation of Trp residue to an oxindole 
moiety, which absorbs maximally at 250nm. 
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The sequence alignment of BfHG-1 with other Gal-1 showed more than 87% 
identity, in agreement with its high conservation throughout evolution. The 
conservation of amino acid residues that interact with carbohydrate ligands allowed us 
to classify it as having type 1 conserved CRD. 
When excited at 280 nm, BfHG-1 exhibited fluorescence emission spectrum 
maximum around 332 nm, typical to that of a Trp group in hydrophobic environment. 
The fluorescent profile of the oxidized galectin showed a remarkable quenching in the 
fluorescence intensity, accompanied with a decreased activity. However, in the 
presence of lactose, oxidation of Trp was prevented, also revealed by a slight decrease 
in the fluorescence of protein-carbohydrate complex. 
Exposure to pHMB, urea and SDS resulted in remarkable quenching in the 
fluorescence intensity, indicating their damaging effect on the structural integrity of 
BfHG-1. A shift in far and near UV-CD, and FTIR spectra showed a major transition 
of native secondary structure of BfHG-1 from P-pleated form to a more open and 
enriched a-helix conformation, thus clarifying the reason for the loss of activity upon 
oxidation. 
The far UV-CD spectra of BfHG-1 showed a low intensity spectrum with 
minimum around 218 nm, consistent with the presence of large extent of P-sheet 
structural profile as reported for other Gal-1. The FTIR spectrum also correlates with 
the CD analysis; consistent with the presence of large extent of p-sheet structure in 
BfHG-1 as suggested by maximum absorbance peak around 1630 cm"'. BfHG-1 FTIR 
spectra were truncated between 1652 and 1576 cm"'. Treatment of lactose with the 
native galectin did not cause any significant change in its secondary topology. 
However, exposure of BfHG-1 to H2O2, urea, pHMB and SDS caused very marked 
changes in far and near UV-CD, and FTIR spectra, concomitant with the loss of P-
sheet structure and its hemagglutination activity. 
Deglycosylation studies 
Chemical analysis using Dubois phenol-sulphuric acid method revealed the 
presence of 3.55% sugar residues in the purified buffalo heart galectin. In order to 
study the role of glycosylation in galectin fianctioning, we removed the sugar residues 
using periodate oxidation method. This method completely removed the sugar 
moieties, as confirmed by the Dubois analysis, PAS staining and the difference in the 
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mobility of the native and deglycosylated galectin on SDS-PAGE. Deglycosylated 
galectin eluted later than the native glycosylated protein. 
Deglycosylation resulted in a decrease in the Stokes radius and a 
corresponding increase in the diffusion coefficient of the purified galectin. The 
thermal and pH stabilities of the deglycosylated galectin were also found to be lesser 
than the native glycosylated galectin. 
Deglycosylation did not result in any changes in the preferential action of thiol 
blocking reagents, denaturants and detergents on the inhibition of BfHG-1 activity. 
Although the deglycosylated galectin exhibited a reduced activity profile both before 
and after oxidation, the effect of H2O2 was much more pronounced on the 
deglycosylated form. 
When treated with increasing concentrations of urea, pHMB and SDS, the 
deglycosylated form exhibited higher fluorescence intensity and a greater red shift as 
compared to the native glycosylated galectin. 
The far UV-CD and near UV-CD maxima of native and deglycosylated 
galectins remained unchanged, but the deglycosylated form exhibited decreased 
circular dichroism than the native galectin. When treated with urea, pHMB and SDS, 
the deglycosylated galectin exhibited decreased circular dichroism than the 
glycosylated galectin, thus highlighting the significance of lectin glycosylation. 
The FTIR spectrum maximum of native and deglycosylated galectins 
remained unchanged, but the deglycosylated form exhibited lesser optical density than 
the native galectin. 
Immunological, oxidative burst and degranulation studies 
Double immunodiffusion revealed high immunogenicity of the purified 
galectin in rabbits, as they readily gave a single line of identity indicating 
homogeneity of protein preparations, and indicated that anti-BfHG-1 antibodies are 
quite specific to BfHG-1. The antiserum showed a high titre value (> 128000), 
suggesting high immunogenic nature of the purified galectin. Dot blot analysis 
established immunological cross reactivity of BfHG-1 with other galectins. 
A gradual increase in superoxide production and lysozyme release was 
observed when the buffalo neutrophils were treated with the BfHG-1 and/or 
neutrophil activators. 
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The results of lysozyme release by various treatments can be summarized as: 
(BfHG-1 + CB) < (BfHG-1 + CB + fMLP) < (BfHG-1 + CB + PMA) < (BfHG-1 + 
CB + fMLP + PMA) < (BfHG-1 + CB + fMLP + PMA), showing a maximum 
release in the presence of lectin and neutrophil activators. However, lysozyme 
release was found to be approximately three times higher than superoxide 
production under similar conditions. Pre-treatment of buffalo neutrophils with HBSS 
and BfHG-1, followed by stimulation with varying concentrations of fMLP and 
PMA did not produce significant differences in superoxide production and lysozyme 
release from the galectin pre-treated and control neutrophils. 
Erythrocyte membrane studies 
Extent of hemolysis of trypsinized rabbit erythrocytes in the presence and 
absence of BfHG-1 showed that agglutinated erythrocytes were significantly 
hemolysed in comparison to unagglutinated erythrocytes. 
A concentration, temperature and incubation time dependent rise in the 
hemolysis of trypsinized rabbit erythrocytes was observed in the presence of BfHG-1. 
The hemolysis of the erythrocytes in the presence of BfHG-1 showed a sharp rise with 
the increasing pH up to 7.5 and became constant till pH 9.5. 
The exposure of BfHG-1 treated trypsinized rabbit erythrocyte suspension was 
exposed to various sachharides revealed that lactose and sucrose provided maximum 
protection against hemolysis, while glucose and galactose provided lesser protection. 
When exposed to superoxide radicals (O ) generated from a pyrogallol auto-oxidation 
system, BfHG-1 treated trypsinized rabbit erythrocyte suspension released higher 
oxyhemoglobin in comparison to the unagglutinated erythrocytes. The extent of 
erythrocyte hemolysis was found to be directly proportional to HOCl concentrations. 
No significant change was observed in the hemolysis of BfHG-1 agglutinated 
erythrocytes collected from pre-operated breast and prostate cancer patients as 
compared to the non-agglutinated, whereas significant increase was observed in the 
lectin agglutinated erythrocytes of normal healthy controls and both the post-operated 
cancer patients. In breast cancer patients, lectin agglutinated pre-operated erythrocytes 
showed 36% and 28% decrease in hemolysis as compared to the control and post-
operated erythrocytes, respectively. While, in prostate cancer patients, lectin 
agglutinated pre-operated erythrocytes showed 49% and 28% increase in the 
hemolysis as compared to the control and post-operated erythrocytes, respectively. 
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Conclusions 
Purification and characterization of buffalo heart galectin 
We for the first time report the purification and extensive physicochemical 
characterization of a Gal-1 from Bubalus bubalis heart. The finding that BfHG-1 is the 
most stable mammalian heart galectin purified till date recommends their preferential 
use in various recognition studies (e.g., molecular imprinting). 
The susceptibility of carbohydrate binding activity of BfHG-1 to oxidative 
inactivation might serve as an important parameter for the measurement of the effect 
of oxidative assault on the galectin expression under various pathological conditions. 
Thus, Gal-1 might have been evolved as a simple tool, which cells could use to 
temporarily modify local interaction with laminin, for themselves as well as for 
neighboring cells. Moreover, marked reduction in the activity of the oxidized galectin 
may suggest its potential role in free radical induced oxidative stress mediated 
cardiovascular disorders. 
Deglycosylation studies 
The startling revelation of BfHG-1 being glycoproteinic in nature and remarkable 
differences observed in the physicochemical properties of the native and 
deglycosylated galectin is maiden attempt in galectin biology, as no mammalian 
glycosylated heart galectin has been reported and effect of deglycosylation 
investigated so far. 
In all the parameters studied, deglycosylation resulted in reduced activity of 
the purified protein. The present study, therefore, holds promise as our findings 
strongly emphasized that glycosylation plays a vital role in maintaining the structural 
and functional integrity of BfHG-1. Hence, laying great emphasis on glycosylation as 
one of the most important post-translational modifications for newly synthesized 
galectins, our findings open further avenues for future investigation in understanding 
the role of glycosylation in galectin functioning and add an important dimension to 
the significance of galectin glycosylation and its associated biological and clinical 
relevance. 
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Immunological, oxidative burst and degranulation studies 
The findings of immunological studies conclusively demonstrated that BfHG-l 
is phylogenetically related with earlier reported Gal-1. Under similar experimental 
conditions, the effect BfHG-l and neutrophil activators on oxidative burst of buffalo 
neutrophils was found to be approximately three times lesser than degranulation of 
buffalo neutrophils, which in tum can be attributed to contrasting differences 
emerging at the molecular signal levels, which rest to be investigated. 
On the basis of our findings, we propose that local Gal-1 concentration under 
physiological conditions might reach suitable levels for neutrophil stimulation, and 
therefore, lectins might act as a natural inducer of oxidative burst (O^' production) or 
degranulation (lysozyme production). Thus, Gal-1 induced free radical production 
may fiirther enhance the existing oxidative stress in vivo which may play a significant 
role under various pathological conditions, especially so during infections. Moreover, 
BfHG-l produced enhanced neutrophil response in vivo in combination with some 
other stimuli like neutrophil activators. 
Erythrocyte membrane studies 
The effect of lectin on the oxidative damage to the erythrocyte membranes 
revealed that the perturbations induced rendered the membranes more vulnerable to 
oxidative attack. The leaks or pores formed in the lipid bilayer might have facilitated 
the superoxide ions to penetrate through the hydrophobic cellular membrane which 
was earlier impermeable to these ions. Therefore, the purified buffalo heart lectin by 
the virtue of its hemolytic and cytolytic functions might be involved in the defense 
mechanism of mammalian system probably by acting directly as a toxic protein to 
invading microorganisms or by neutralizing foreign substances by binding to their 
carbohydrate moieties and thus making them susceptible to oxidative attack. 
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Abstract A soluble /J-galactoside-binding lectin was 
purified by gel filtration chromatography from Buhalus 
biihalis heart. Its metal-independent nature, molecular 
weight of 14.5 kDa, preferential affinity for fi-D-laclose, 
and 87-92% identity with carbohydrate recognition 
domain of previously reported galectin-1 confirmed its 
inclusion in galectin-1 subfamily. Stokes radii determina-
tion using gel filtration under reducing and non-reducing 
conditions revealed its homo-dimeric nature, further con-
firming its Gal-1 nomenclature. The purified lectin was 
found to be the most stable mammalian heart galectin 
purified till date, suggesting its preferential use in various 
recognition studies. Treatment of the purified lectin with 
oxidizing agent, thiol blocking reagents, denaturants, and 
detergents resulted in significant changes in UV-VIS, 
fluorescence, CD and FTIR spectra, which strongly 
emphasized the impwrtant aspect of regular secondary 
structure of galectins for the maintenance of their active 
conformation. Reduction of the activity of the purified 
lectin after oxidafion by H2O2, with remarkable fluores-
cence quenching, may suggest potential role for galectin-1 
in free radical-induced, oxidative stress-mediated cardio-
vascular disorders. The predictions of bioinformatics 
studies were found to be in accordance with the results 
obtained in wet lab. 
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Introduction 
Galectins are the family of proteins defined by at least one 
characterisfic carbohydrate recognition domain (CRD) with 
affinity for /^galactosides, sharing certain conserved 
sequence elements, and requiring a reducing environment 
but not divalent cations for their binding activity (Barondes 
et al. 1994). They are distinguishable from all other animal 
lectins by their molecular weight and variable sub-cellular 
location. The CRD of galectins consist of 134 amino acid 
residues tightly bound into a sandwich of a six stranded and 
a five stranded anti-parallel /^sheets that form extended 
/{-sandwich with a typical jelly-roll topology (Liao et al. 
1994). Fifteen members of this gene family have now been 
isolated, purified, and characterized from vital organs of 
almost all taxa of the living world (Hasan et al. 2007). 
Galectin-1 (Gal-1) is the most abundant member of the 
galectin family ubiquitously distributed in animal tissues, 
including heart of mammals (Bardosi et al. 1990), and has 
been reportedly involved in a wide range of significant 
biological functions (Hasan et al. 2007). In mammalian 
heart, Gal-1 is localized mainly in endocardial tissue, 
myocardial cell constituents, connective-tissue elements, 
and vascular structures (Bardosi et al. 1990). The basic 
physiological function assigned to Gal-1 in a healthy 
individual heart includes adhesion, transport and apoptosis. 
Although galectin activity in mammalian heart was first 
reported almost four decades ago (Waard et al. 1976), only 
few mammalian heart galectins have been thoroughly 
characterized till date. However, Gal-1 involvement in 
Published online: 31 March 2010 Springer 
G. M. Ashraf et al. 
various cai-diovascular disorders like Chagas' disease 
(Giordanengo et al. 2001), hypoxia-induced pulmonary 
hypertension (Case et al. 2007), atherogenesis (Chellan 
et al. 2007), atherosclerosis and restenosis (Moiseeva et al. 
2003) strongly recommends detailed exploration of mam-
malian heart gaiectins. 
In the present study, we purified and extensively charac-
terized a .soluble /i-galactoside-binding lectin from Buhalus 
bubalis. The thermal and pH stability range of the purified 
lectin was determined, and the extent of conformational 
changes induced by interaction of the lectin with thiol 
blocking reagents, denaturants, and detergents were moni-
tored. The effect of an oxidizing agent on the lectin activity 
was monitored to gain information regarding its possible 
functional involvement in free radical-induced, oxidative 
stress-mediated cardiovascular disorders (Elola et al. 2005; 
Aragno et al. 2008). Amino acid sequencing of the purified 
lectin confirmed its inclusion in Gal-1 subfamily, and its 
structural analysis helped understand the important aspect of 
secondary structures. Bioinformatics studies were carried 
out to further analyze the results obtained in wet lab. 
phosphate buffer pH 7.2, containing 0.15 M NaCl, 5 mM 
/}-ME and 0.02% (w/v) sodium azide]. After extensive 
dialysis against PBS 'B', the samples were centrifuged for 
30 min at 15,000 rpm at 4°C to remove any aggregate 
formed, and the clear supernatant was subjected to 
Sephadex G50 gel filtration column packed according to the 
method of Laurent and Killander (1964) with some modi-
fications. A purification column (2 x 60 cm) was prepared 
with sufficient amount of pre-swelled, fines removed 
Sephadex G50 gel (56 cm length). The dialyzed sample 
obtained after ammonium sulfate fractionation was applied 
at room temperature to the column. The column was then 
eluted with PBS 'B' at a flow rate of 10 ml/li, 3 ml frac-
tions were collected, and protein concentration was deter-
mined in each fraction by the method of Lowi"y et al. 
(1951). Hemagglutination activity of the lectin .samples 
were determined with tryp.sinized rabbit erythrocytes by 
twofold serial dilution on microliter V-shaped plates (Lis 
et al. 1994). 
Polyacrylamide gel electrophoresis (PAGE) 
Materials and methods 
Materials 
Molecular weight markers, sugars, Sephadex GKX) and Gsn, 
acrylamide, bisacrylamide, cysteine, sodium phosphate, 
sodium chloride (NaCl), ethylene diamine tetra acetic acid 
(EDTA), /i-mercaptoethanol (/i-ME), lactose, sodium 
azide, Coommassie brilliant blue G-250, and R-250 were 
purchased from Sigma Chemical Co, USA. Microtiter 
plates (V-shaped, 96 wells) were purchased from Laxbro, 
India. All the other chemicals used were of analytical grade 
and purchased from Merck India Ltd, Qualigens Fine 
Chemicals, India. 
Isolation and purification of buffalo heart lectin 
Freshly obtained heart tissue (100 g) was removed from its 
pericardium, minced into small piece.s, and suspended in 
200 ml ice-chilled PBS 'A' [75 mM sodium phosphate 
buffer pH 7.2, containing 0.15 M NaCl, 10 mM EDTA, 
5 mM li-ME, 200 mM lactose, and 0.02% (w/v) sodium 
azide]. Homogenization was carried out at 4°C in a stain-
less steel vessel using mixer table homogenizer. The 
homogenate was centrifuged in a Beckman C-24 BL 
cooling centrifuge (JA-20 rotor) for 30 min at 10,000 rpm 
at 4°C; the supernatant thus collected was centrifuged 
twice for 30 min at 15,0(X) rpm at 4°C and subjected to 
30-70% ammonium sulfate fractionation. The precipitate 
obtained wa.s dissolved in PBS 'B' [75 mM sodium 
To test homogeneity of the purified lectin, both native and 
sodium dodecyl sulfate (SDS)-PAGE were performed by 
the method of Laemmli (1970) using slab gel apparatus 
manufactured by Genei Pvt. Ltd., Bangalore, India. Rou-
tinely 12.5 and 15% acrylamide gels were run. Stock 
solutions of 30% acrylamide, containing 0.8% bi.sacryl-
mide, 1.0 M Tri.s-HCl (pH 6.8), 37 nl TEMED, and a 
pinch of ammonium persulfate were mixed in specific 
proportion to give desired percentage of acrylamide gel. 
The lectin samples to be loaded on tlie native PAGE were 
mixed with 10 mM Tris-HCl buffer (pH 8.0), containing 
1 mM EDTA, 10% glycerol, 2.5% (v/v) 2-mercaptoethanol 
and traces of bromophenol blue as a tracking dye. Elec-
trophoresis was carried out in Tris-glycine buffer (0.025 M 
Tris + 0.2 M glycine) at 100 V till the tracking dye 
reached the gel bottom. 
The lectin samples to be loaded on the SDS-PAGE were 
mixed with 10 mM Tris-HCl buffer (pH 8.0), containing 
1 mM EDTA, 2% SDS, 10% glycerol and 2.5% (v/v) 
2-mercaptoethanol and traces of bromophenol blue as a 
tracking dye. Samples were then boiled for 5 min in a 
boiling water bath and electrophoresis was carried out in 
Tris-glycine buffer (0.025 M Tris -f 0.2 M glycine -|-
0.02% SDS) at 100 V till the tracking dye reached the gel 
bottom. The electrophoresed gels were then stained with 
CBB R-250 dye. 
Molecular weight determination 
Molecular weight of the purified lectin was determined 
using Sephadex GHX) gel filtration column (2 x 60 cm) 
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under native (without /i-ME) as well as reduced (with 
li-ME) conditions. The purified lectin along with standard 
molecular weight markers was loaded on the column. The 
column was then eluted with PBS 'B' at a flow rate of 
10 ml/h; 3 ml fractions were collected, and protein con-
centration was determined in each fraction by the method 
of Lowry et al. (1951). The data were analyzed according 
to the theoretical treatment of Andrews (1965). The linear 
plot between elution volume (Ve)/void volume (Vo) and 
log M was used and calculated the molecular weight of the 
lectin. 
The subunit molecular weight of the purified lectin was 
calculated by the procedure of Weber and Osbom (1969), 
using its mobility on SDS-PAGE. The mobility of the 
maiker proteins determined under identical conditions was 
plotted against the logarithm of molecular weight. The 
analysis of data indicated a linear relationship between 
log M and relative mobility (Rm), and the plot wa.s used for 
calculating molecular weight of the lectin. 
Stokes radius determination 
Gel filtration data were used to determine Stokes radius of 
the purified lectin. The partition coefficient {K^) value of 
each marker protein was calculated from the formula 
/i^ av = (Ve - V;,)/(V, - VJ, where V, stands for 'total bed 
volume'. A linear plot between the square root of the 
negative logarithm of K^^ and Stokes radii of the marker 
proteins was used for calculating Stokes radius of the 
purified lectin. 
Determination of diffusion coefficient 
Diffusion coefficient (D) of the purified lectin was com-
puted by the equation, D = KTI6nr]r, where, K is the 
Boltzman constant (1.386 x 10"'^ erg/deg), T is the 
absolute temperature (303 K), r\ stands for the coefficient 
of viscosity of the medium (0.0100/* for water and dilute 
aqueous salt solutions at 20°C) and r is Stokes radius. 
Carbohydrate-binding specificity 
Sequencing of tryptic and chymotryptic peptides: 
enzymatic digestion and purification 
Purified lectin (2 mg in 3 ml of PBS containing 5 mM /<-ME 
and 0.5 M NaCl) was dialyzed against 0.01 M ammonium 
hydrocarbonate and iyophilized. The lyophilized lectin was 
dissolved in 400 pi of 8 M deionized urea/0.05 M Tris-HCl 
pH 8.3, reduced with 0.045 M dithiothreitol (40 nl) at 50°C 
for 30 min, and then carboxamidomethylated with 0.1 M 
iodoacetamide (80 pi) under nitrogen atmosphere at room 
temperature for 2 h. The carboxamidomethylated galectin 
was diluted to 2 ml with distilled water and digested with 
trypsin and high specificity chymotrypsin at 37°C for 20 h 
using a 1:20 enzyme/substrate ratio. Tlie tryptic and chy-
motryptic peptides were separated by reverse phase HPLC 
(Pharmacia LKB, Sweden) on a Vydac C18 column 
(4.7 X 250 mm) equilibrated with 0.1% trifluoroacetic acid 
in water (v/v). The column was eluted at a flow rate of 
1.0 ml/min with 0-60% acetonitrile linear- gradient in 0.1% 
trifluoroacetic acid (v/v) during 10 min. 
Amino acid sequencing and computerized sequence 
comparison 
The peptide fragments were then applied to a polybrene-
coated glass filter and sequenced in an Applied Biosystems 
model 477A automatic .sequencer mn according to the 
manufacturer's instructions. Searches for similarities to 
the determined sequences were performed with the aid of 
the Swiss-Prot protein sequence data bank and ExPASy 
tools. The peptides were then aligned by tlieir similarities. 
Effect of divalent metal cations 
To examine the effect of divalent metal cations on the 
activity of the lectin, demetallization of purified lectin 
(100 pg/ml) was canied out u.sing 0.1 M EDTA followed 
by remetallization of the sample with 0.1 M CaCl2 and 
MnClz, [Sr(CH3CC)0)2], MgClj, and NiClj in PBS 'B'. 
Hemagglutination activity of each sample was tested by 
using a microtiter plate assay. 
Standard saccharide solutions (100 mM each) were pre-
paied with appropriate concentration in 0.15 M NaCl. To 
determine the minimum concentrations required for the 
inhibition of hemagglutination by these sugars, 25 pi of 
serially diluted test sugars were added to each well con-
taining 25 pi of lectin samples containing four agglutinat-
ing units. Fifty microliters of trypsinized erythrocytes were 
added into each well, and the contents were mixed by 
gentle shaking and incubated for an hour at room temper-
ature. Hiphest dilution of the test saccharides required for 
complete inhibition was noted. 
Human blood group specificity 
Hemagglutination ability of tire purified lectin was also 
scanned using trypsinized as well as untrypsinized prepa-
rations of human erythrocytes (blood groups A, B, AB and 
O) by the twofold serial dilution method. 
Determination of sulfhydryl groups 
The exf)osed thiol (-SH) groups were determined accord-
ing to the procedure of EUman (1959). The number of free 
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thiol groups was calculated in 'millimoles' using cysteine 
as standard. 
Thermal stability 
The purified lectin (100 jig/ml) was incubated in PBS 'B' 
at various temperatures (30-80°C) for 30 min. The samples 
were then cooled on ice, and hemagglutination activity of 
each sample was tested by using a microliter plate assay. 
pH stability 
For determining the pH stability, the purified lectin 
(100 |ig/ml) in 50 l^l of normal saline containing 5 mM 
/(-ME were incubated for 24 h at 4°C with 50 ml of the 
following buffers: 0.1 M sodium acetate buffer (pH 3.5-
5.5), 0.1 M sodium phosphate buffer (pH 6.5-7.5), 0.1 M 
Tris-HCl buffer (pH 8.5-9.5), and 0.1 M glycine-NaOH 
buffer (pH 10.5-11.5). Hemagglutination activity of each 
sample was tested by using a microliter plate assay. 
Effects of thiol blocking agents 
The rates of reaction of the purified lectin (1(K) ng/ml) with 
70 mM each of iodoacetamide, iodoacetate, /;-hydroxy-
mercuric benzoate (pHMB), and A^-ethylmaleimide (NEM) 
were determined at room temperature in PBS 'B'. After the 
designated time, the hemagglutination activity of each 
sample was tested by using a microliter plate assay. 
Effects of denaturing agents 
The effects of the denaturants on the purified lectin 
(100 ng/ml) were determined by incubating tlie lectin 
samples with increasing concentrations (0-8 M) of urea, 
guanidine HCl (GdnHCl), and thiourea in PBS 'B' al 37°C 
for 1 h. Hemagglutination activity of each sample was 
tested by using a microliter plate assay. 
Effects of detergents 
The effects of different detergents were monitored by 
incubating the purified lectin sample (100 ng/ml) with 
increasing concentrations (1-5 M) of SDS, Tween-20 and 
Triton X-100 in PBS 'B' at 37°C for 1 h. Hemagglutination 
activity of each sample was tested by using a microliter 
plate assay. 
Equilibrium dialysis 
The binding of lactose to the purified lectin was quantita-
tively studied in PBS 'B' by equilibrium dialysis in dialysis 
bags (3 ml capacity) made from Sigma cellulose 
membrane. The dialysis bags containing 100 [ig/ml of the 
lectin solution were placed in plastic vials containing 1 ml 
of lactose solution in the range of 40-400 |xM. After 
equilibrating for 24 h at 37°C, a portion was taken from the 
lectin-free compartment, and its carbohydrate content was 
estimated (Dubois el al. 1956). The amount of lactose 
bound per mole of galectin was calculated according to 
Scalchard analysis. 
UV-VIS spectroscopy 
The requirement of a reducing agent for maintenance of 
lectin activity was further investigated by measuring the 
time-course effect of an oxidizing agent on native lectin by 
adding 5 mM H2O2 in PBS 'B' in the absence of [i-ME. 
The UV spectra of native (100 ^g/ml in PBS 'B' con-
taining ^-ME) and oxidized lectin (100 )ig/ml in PBS 'B' 
containing 5 mM H2O2 in the absence of /<-ME) were 
measured with an UV-1700 Pharmaspec UV-VIS double 
beam spectrophotometer (Shimadzu Corp., Kyoto, Japan) 
in the wavelength range of 220-320 nm. 
Fluorescence spectro.scopy 
Intrinsic fluorescence of the purified lectin (100 |ig/ml) was 
measured al 25°C in a Hitachi F-200 spectrofluorometer 
(Hitachi, Tokyo, Japan) equipped with a DR3 recorder. The 
lectin was selectively irradiated using an excitation wave-
length of 280 nm with 10-nm band-pass. Emission spectra 
were measured in the range of 300-400 nm. Changes in the 
fluorescence spectra in the presence of 0.1 M lactose, 
5 mM H2O2, 8 M urea, 70 mM pHMB, and 5 M SDS 
solutions were also recorded. Appropriate controls con-
taining the substances used for treatment were also evalu-
ated. Each spectrum was the average of five scans. 
Circular dichroism (CD) spectroscopy 
All CD measurements were carried out on Jasco spectro-
photometer model J-810 using a SEKONIC XY plotter 
(model SPL-4301A) with a thermostatically controlled 
(25°C) cell holder attached to a NESLAB model RTE-210 
water bath with an accuracy of ±0.10°C. The instrument 
was equipped with a microcomputer and pre-calibrated 
with ("f )-10-camphorsulfonic acid. CD measurements were 
taken in the far UV region (200-250 nm) as well as the 
near UV region (250-350 nm) using purified lectin con-
centration of 250 |ig/ml and 1 mg/ml, respectively. Spectra 
of the native lectin were recorded with a scan speed of 
100 nm/min with a response time of 1 s. Changes in the 
CD spectra in the presence of 0.1 M lactose, 5 mM H2O2, 
8 M urea, 70 mM pHMB, and 5 M SDS solutions 
were also recorded. Appropriate controls containing the 
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substances used for treatment were also evaluated. Each 
spectrum was the average of five scans. 
Fourier transform infrared (FTIR) spectroscopy 
The FTIR measurements were carried out on NICOLET 
(ESP) 560 spectrophotometer (USA) equipped with a 
transmission OMNIC ESP 5.1 software and a DTGS 
detector. Spectra of the native galectin (150 (xg/ml in PBS 
'B') were recorded at 37°C with a resolution of 4 cm~' and 
128 scans. Changes in the FTIR spectra in the presence of 
0.1 M lactose, 5 mM H2O2, 8 M urea, 70 mM pHME, and 
5 M SDS solutions were also recorded. The changes in the 
peak frequency and intensity were then assigned to the 
conformational change within the lectin. Appropriate 
controls containing the substances used for treatment were 
also evaluated. Each spectrum was the average of five 
.scans. 
Bioinformatics studies 
The amino acid sequence of the purified lectin was for-
matted using DNA tools (http://biology.semo.edu/cgi-bin/ 
dnatools.pl). BLAST-P (http://www.ncbi.nlm.nih.gov/ 
BLAvST) and CLUSTALW (http://www.ebi.ac.uk/clustalw 
) tools were used to further corroborate the amino acid 
sequence. The Peptide cutter program of ExPASy tools was 
u.sed to predict the digestion pattern of the purified galectin 
by trypsin and high specificity chymotrypsin in reverse 
phase HPLC. The theoretical average mass and monoiso-
topic mass of the purified lectin were predicted using 
ExPASy tools and compared with the findings of wet lab. 
Probable secondary structure of the purified lectin was 
explored using the 3D-J1GSAW Comparative Modeling 
Server program of ExPASy tools. 
Results and discussion 
About 70% of total active protein was precipitated between 
30 and 70% of ammonium sulfate saturation, resulting in 
3.95-fold purification. After extensive dialysis against PBS 
'B ' , the salt-fractionated protein was chromatographed on 
Sephadex G50 gel filtration column equilibrated with the 
same buffer. Table 1 shows the purification of lectin from 
100 g buffalo heart tissue. The purified lectin yield of 
0.97 mg represented 63% recovery with a 1,715.3-fold 
purification. The purified lectin moved as a single band on 
both the native (Fig. 1, inset 'a') and SDS-PAGE (Fig. 1, 
inset 'b'), suggesting homogeneity of the preparation with 
resjject to charge and mass. 
On Sephadex Gioo gel filtration column, the purified 
lectin eluted as a monomer of 14.5 kDa under reducing 
conditions, whereas it eluted as a dimer of 29 kDa under 
non-reducing conditions (Fig. 1), which revealed its homo-
dimeric nature. SDS-PAGE also demonstrated the molecular 
weight of the purified lectin as 14.5 kDa (Fig. 1, inset 'b ') . 
The Stokes radii of the monomer and the dimer lectin were 
found to be 17.8 and 26.3 A, respectively. The diffusion 
coefficients of the monomeric and dimeric forms of the lectin 
corresponding to their respective Stokes radii were com-
puted to be 12.5 X 10~'^ and 8.47 x 10"'^ cm^/s, respec-
tively. These findings further confirmed the homo-dimeric 
nature of the purified buffalo heart lectin. 
Structural variations in the CRD topology of galectins 
have been reported to contribute to their extraordinary sen-
sitivity toward corresponding sugar residues (Reuter and 
Gabius 1999), and formed the basis of our studies regarding 
their specificity toward various saccharides. Hemaggluti-
nation inhibition studies using a number of saccharides 
(Table 2) led to the conclusion that the purified lectin was 
sjjecific for saccharides bearing non-reducing terminal 
D-galactose linked in a /^-configuration. This was further 
supported by tlie observation that methyl-a-D-galactopy-
ranoside andp-nitrophenyl-a-D-galactopyranoside are weak 
inhibitors (>100 mM required for inhibition) as compared 
to methyl-/f-D-galactopyranoside and /j-nitrophenyl-/^D-
galactopyranoside (5.4 and 5.6 mM, respectively, required 
for inhibition). The affinity for /^galactosides satisfied the 
first major criterion for inclusion of the purified buffalo heart 
lectin in Gal-1 subfamily. The fulfillment of second major 
criterion (conserved 134 amino acid CRD) for inclusion of 
Table 1 Purification table of BrHG-1 
Step fraction 
Crude homogenate 
Ammonium sulfate firaction 
Gel filtration chromatography 
Total ] 
(mg)' 
2,730 
586 
0.97 
protein Total activity 
(titer)'' 
19,888 
13,952 
12.544 
Specific activity 
(titer/mg protein) 
7.03 
27.75 
12,058.8 
Purification 
fold 
1.0 
3.95 
1,715.3 
Yield (%) 
100 
70 
63 
Values are means of three different preparations from 100 g fresh buffalo heart tis.sue 
Yield (%) of the fraction = (total activity of the fraction x 100)/total activity of crude homogenate 
" Determined by the method of Lowry et al. (1951) 
'' The titer of the tested galectin is expressed a,s reciprocal of the highest dilution showing agglutination of trypsinized rabbit erythrocytes 
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Table 2 Effect of saccharides on hemagglutination activity of BrHG-
1 
Saccharides Minimum inhibitory 
concentration (mM) 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 
Relative mobility (Rm) 
Fig. 1 Purification and molecular weight determination of BfHG-1: 
Jnset A shows native PAGE of the purified protein (35 \ig). Inset B 
shows SDS-PAGE of the purified protein: lane a contains molecular 
weight markers (35 ng) in descending order of their molecular 
weights, and lane b contains purified protein (35 ng). Molecular 
weight of the purified protein was determined by gel filtration 
chromatography under native (without ^-ME) as well as reduced 
(with ^-ME) conditions. The purified protein along with standard 
molecular weight mariLers were loaded on the column calibrated with 
PBS 'B' and eluted with a flow rate of 10 ml/h. The linear plot 
between elution volume (Ve)/void volume (Vo) and log M was drawn 
using linear fit and used for calculating the molecular weight. The 
elution position of monomer and dimer BfHG-I are indicated by 
arrows. The molecular weight markers u.sed were: PB phosphoryla.se 
h (97.4 kDa); BSA bovine serum albumin (68 kDa); OA ovalbumin 
(45 kDa); CA carbonic anhydrase (29 kDa); STl soyabean trypsin 
inhibitor (20.1 kDa); Lys lysozyme (14.4 kDa). The relative mobil-
ities (Rm) of the marker proteins were plotted against their molecular 
weight using least square analysis of the data 
the purified lectin in Gal-1 subfamily required its amino acid 
sequencing. 
For determining the amino acid sequence the purified 
lectin was subjected to tryptic and chymotryptic hydrolysis. 
The peptide fragments thus obtained were separated by 
reversed phase HPLC (Fig. 2). The peaks Tj-Fg repre-
.senting pure peptides (Fig. 2a) were subjected to amino 
acid analysis and automated sequencing (Fig. 3), except for 
T6. The presence of an acetyl group was deduced from 
blocked N-terminus of the T6 fragment, as reported for 
other Gal-1 (Shahwan et al. 2004). Figure 2b represents the 
HPLC profile of fragments obtained by chymotryptic 
digestion. The sequence not established by Uyptic digestion 
(T6) was subjected to Edman degradation, and the resulting 
fragments were designated C1-C3. Sequence alignment of 
the purified lectin with other Gal-1 characterized from 
cattle myelin sheath (Abbott et al. 1989), bovine heart, 
human brain, rat lung, and sheep brain (as referred in 
-^D-Lactose 0.5 
D-Galactose 3.0 
Methyl-^-D-galactopyranoside 5.4 
/>-Nitrophenyl-^ -D-galactopyranoside 5.6 
D-Galactosamine 27.0 
Methyl-a-D-galactopyranoside >100 
p-Nitrophenyl-a-D-galactopyranoside >100 
D-Glucose >100 
Standard solution of various saccharides (100 mM) were prepared in 
0.15 M NaCl, and four agglutinating units of the BrHG-1 was used in 
twofold .serial dilution method to determine the minimum concen-
tration required for inhibition of hemagglutination by various sugars 
The following substances were tested and had no inhibitory activity at 
100 mM: o-mannose, o-fucose, D-sucrose (Glc-a-l,2-Fuc), o-melibi-
ose, D-glucosamine, t)-cellobiose, o-fructose 
Shahwan et al. 2004) showed a significant degree of 
identity (87-92%), in agreement with its high conservation 
throughout evolution. These results suggested that the 14.5-
kDa Gal-1 was species specific rather than organ specific 
(Bladier et al. 1991). In addition, the con.servation of amino 
acid residues that interact with carbohydrate ligands 
(His44, Asn46, Aig48, His52, Asp54, Asn61, Trp68, 
Glu71, and Arg73) allowed us to classify it as having type 
1 con.served CRD (Fig. 3). The conserved 134 amino acid 
CRD satisfied the second major criterion for inclusion of 
the purified buffalo heart lectin in Gal-1 subfamily. 
The amino acid sequencing allowed us to explore the 
molecular determinants of saccharide-binding .specificity. 
Inhibition of the lectin activity by D-galactose and 
D-galactosamine indicated that a free hydroxyl or a free 
amino group at C2 was required for a monosaccharide to 
cause inhibition. Moreover, the configuration at C4 was 
also important, since neither D-glucose nor D-glucosamine 
caused inhibition. The fact that lactose was far more potent 
inhibitor for hemagglutination activity of the purified lec-
tin, suggesting that carbohydrate-binding site of the 
galectin could have extended geometry, which was only 
partially occupied by the galactose molecule. It appeared 
that the aromatic side chain of the conserved Trp68 stacks 
adjacent to the galactose ring. Such van der Waal inter-
actions between sugar and aromatic side chains are quite 
common in protein-carbohydrate complexes (Kasai and 
Hirabaya.shi 1996). The axial 4-OH of galactose, a main 
determinant of the galectin specificity, formed two key 
electrostatic interactions: one with the N atom of Arg48 
and the other with the N atom of His44 (Shahwan et al. 
2004). Both are found as invariant residues in the 
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Fig. 2 HPLC profile of peptides obtained by tryptic (a) and 
chyinotryptic (b) digestion of BrHG-1. Peptides were separated by 
reversed phase HPLC on a Vydac CIS column equilibrated with 0.1% 
(v/v) trifluoroacetic acid in water. Elution was performed at a flow 
rate of 1.0 ml/min with 0-60% acetonitrile linear gradient in 0.1% 
(v/v) trifluoroacetic acid for 10 min, and the elution was monitored at 
220 nm. Peaks Ty-Tq represent tryptic peptides, and Cy-Ci represent 
chymotryptic peptides, whose sequence was determined by Edman 
degradation and established from amino acid sequence 
sequences of various galectins (Fig. 3). An ammonium 
group on C2 (D-galactosamine, D-glucosamine) decreased 
the inhibitory properties, likely because of its positive 
charge. Unlike human brain galectin-1, which required low 
concentrations of ^-D-galactose, p-nitrophenyl-^-D-galac-
toside and D-fucose (1.4, 0.4, and 25 mM, respectively) for 
complete hemagglutination inhibition (Bladier et al. 1989), 
the purified buffalo heart lectin required higher concen-
trations of these saccharides (3.0, 5.6, and >100 mM, 
re.spectively), suggesting its own unique specificity. 
Like other members of Gal-1 subfamily, the purified 
buffalo heart lectin was also found to be a homo-dimer 
composed of two subunits having one CRD each of 134 
amino acids. It can also be classified as 'prototype' 
according to its molecular architecture as it neither had a 
link peptide joining two CRDs nor had the CRD joined to 
different types of domains as found in 'tandem repeat' and 
'chimera' topologies, respectively. Besides, the purified 
lectin showed the characteristics of cytoplasmic proteins. 
such as an acetylated N-terminal amino group and the lack 
of hydrophobic trans-membrane .segment and secretion 
signal peptide similar to other Gal-1 (Barondes et al. 1994). 
These findings confirmed that the purified lectin belongs to 
Gal-1 subfamily, and hence can be named as buffalo heart 
galectin-1 (Bj-HG-l). The metal-independent nature of the 
purified lectin activity further confirmed its inclusion in 
Gal-1 family, similar to other Gal-1 (Ola et al. 2007). 
The concentration of purified lectin required for hem-
agglutination varied markedly with the type of human 
erythrocytes. BfHG-1 agglutinated native human erythro-
cytes with marked preference for the blood group A, with 
the overall order of preference being A > 0 > AB > B. 
Exposed thiol group analysis of BfHG-1 indicated a molar 
ratio of 2.9, suggesting the presence of approximately 
3 moles of sulfhydryl group per mole of lectin. The hem-
agglutination activity of the purified lectin was fully 
retained up to 48°C, and then gradually dropped and 
completely lost at 68°C. The purified lectin was found to be 
quite stable in the pH range of 4.5-10.5; however, it 
showed maximum hemagglutination activity near physio-
logical pH 7.4. These findings suggested that BfHG-1 may 
be the mo.st stable mammalian heart galectin that have been 
purified till date. 
The structural and functional integrity of BfHG-l was 
assayed in the presence of various thiol blocking reagents, 
chaotropic denaturants, and detergents in order to highlight 
its susceptibility to them. The need of reduced form of 
cysteine for the maintenance of BfHG-1 in its active foiTn 
(Shahwan et al. 2004; Ola et al. 2007) was further con-
firmed by its differential inhibition in the presence of 
various thiol blocking reagents. The lost of galectin activity 
might be due to the possible conformational changes that 
occurred during modification of cysteine residues (Liao 
et al. 1994). However, relatively slower rate of inactivation 
pointed toward the possibility of cysteine molecules being 
partially buried inside the lectin, and pos.sibly not involved 
directly in carbohydrate binding, rather being present at a 
relatively distant site (All and Salaliuddin 1989). This 
perhaps explained the effectiveness of pHMB, the most 
hydrophobic thiol blocking reagent, which most readily 
inhibited the hemagglutination activity (50% inhibition in 
20 min) followed by lesser hydrophobic NEM (50% inhi-
bition in 30 min), iodoacetate (50% inhibition in 47 min), 
and iodoacetamide (50% inhibition in 60 min). 
As the chaotropic denaturants urea caused maximum 
lost in the BfHG-1 activity (50% decrease at 3.0 M), fol-
lowed by GdnHCl (50% decrease at 5.0 M) and thiourea 
(50% decrease at 6.0 M). These findings indicates that 
BfHG-1 is also stabilized mainly by hydrogen bonding and 
hydrophobic interactions like other lectins (Nelson and 
Cox 2001), which are susceptible to denaturant induced 
alteration. 
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Fig. 3 Comparison of BfHG-l 
amino acid sequence of with 
other Gal-1. BtHG-1 
notnenclature of the peptides 
was found to be consistent with 
Fig. 2. BfHG-l sequence was 
compared with other Gal-1: 
CMG-1 cattle myelin Gal-1; 
BHG-1 bovine heart Gal-1; 
SBG-1 sheep brain galectin; 
HBG-J human brain Gal-1; 
RLGl rat lung Gal-1. Identities 
to BfHG-l sequence are shown 
at the bottom right. Amino acids 
conserved in all Gal-1 are 
de.signated with asterisks. 
Amino acids from other Gal-1, 
which differ from those present 
at the same position in Bi-HG-I, 
are indicated by dots. Critical 
amino acids shown to be 
involved in the interaction with 
lactose and Af-acetyllactosamine 
are designated with (colon.':) for 
hydrogen bonding and with 
(boxe.^) for hydrophobic 
interaction, and these residues 
correspond to tfie type 1 CRD 
invariant amino acids 
CLU3TAL 2 . 0 . 1 1 m u l t i p l e .sequence al ignment; 
BfHG-l 
CMG-1 
EHG-1 
SBG-1 
HBG-1 
RLG-1 
HjHG-
CMG-1 
BHG-1 
SBG-1 
HBG-1 
RLG-1 
BfHG-
CMG-1 
BHG-1 
SBG-1 
HBG-1 
R1X3-1 
acACGLVASNLNLKPGECLRVRGEVAPDAKSFLLNLGKDDNMLCLHFt'JPBFNAHGDINTIVC 60 
I T6- —I I T l 1 I T7 II T5 
I-C2-II-C1--1 I—C3 1 
acACGLVASNLNLKPGECLRTOGEUAADAKSFLLNLGKDDNNLCLHFNPRFNAHGDVNTIVC 6 0 
acACGLVASNLNLKPGECLRVRGEVAADAKSFLLNLGKDDNNLCLHFNPRFNAHGDVNTIVC 6 0 
acACGLVASNLNLKPGECLRVRGEVAADAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVC 6 0 
acACGLVASNLNLKPGBCLRVRGEVAPDAKSFVLNI^KDSNNlCLHFNPRFNAHGDANTIVC 60 
acACGI.VA3NIjNLKPGF,CLKVRGELAPDAKSFVI;Nl.GKDSNNejCLHFMPRFNAHGDA!>]'riVC 60 
* * * * * * * * * * * * * * * * * • * * * * , , * * * * * * , * * * * * * * + * • *•*« t , * * * J 
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.,1'VKLPDGYEFKFPNRUILE/vINYM 120 
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The SDS, a well-known ionic detergent, denatured 
BfHG-l even at a very low concentration, possibly by 
changing the order of protein water molecules and also by 
intercalating into hydrophobic clefts of the lectin with its 
long hydrocarbon chain (Lanio et al. 2CX)3). Tween-20 and 
Triton X-100 being neutral detergents showed less inhibi-
tion on lectin activity for they do not bind to galectins in 
detectable amount, and were found not very efficient in 
breaking non-covalent bonds, which are responsible for the 
quaternary structure of multimeric proteins (Helenius and 
Simons 1972). 
The BfHG-l readily reacted with lactose according to 
the following reaction: 
BfHG-l 4 - / i (Lac )^ BfHG-l(Lac)« (1) 
[BfHG-l Lacn] 
K, [BfHG-l] [Lac]« 
l-l-^a[Lac] 
(2) 
(3) 
where n is the number of carbohydrate-binding sites in 
the BfHG-l dimer, 'Lac' designates lactose, 'u' stands for 
the amount of lactose bound per mole of galectin, and K.^ 
is the association constant for interaction of Lac with 
BfHG-l. 
Equation 3 can be rearranged as follows: 
n 
-K.u + nK. [Lac] (4) 
'ij' was determined in triplicate and plotted according to 
Eq. 4. 
The linear Scatchard plot of equilibrium dialysis data of 
BfHG-l in PBS 'B ' with lactose at 37°C was drawn. The 
slope of the plot gave a binding constant value, 
K^ = 7.08 X 10"' M~'. The number of binding sites was 
found to be 2.1 per lectin molecule. 
Cerra et al. (1985) reported that a reducing agent is 
necessary for initial purification of galectins, but is not 
required for their continued activity. Stability studies also 
demonstrated the role of lactose in maintaining active 
conformation of the purified protein even in the absence of 
a reducing agent, possibly by preventing its oxidative 
inactivation due to formation of intra-molecular disulfide 
linkages (Cho and Cummings 1995). Since galectins 
remain in active conformation in the presence of reducing 
agents, we speculate that they might contain a susceptible 
oxidizable residue whose integrity is cnicial for their 
activity. BfHG-l showed a UV spectrum maximum at 
280 nm, corresponding to the presence of a single Trp 
residue and a large number of other aromatic residues. 
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Fig. 4 a Fluorescence spectra. 
Intrinsic fluorescence of BfHG-1 
(100 |ag/ml)inof PBS 'B' was 
measured in the wavelength 
range of 300-400 nm. b Far 
UV-CD spectra. Far UV-CD 
spectrum of BfHG-1 
(250 |ig/ml) was recorded 
between 2(X) and 250 nm using 
0.1-cm path length, c Near 
UV-CD spectra. Near UV-CD 
spectrum of BrHG-1 (1 mg/ml) 
was recorded between 200 and 
350 nm using 0.1-cm path 
length, d FTIR spectra. 
FTIR spectrum of BrHG-l 
(150 fig/ml) at 37°C was 
recorded with a resolution of 
4 cm"' and 128 scans. Changes 
in the fluorescence, far UV-CD, 
near UV-CD and FTIR spectra in 
the presence of lacto.se, H2O2, 
urea, and SDS were also 
recorded 
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However, oxidation of BfHG-i in the presence of 5 mM 
H2O2 (without (i-ME) resulted in the shift of the absorption 
peak to 250 nm suggesting oxidation of Trp residue to an 
oxindole moiety, which absorbs maximally at 250 nm 
(Levi and Teichberg 1981). This result possibly suggested 
tliat the reducing agents not only prevent oxidation of Cys 
residues in galectins but also protect Trp from oxidation. 
When excited at 280 nm, BfHG-1 exhibited maximum 
fluorescence emission at 332 nm (Fig. 4a), typical of Trp 
residue in a hydrophobic environment. The fluorescence 
profile of the oxidized lectin showed a remarkable 
quenching in the fluorescence intensity accompanied with a 
blue shift from 320 to 342 nm. Oxidized lectin also 
exhibited a decreased activity, thus implicating intra-
molecular disulfide bonding as the basis of active confor-
mation of BfHG-1 (Whitney et al. 1986). However, the 
presence of lactose prevented the oxidation of Trp which 
was supported by a slight decrease in the fluorescence of 
the protein-carbohydrate complex. These findings stress 
upon the relevance of a reducing environment which is 
probably needed to reduce molecular oxygen normally 
present in the solutions to prevent it from oxidizing Trp 
residues (Levi and Teichberg 1981). It is also indicated that 
probably the fluorophore is present within or in the vicinity 
of lactose-binding .site and may be readily accessible to 
lactose (Levi and Teichberg 1981). This finding has been 
supported by quenching experiments carried out with H2O2 
in the presence of disaccharides in galectin solution. The 
involvement of Trp68 aromatic ring (a highly conserved 
amino acid) in an interaction with the hydrophobic part of 
the side chain of the conserved Lys63 assured its optimal 
orientation for interaction with lactose residues (Shahwan 
et al. 2(X)4). The fluorescence emission spectrum of BfHG-
1 in the presence of urea, / J H M B , and SDS .showed a 
decrease in the fluorescence intensity indicating that the 
Trp residue in native lectin is located near an intra-
molecular quenching group, and lectin denaturation 
increased this interaction. The effect of the oxidant was 
also monitored by CD and FTIR analyses. A shift in far 
UV-CD (Fig. 4b), near UV-CD (Fig. 4c), and FTIR 
(Fig. 4d) spectra showed a major transition of native sec-
ondary structure of BfHG-1 from /i-pleated form to a more 
open conformation enriched in a-helix, thus clarifying the 
reason for the loss of activity upon oxidation (Lis and 
Sharon 1993). 
The far UV-CD spectrum of native BfHG-1 showed a 
low intensity spectrum with minimum around 218 nm 
(Fig. 4b), consistent with a predominantly /i-sheet structure 
profile in accordance with other Gal-1 (Shahwan et al. 
2004). The FTIR spectrum also correlates with CD analy-
sis, consistent with tlie presence of a large percentage of 
/i-sheet structure in native BfHG-1 as suggested by 
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maximum absorbance peak at 1,630 cm" ' (Fig. 4d). The 
FTIR spectrum of native BfHG-1 was found to be truncated 
between 1,652 and 1,576 cm~'. The presence of lactose 
did not result in any significant change in secondary 
structure of native BfHG-1. However, exposure of BfHG-1 
to H2O2, urea, pHMB, and SDS caused a very marked 
change in far UV-CD (Fig. 4b), near UV-CD (Fig. 4c), as 
well as FTIR spectra (Fig. 4d), concomitant with the loss 
of fS-sheet structure. The .spectral change was consistent 
with the disruption of regular secondary structures 
(25-50% a-helix and 35-60% ^-sheet) to a random coil 
structure. It may be possible that the formation of disulfide 
bonds locks the lectin into a new inactive conformation, 
that neither can form the usual secondary structure and nor 
can bind saccharides. This strongly emphasizes the 
Table 3 Peptide cutter program of ExPASy tools was performed to 
validate the result obtained in reverse phase HPLC for digestion of 
BfHG-l by high specificity chymotrypsin and trypsin 
Name of enzyme No. of 
cleavages 
Positions of 
cleavage sites 
Chymotrypsin-high specificity 
(C-term to [FVW], 
not before P) 
Trypsin 
10 30 45 49 68 79 91 106 
119 126 133 
11 20 28 36 48 63 73 99 
107 111 127 129 
requirement of the regular secondary structure and of the 
presence of the complete polypeptide chain for maintaining 
the active BfHG-1 conformation. 
The predictions of bioinformatics studies were soundly 
in agreement with the results obtained in wet lab. BLAST-
P and CLUSTALW established BfHG-1 amino acid 
sequence similarity with other Gal-1. The predictions for 
trypsin and high specificity chymotrypsin digestion of the 
purified lectin using the Peptide cutter program of ExPASy 
tools were in accordance with the results obtained for 
reverse phase HPLC (Table 3). ExPASy tools predicted 
average mass as well as monoisotopic mass of the purified 
lectin as 14.5 kDa, thus conoborating our findings. Sec-
ondary structure prediction of BfHG-1 using 3D-J1GSAW 
Comparative Modeling Server of ExPASy tools (Fig. 5) 
was in accordance with the known secondai^ structures of 
other Gal-1. 
Conclusion 
We for the first time report the purification and extensive 
physicochemical characterization of a Gal-1 from Buhalus 
huhalis heart. The finding tliat BfHG-1 is the most stable 
mammalian heart galectin purified till date recommends its 
preferential use in various recognition studies. The sus-
ceptibility of carbohydrate-binding activity of BfHG-1 to 
Fig. 5 Secondary .structure 
prediction of BfHG-l. 
Secondary structure prediction 
of BrHG-l using 3D-JIGSAW 
Comparative Modeling Server 
program of ExPASy tools was 
in accordance with the known 
secondary structure of other 
Gal-1, and thus corroborated the 
results obtained in wet lab 
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oxidative inactivation might serve as an important param-
eter for the measurement of the effect of oxidative assault 
on the lectin expression under various pathological condi-
tions. Thus, Gal-1 might have been evolved as a simple 
tool, which cells could use to temporarily modify local 
interaction with laminin, for themselves as well as for 
neighboring cells. Moreover, a marked reduction in the 
activity of oxidized lectin may suggest its potential role in 
free radical-induced, oxidative stress-mediated cardiovas-
cular disorders. Thus, the present detailed findings 
regarding BfHG-1 are important to gain a deeper under-
standing of the role of galectins in potentially life-threat-
ening cardiova.scular diseases. 
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Abstract 
Galectins are a family of galactose binding lectins that have become the focus of attention of cancer biologists due to 
their numerous regulatory roles in normal cellular metabolism and also because of their altered levels in various cancers. 
They are reportedly similar to several prominent and established modulators of apoptosis. In this review, we present a brief 
outline of the advancements in the methodology used to detect and ideBtify them and their therapeutic applications in can-
cer. Their possible interactions with other glycoconjugates are also discussed and a vision for their future use in diagnosis 
and therapeutics is provided. 
© 2006 Elsevier Ireland Ltd. All rights reserved. 
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1. Introduction to galectins 
Structure-specific recognition between cognate 
biomolecules is being increasingly proved to be the 
initiator of events that mark major biological 
Abbreviations: CRD, carbohydrate recognition domain; SMN, 
survival of motor neurons; TTP-i, thyroid specific transcription 
factor-1; Rb, retinoblastoma; PCNA, proliferating cell nuclear 
antigen; RCF, replicatioft factor C; ECM, extracellular matrix; 
PCTA-1, prostate cgjfiMoma tumor antigen-1; GMj, A/-acetylne-
uraminosyl-{Gt2-3)-gS||iirt:|syl-(pi-4)-glucosylceramide; RT-PCR, 
reverse transcriptase pi«i|i'merase chain reaction; ELISA, enzyme-
linked immunosorbant Sissay; Glyc, carbohydrate moiety; PAA, 
polyactylamide; Fluo, fluorescein based label; LacNAc, galacto-
syl p (1-4) /V-acetyl glucosylamine; Tyr, tyrosine. 
' Corresponding author. Tel.: +91 9897000193. 
E-mail address: naheedbanu7@yahoo.com (N. Banu). 
processes, be they normal such as fertilization, 
growth and differentiation or pathological such as 
infection and cancer. Lectins which are proteins of 
non-immune origin that recognize and bind corre-
sponding sugar residues without altering the struc-
ture of the latter [1,2] play a major role in 
biological recognition. Herman Stillmark published 
one of the first reports of these molecules in 1888 
when he discovered an agglutinin of erythrocytes in 
extracts of castor beans [3]. The main interest in plant 
lectins lay in their potential use as biological reagents 
that could bind specific cell surface glycoconjugates. 
With the development of mammalian cell culture 
techniques, lectins were used to study changes in gly-
coconjugates on the surface of cancer cells, and as 
mitogens that could induce the proliferation of 
lymphocytes. One of the members of this group of 
0304-3835/$ - see front matter © 2006 Elsevier Ireland Ltd. All rights reserved. 
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proteins is the galectins. Identified as A^-acetyllactos-
amine binding proteins in the electric eel [4], they 
have been found in all taxa of the living world from 
sponges to humans [5-7]. They were formally classi-
fied into a family based on their characteristic feature 
of possessing a carbohydrate recognition domain 
and affinity for p-galactosides, besides sharing cer-
tain conserved sequence elements that require a 
reducing environment for action but no divalent ions 
[5]. Sequencing of many proteins that exhibited the 
property of binding P-galactosides revealed extensive 
sequence similarity, in addition to the already recog-
nized capacity to bind specific sugars [8]. 
7.7. Structural featttrex of galectins 
The CRD consists of 5-6 anti-parallel p-pleated 
sheets that form an extended sandwich with a typ-
ical jellyroll topology and is around 135 amino 
acids long [9]. The core sequence of this domain lies 
between the 30th and 90th residues and is encoded 
by a single exon [8]. The number and arrangement 
of the CRDs can vary and has been used as a basis 
of their classification [10]. The proto-type galectins 
are non-covalent homodimers of two identical 
CRDs that are able to cross-link ligands on cell sur-
faces and extracellular matrix [11] and include Cae-
norhahditis elegans 16kDa galectin [16], frog 
galectins [17], electrolectin [18], chicken isolectins 
C-14 and C-16 [19,20], galectins-1 [7,12], - 2 [13], 
- 5 [14], - 7 [15], -10 [10], -11 [10], -13 [10], 
-14 [10] and human Charcot-Leyden crystal pro-
tein [21]. The next class of galectins is.called the chi-
mera type galectins and possessij#';|ombined 
structure composed of a C-terniJiial €!RD linked 
to a proline, glycine and tyrosiflSj.jrich N-terminal 
domain that is important fip^jliS-'formation of 
higher order oligomers [22]. i5al.eltin-3 is the only 
member of this family^jlhi^iiihas been described in 
mammals and chicken, ,pil;;jj|,ctivated macrophages, 
basophils, mast cells alii: soigSe epithelial and tumor 
cells [23]. The tandem repeat galectins constitute 
the last class of galectins and have two distinct 
CRDs. Galectins-4 [24], - 6 [25], - 8 [26], - 9 [27] 
and -12 [10] fall in this category. 
1.2. Cellular Junctions of galectins 
Several roles have been assigned to galectins that 
range from cell adhesion [28], regulation of cell 
growth [29,30], embryonic development [31] and 
immune processes like inflammation [32]. Even 
metastasis [33,34] and apoptosis [35-37] are modu-
lated by the interactions of these molecules. The 
underlying principle of all these functions is carbo-
hydrate recognition. Galectin-1 has been shown to 
promote growth at low concentrations and to inhib-
it cellular growth at higher levels, under in vitro con-
ditions [30], Moreover, their functions include the 
regulation of gene expression. Algng with gemin-4, 
galectin-1 and - 3 act as pre-jiRNi^: splicing factors 
in the SMN splicing com|!lel|Jbr*ithe gene whose 
aberrant expression is irnppiat^d in spinal muscular 
atrophy [38,39]. It is, thfer^re* imperative that the 
expression of these ,|p61feeiiiles be tightly regulated 
as is validated by l ie Observation of their varying 
levels in specific stagStfef development [31]. Galectin 
expression has been found to be sensitive to viral 
infections ;;|4p], tumor suppressor genes [41] and 
inflammatp.rpa^ents [42]. In addition, the use of a 
differentipip|:;::agent - sodium butyrate was shown 
to modulate;! the expression of galectin-1 by tran-
scriptional regulation and histone deacetylation in 
human head and neck squamous carcinoma cells 
[43] but other than this study, not much advance-
ment has been made in this direction. Their unusual 
secretion mechanism has also been an enigma. 
Although they lack a specific secretion signal 
[28,44], galectins are secreted by a mechanism that 
is not yet understood properly. It has been suggest-
ed that some transmembrane carriers export galec-
tin-1 out of the cells by a mechanism similar to 
the export of bacterial toxins [45]. An alterative 
refers to the possible accumulation of the molecule 
to high levels of concentration at the plasma mem-
brane, which is followed by their secretion in vesi-
cles [28]. Galectins are, therefore, placed under 
regulatory controls at the level of gene expression 
and secretion and their actions are modulated by 
the regulation of the synthesis and modifications 
of their glycan ligands by glycosyltransferases, the 
presentation of their ligands by specific glycoprotein 
counterreceptors and intracellular pathways of sig-
naling that are initiated by their binding to counter-
receptors [46]. 
2. Molecular basis of cancer development due to 
galectins 
The rationale for the development of molecules 
that share sequence homology yet perform opposite 
functions can be cryptic but is nevertheless a com-
mon phenomenon in biological systems. The eluci-
dation of the functioning of Bcl-2 family of 
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apoptosis regulators provides a case in point. Cell 
death is inhibited by Bcl-2 and BCI-XL and is pro-
moted by Bax, Bad and Bak. On parallel lines, 
galectin-1 [35,36,47] causes apoptosis in T cells 
while galectin-3 [37] prevents it. Galectin-3 has sig-
nificant sequence homology with Bcl-2 [48] and they 
can be coimmunoprecipitated from Jurkat T cells 
[37]. Galectin-3 has been shown to inhibit apoptosis 
induced by Fas, staurosporine and other agents [37] 
by preserving the integrity of mitochondria and pre-
venting cytochrome c release in breast cancer cells, 
besides not allowing reactive oxygen species to form 
[49]. The myriad critical functions of galectins make 
them potent tumorigenic molecules. While there is 
no paucity of data [50], no recognizable trends 
emerge from the studies of expression alterations. 
The conflicting information in defining the roles of 
galectins is probably a result of differences in meth-
odologies and the chosen models. In this respect, 
galectin-3 is one of the best understood of all the 
members of its family [50]. Its expression in tumors 
is associated with poor prognosis because the mole-
cule protects the cancerous cells from undergoing 
death [11]. It could be used as a prognostic marker 
for thyroid cancer, colon cancer and cancers of head 
and neck squamous cells, pancreas, bladder, stom-
ach and kidneys [51]. In addition to galectin-3f 
galectin-1 is also involved in cancer development 
as it anchors the molecule Ras, which is involved 
in cellular transformation [52]. 
Galectin-3 endows metastatic potential uport 
tumor cells. Its expression in breast carcinoma cell 
line leads to rapid spread of the cells,;.§53,54]. The 
use of galectin-3 antisense cDNA,in|g;'fi|alignant 
breast cancer cell line restores the claractSristic fea-
tures of normal cells, including contact inhibition, 
serum dependence, and anchorag^ dependence 
[11]. Normal astrocytes, oligodendrocytes and their 
precursor cell lines and glial progenitor cells do not 
express this protein but glioma cell lines show its 
presence [11]. Its functioo also depends on the site 
of its localization as has been demonstrated in pros-
tate cancer studies m which cytosolic accumulation 
of galectin-3 promoted metastasis, angiogenesis 
and abolition of anchorage dependence while its 
nuclear localization inhibited metastasis, anchorage 
independence and promoted apoptosis [55-60]. Its 
interaction with the highly conserved TTF-1, which 
possesses differentiation and proliferation potential 
and is thus implicated in thyroid cancer, indicates 
that galectin-3 may regulate transcription in several 
cell types [38,61]. Moreover, the increased expres-
sion of galectin-3 in normal thyroid follicular cells 
by transfecting them with galectin-3 cDNA has 
been shown to lead to the development of a malig-
nant phenotype [62] in the cells, which is associated 
with the increased expression of Rb, PCNA and 
RCF [62], all known modulators of the Gj to S 
transition and cellular proliferation. 
Galectin-1 has also been shown to play an impor-
tant role in metastasis. It induces proliferation or 
apoptosis if its localization is extracellular and 
arrests growth if it is intracellular, thereby displaying 
the hallmark of location dependent function of 
galectins [11]. Increased malignant potential of 
human thyroid tumors [63], glioma [64] and prostate 
adenocarcinoma [65,66] has been correlated with 
enhanced expression of galectin-1. Cyclophospha-
mides administered in low doses have been shown 
to modula|g i%<!{els of galectin-1 and Bcl-2 [67]. 
Galectin-l;|q!i%: increase adhesion of cancer cells to 
ECM. It:: trikj^ - also promote apoptosis in T cells, 
therebl pfcotecting the tumor from immune 
respaaseSi" In cultures of human neoplastic astro-
cyiis, jgalectin-l addition is found to increase cell 
motility that is associated with reorganization of 
the actin cytoskeleton [11]. It also raised the levels 
of RhoA, a protein that regulates the polymerization 
and depolymerization of actin [64]. Moreover, glio-
blastoma cell migration is also increased by this 
galectin. 
While an established correlation between galec-
tin-1 mRNA expression and immunoreactive pro-
tein [68] exists, there is a dearth of clear 
understanding of the molecular cascades involved 
in galectin-1 mediated development of metastasis. 
Most probably, it is the modulation of adhesion 
of cancer cells by galectin-1 that is partly responsi-
ble for metastasis, as the molecule is known to both 
stimulate and inhibit cellular adhesion by cross-link-
ing oligosaccharides on integrins or by binding to 
laminin and sterically blocking its accessibility to 
integrins [69]. 
Much attention has been focused upon galectin-
1 and -3 but similar advances lack in elucidation of 
molecular aspects of functioning of other galectins. 
Some studies have been carried out with the result 
that galectin-7 is now suggested to be an early tran-
scriptional target for the p53 product [70] and 
galectin-8 has been recognized as the most abun-
dant galectin found in tumor cells of different ori-
gins [71], besides being identified as closely related 
to PCTA-1, a surface marker of prostate cancer 
[72]. In other studies, galectin-9 and its allelic 
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variant ecalectin were found to be expressed in 17 
of 21 tested human colorectal cancer lines [73]. Sub-
sequently, a frame shift mutation was identified in 
the coding sequence of the LGALS3 gene [73]. 
The very fact that they are possibly redundant in 
function makes the study of other galectins indis-
pensable. The failure of single and double knockout 
mice to show significant phenotypic aberrations is 
enough reason to direct efforts toward other galec-
tins [74,75]. 
3. Role of glycosylation in galectin functioning 
Glycosylation is an event known to be of para-
mount importance to cellular functioning and inter-
actions. Its aberrations have been found in all types 
of cancers and several glycosyi epitopes function as 
tumor associated antigens [76]. Yet, the information 
available about its role in carcinogenesis is quite 
nebulous, primarily because of the lack of attention 
given to this field of investigation in comparison 
with more attractive and rewarding avenues like 
genetic studies. However, the implications of abnor-
mal glycosylation in cancer development are being 
recognized. 
The specific steps involved in the development of 
cancer because of incorrect glycosylation are not 
known. One molecule that has been studied in 
much detail is GM3. It is found on the cell svlfface 
[77]. Its interaction with CD9 and CD82 beitgWS 
anti-metastatic potential on the cell [78]. (jM% 
and CD9 have even been found to be co-expressed 
in several colorectal [79] and bladder .cell lines [80]. 
A reduction in the expression of tlu#g|nglioside 
may correlate with increased chantes of metastasis 
While there is a shortage Qpi|piaiibiguous data, 
the possibility that there is a ilpMianalogy between 
the expression patterns ,(G|fgl§!|pc6njugates and their 
binding galectins canriols|?g riiled out. GM3 has 
been found to be a l igiy. p r galectin-8 [81]. This 
galectin has two ClilE|s. [26] and is involved in 
cross-linking of its'ligaiiids. Extracellularly, it can 
organize cell ^iftegiep molecules on the same cell 
as well as on dii|efent cells and the matrix [82]. A 
change in the liglnds of such a cellular anchor 
may be very important, if not tantamount, to 
metastasis. This could also be the missing link in 
the elucidation of galectin functioning and further 
studies to explore similar interactions between 
other galectins and their ligands should direct the 
course of research in the future. 
4. Detection and identification of galectins 
The detection and identification of galectins has 
come a long way from the time when their ability 
to bind P-galactosides and their cross-reaction with 
other galectins were exploited [83]. Haemagglutina-
tion of trypsin treated erythrocytes was also widely 
used as an indicator of their presence but suffered 
from the problem of haemolysis of the cells, even 
under isotonic conditions £84]. This drawback was 
overcome when glutaraldehyde was used to 
strengthen the cells before they were used for galec-
tin detection [85]. 
With advances in techniques of molecular biology, 
the methods of detection of galectins were also revo-
lutionized. Immunoscreening of cDNA was an 
advancement over these primitive methods and 
resulted in the discovery of galectin-5 and -8 
[14,26]. Screening the tumor cDNA libraries from 
sera of afflicted patients identified another molecule, 
galectin-9 [27]. RT-PCR was another technique that 
was used to detect, with much success, the differential 
expression of galectins [86] and its results match well 
with Western blot data [87]. For all its popularity, the 
method still provides only an indirect estimate of 
galectin levels. 
Recently, search algorithms have been developed 
to search for sequences that encode structures simi-
lar to the known galectin domains [8]. The screening 
of the GenBank databases identified seven new 
putative galectins genes [8]. The fact that six of these 
sequences are expressed is a confirmation that they 
are not pseudogenes [8]. Similar approaches have 
been applied to other organisms with the result that 
there has been a massive increase in the number of 
possible galectins. Amongst a total of 20,000 genes 
in C. elegans, 26 have been identified as candidate 
galectin genes [8]. 
The ubiquitous distribution of galectins is evident 
from the identification of candidate genes in the 
Mastadenovirus (U25120) [88], a lymphocystis 
disease virus (L63545, 26549-27313 = 053R) [8], 
Drosophila (LP06039) [8], zebrafish (AI384777 and 
G47571) [8] and Arahidopsis (AC000348, T7N9.14) 
[8], with the report in Arahidopsis being the first in 
any plant [8]. 
While all these methods are useful in the research 
laboratory, and have yielded 15 mammalian galec-
tins till date [89], advances made in clinical studies 
of galectins and their implication in tumorigenesis 
has made the need to develop rapid and accurate 
protocols for their accurate detection and estimation 
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very pressing. Western blotting using anti-galectin 
antibodies lias been one of the biggest success stories 
as far as detection is concerned and lias been used to 
confirm the increased expression of galectin-1 in 
pancreatic tumors [90,91]. Labeled antibodies have 
also been used in situ to study expression patterns 
of galectin-1 and -3 in lung cancer [92]. Membrane 
based methods have utilized the use of a LacNAc-
conjugated biotinylated-polyacrylamide probe to 
demonstrate the increased expression of galectin-3 
in Escherichia coli [93]. The detection system was 
based on enzyme-streptavidin conjugates [93]. 
Quantification of galectins was not possible until 
the advent of ELISA, which provided information 
about the amounts of different galectins [89]. Com-
mercially available detection and quantification sys-
tems can detect galectin-3 at as low a concentration 
as0 .2ngmL- ' [94]. 
With the emphasis on cancer-based research in 
galectins, flow cytometry has been used to detect 
total lectin, as well as galectin activity in cancer cells 
[95]. This methodology is based on the use of Glyc-
PAA-fluo probes. The technique has proved 
effectual for galectin-3 with the use of LacNAc 
and asialoGM-1 and the data match well with other 
studies [89]. 
The problem with most of the methods described 
so far is their dependence on specific anti-galectin 
antibodies. Recently, efforts have been made to 
devise strategies based on chemical approaches. 
Photoaffinity based probes are being synthesized 
[89]. In one case, benzophenone was attached on 
galactose-C3 and irradiated to link the..galectin cap-
tured by the sugar from a mixture,oi;|(#oipins and 
the complex was visualized, in get^  by 'tlie use of 
fluorescent label attached to the other end of the 
probe. While this method annuls the need for anti-
bodies, it is still not proven for its efficacy as a diag-
nostic and prognostic tool. 
5. Research into therapeutic applications of galectins 
The ubiquitous distribution of galectins across 
taxa is paralleled by an equally imposing level of 
redundancy in their functions [49]. This has ham-
pered studies based on gene knockout models. 
While galectin-1 and -3 knockouts have been shown 
to possess defects, respectively, in olfactory axon 
pathfinding [96] and neutrophil accumulation dur-
ing inflammation [97], not much progress has been 
possible because of the pleiotropic nature of galec-
tins. The elimination of one from a model system 
does not vitiate the effects of others. The most logi-
cal approach under such circumstances would be 
the use of chemical inhibitors which is also a poten-
tial means of treatment of cancer. 
Modified citrus pectin is one compound that has 
been tested to treat metastasis and it has been found 
to inhibit galectin-3 [89]. A water-soluble derivative 
of citrus pectin, which is a heterogeneous, high 
molecular weight branched polysaccharide, has 
been shown to reduce tumor growth, metastasis 
and angiogenesis in mice that were administered 
the inhibitor orally [89], In aitro studies on human 
umbilical vein endothelial cells also yielded similar 
results [98]. Another modified derivative of citrus 
pectin, GCS-lOO, induced apoptosis in myeloma 
cells but direct involvement of galectin-3 has not 
been implicated [99]. 
An altern.ati%?, to sugar based inhibitors is artifi-
cial peptidfeiifilbifeitors [89]. These offer the advan-
tage of easeSfiif synthesis, along with equally potent 
immune responses [100] that may facilitate the dis-
covery of naturally occurring molecules. Pentapep-
tides based on the common Tyr-X-Tyr motif 
found in glycomimetic peptides [101-106] have been 
used and found to be effective in millimolar ranges 
in preventing binding of several galectins [107]. 
The development of phage-display based analytical 
techniques has demonstrated that peptides as long 
as 15 residues are effective at nanomolar affinity 
for the anti-apoptotic galectin-3 [108]. They are also 
quite specific in their action and inhibit metastasis-
associated cell adhesion [89]. 
A rather futuristic but nonetheless relevant 
approach of dealing with galectin-induced cancer is 
gene therapy. It has been established that human 
galectin-3 is phosphorylated at serine 6 by casein 
kinase [109,110] and this results in reduced binding 
of laminin and asialomucin. Dephosphorylation 
returns the sugar binding capacity to the galectin. 
Interestingly, mutations in serine 6 resulted in a 
diminished ability of galectin-3 to protect cells from 
death induced by c/.y-platin [62], which is a common 
anti-tumor agent. This finding should pave way for 
the targeting of the galectin-3 gene in patients who 
are found to suffer from galectin-3 induced cancers 
and should be able to restore the potency of c/.v-platin. 
The information provided by knockout studies is 
relevant, but with the discovery of potent inhibitors, 
the absence of successful models with disrupted 
galectin genes and the rather nascent stage of devel-
opment of gene therapy in the present context, 
research in galectins can progress only with the 
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use of such mechanism based molecules. These 
results validate the use of inhibitors, although much 
remains to be done to achieve consistency of data in 
different cancer cell lines and to establish a complete 
picture with regard to the information storing 
capacity of these molecules and their actions 
[111,112]. 
6. Summary 
Through the annals of history, the malaise of 
cancer has ailed humans. It is responsible for the 
second greatest number of deaths in Western coun-
tries. Of the various molecules involved in the dis-
ease, the plethora of functions performed by 
galectins makes them one of the obvious candidates 
for implication in the etiology of cancer. While it is 
known that their information storing capacity is 
immense, their effects are largely an enigma. 
Research in galectins might contribute significantly 
to the understanding of the causes and mechanism 
of carcinogenesis and hence, the thrust in research 
ought to be focused on elucidating the molecular 
mechanisms of actions of galectins and their interac-
tions with genes, enzymes, glycoconjugates and 
other biomolecules, with the aim of providing leads 
to improve the currently available means of detec-
tion and treatment of cancer and also to develop 
more sophisticated tools in the future. 
Acknowledgements 
The authors are grateful to A.M.Uaiversity, Ali-
garh for providing necessary facilities and to Kabir 
Hassan Biswas, IISc, Bangalore for reference 
material. 
References 
[1] K. Drickamer, Two distinct classes of carbohydrate-recog-
nition domains in aninD4 lectins, J. Biol. Chem. 263 (1988) 
9557-9560. 
[2] N. Sharon, H. Lis,. Lectins as cell recognition molecules. 
Science 246 (1989) 227-234 
[3] S.H. Baronctes, CJsJectins: a personal overview. Trends 
Glycosci. Glycotechnol. 9 (1997) 1-7. 
[4] V.L Teichberg, I, Silman, D.D. Beitsch, G. Resheff, A f3-D-
galactoside bindmg protein from electric organ tissue of 
electrophorus electricus, Proc. Natl. Acad. Sci. USA 72 
(1975) 1383-1387. 
[5] S.H. Barondes, V. Castronovo, D.N.W. Cooper, R.D. 
Cummings, K. Drickamer, T. Feizi, M.A. Gitt, J. Hira-
bayashi, C. Hughes, K. Kasai, H. Leffler, F. Liu, R. 
Lotan, A.M. Mercuric, M. Monsigni, S. Pillai, F. Poirer, 
A. Raz, P.W.J. Rigby, J.M. Rini, J.L. Wang, Galectins: a 
family of animal galactoside-binding lectins. Cell 76 (1994) 
597-598. 
[6] S.H. Barondes, D.N.W. Cooper, M.A. Gitt, H. Leffler, 
Galectins: structure and function of a large family of animal 
lectins, J. Biol. Chem. 269 (1994) 20807-20810. 
[7] J. Hirabayashi, K. Kasai, Human placenta ^galactoside-
binding lectin. Purification and some properties, Biochem. 
Biophys. Res. Commun. 122 (198%938-944. 
[8] D.N.W. Cooper, S.H. Barondes*,Cr|s! must love galectins: 
he made so many of them, Glp?ii)iSiig|y 9 (1999) 979-984. 
[9] D.L Liao, G. Kapadia,,:Jir%mieia, G.R. Vasta, O. 
Herzberg, Structure of S-lMtjhgiSi deveiopmentally regulat-
ed vertebrate beta-galapiSSiie-biiiiding protein, Proc. Natl. 
Acad. Sci. USA 91 (19i^,Ji28-1432. 
[10] J. Hirabayashi, K;;|^asai; The family of metazoan metal-
independent p-gajjictc^de binding lectins: structure, 
function and molecufii' evolution, Glycobiology 3 (1993) 
297-304. 
[11] B.N. Slillman, P.S. Mischel, L.G. Baum, New roles for 
galectirisSiB: brain tumors-from prognostic markers to 
therapfstjp liifgets. Brain Pathol. 15 (2005) 124-132. 
[12] M.A;;;Crii(|iS.H. Barondes, Genomic sequence and organi-
zation SfiSwo members of a human lectin gene family, 
^iioci«ftistry 30 (1991) 82-89. 
[13] M-^ivGitt, S.M. Massa, H. Leffler, S.H. Barondes, Isola-
tion and expression of a gene encoding L-M-H, a new 
human soluble lactose-binding lectin, J. Biol. Chem. 267 
(1992)10601-10606. 
[14] M A. Gitt, M.F. Wisers, H. Leffler, J. Herrmann, Y.-R. 
Xia, S.M. Massa, D.N.W. Cooper, A.J. Luis, S.H. Baron-
des, Sequence and mapping of galectin-5. a P-galactoside-
bmding lectin, found in rat erythrocytes, J. Biol. Chem. 270 
(1995) 5032-5038. 
[15] T Magnaldo, F. Bernerd, M. Darmon, Galectin-7, a 
human 14-kDa S-lectin, specifically expressed in keratino-
cytes and sensitive to retinoic acid. Dev. Biol. 168 (1995) 
259-271. 
[16] J. Hirabayashi, T. Ubukata, K. Kasai, Purification and 
molecular characterization of a novel 16-kDa galectin from 
the nematode Caenorhabditis elegant, i. Biol. Chem. 271 
(1996)2497-2505. 
[17] G.R. Vasta, H. Ahmed, L.M. Anizel, M.A. Bianchet, 
Galectins from amphibian species: carbohydrate specificity, 
molecular structure and evolution. Trends Glycosci. Gly-
cotechnol. 9 (1997) 131-144. 
[18] P. Paroutaud, G. Levi, V.I. Teichberg, A.D. Strosberg, 
Extensive amino acid homologies between animal lectins, 
Proc. Natl. Acad. Sci. USA 84 (1987) 6345-6348. 
[19] Y. Ohyama, J. Hirabayashi, Y. Oda, S. Oono, H. Kawa-
saki, K. Suzuki, K. Kasai, Nucleotide sequence of chick 
14 K |3-galactoside-binding lectin mRNA, Biochem. Bio-
phys. Res. Commun. 134(1986) 51-56. 
[20] Y. Sakakura, J. Hirabayashi, Y. Oda, Y. Ohyama, K. 
Kasai, Structure of chicken 16-kDa P-galactoside-binding 
lectin: complete amino acid sequence, cloning of cDNA and 
production, J. Biol. Chem. 265 (1990) 21573-21579. 
[21] S.J. Ackerman, S.E. Corrette, H.F. Rosenberg, J.C. Bennet, 
D.M. Mastrianni, A. Nicholson-Weller, P.F. Weller, D.T. 
Chin, D.G. Tenen, Molecular cloning and characterization 
of human eosinophil Charcot-Leyden crystal protein 
(lysophospholipase), J. Immunol. 150 (1993) 456-468. 
S.S. Hasan el al. I Cancer Letters 253 (2007) 25-33 31 
[22] J.M. Rini, Lectin structure, Annu. Rev. Biophys. Biomol. 
Struct. 24 (1995) 551-577. 
[23] R.C. Hughes, Mac-2: a versatile galactose-binding protein 
of mammalian tissues, Glycobiology 4 (1994) 5-12. 
[24] Y. Oda, J. Herrmann, M.A. Gitt, C.W. Turck, A.L. 
Burlingame, S.H. Barondes, H. Leffler, Soluble lactose-
binding lectin from rat intestine with two different carbo-
hydrate-binding domains in the same chain, J. Biol. Chem. 
268 (1993) 5929-5939. 
[25] M.A. Gitt, C. Colnot, F. Poirier, K.J. Nani, S.H. Barondes, 
H. Leffler, GaIectin-4 and galectin-6 are two closely related 
lectins expressed in mouse gastrointestinal tract, J. Biol. 
Chem. 273 (1998) 2954-2960. 
[26] Y.R. Hadari, K. Paz, R. Dekel, T. Mestrovic, D. Accili, Y. 
Zick., Galectin-8: a new rat lectin, related to galectin-4, J. 
Biol. Chem. 270 (1995) 3447-3453. 
[27] O. Tureci, H. Schmitt, N. Fadle, M. Pfreundschuh, U. 
Sahin, Molecular definition of a novel human galectin 
which is immunogenic in patients with Hodgkin's disease. J. 
Biol. Chem. 272 (1997) 6416-6422. 
[28] D.N.W. Cooper, Galectin-1: secretion and modulation of 
cell interactions with larainin. Trends Glycosci. Glycotech-
nol. 9 (1997) 57-67. 
[29] V. Wells, L. Mallucci, Identification of an autocrine 
negative growth factor: mouse P-galactoside-binding pro-
tein is a cytostatic factor and cell growth regulator, Cell 64 
(1991)91-97. 
[30] L. Adams, S.G. Kenneth, C. Weinberg, Biphasic modula-
tion of cell growth by recombinant human galectin-1. 
Biochem. Biophys. Acta 1312 (1996) 137-144. 
[31] F. Poirier, P.M. Timmons, C-T. Chan, J.L. Guenet, P 
Rigby, Expression of the L14 lectin during mouse embryo-
genesis suggests multiple roles during pre and post-implan-
tation development. Development 115 (1992) 143-155, 
[32] A. Yamaoka, L Kuwabara, L.G. Frigeri, F.T. Liu, A 
human lectin, galectin-3 (epsilon-BP/ Mac-2) stimulates 
superoxide production by neutrophils, J. Immunol. 154 
(1995)3479-3487. 
[33] A. Raz, R. Lotan, Endogenous galactoside-binding lectins: 
a new class of functional tumor cell s#i%^: molecules 
related to metastasis. Cancer MetajLiReyS: 6 (1987) 
433-452. 
[34] R.S. Bresalier, N. Mazurek, L.R. Sternberg, J.C. Byrd, 
C.K. Yunker, P.N. Makker, A. Raz» Metastasis of human 
colon cancer is altered by modifying expression of the P-
galactoside binding protein galecttn-3. Gastroenterology 
115(1998)287-296. 
[35]G.A. Rabinovich, M.M. Igjesias, N.M. Modesti, L.F. 
Castagna, C. Wolfenstdba-Todei, C M . Riera, C.E. Soto-
mayor. Activated rat m(Mjrophages produce a galectin-1-like 
protein that induces spoplOsis of T cells: biochemical and 
functional characterizafion, J. Immunol. 160 (1998) 
4831^840. 
[36]N.L. Perillo, K,E Pace, J.J. Seilhamer, L.G. Baum, 
Apoptosis of T-cdIls mediated by galectin-1. Nature 378 
(1995) 736-739. 
[37] R.Y. Yang. D.K. Hsu, F.T. Liu, Expression of galectin-3 
modulates T cell growth and apoptosis, Proc. Natl. Acad. 
Sci. USA 93 (1996) 6737-6742. 
[38] J.W. Park, P.G. Voss, S. Grabski, J.L. Wang, R.J. 
Patterson, Association of galectin-1 and galectin-3 with 
Gemin4 in complexes containing tlie SMN protein, Nucleic 
Acid Res. 29 (2001) 3595-3602. 
[39] L. Pellizoni, N. Kataoka, B. Charroux, G. Dreyfuss, A 
novel function for SMN, the spinal muscular atrophy 
disease gene product, in pre-mRNA gene splicing, Cell 95 
(1998)615-624. 
[40] D.K. Hsu, S.R. Hammes, I. Kuwabara, W.C. Greene, F.T. 
Liu, Human T lymphotropic virus-I infection of human T 
lymphocytes induces expression of the beta-galactoside 
binding lectin, galectin-3. J Biol, Chem 148 (1996) 1661. 
[41] J.C. Gaudin, C. Arar, M Monstgny, A. Legrand, Modu-
lation of the expression of thtf rabbit gatectin-3 gene by p53 
and c-Ha-ras proteins and PMA, Glycobiology 7 (1997) 
1089-1098. 
[42] S. Sato, R.C. Hughes, Regulation of secretion and surface 
expression of Mao-2, a galactoside-binding protein of 
macrophages, J. Bi%|:j<im. 269 (1994) 4424-4430. 
[43] A. Gillenwater, X.C. XS; Y. Estrov, P.G. Sacks, D. Lotan, 
R. Lotan, Modulation of galectin-1 content in human head 
and neck squamous carcinoma cells by sodium butyrate. 
Int. J. Cancw 75 (1998) 217-224. 
[44] K Kasai, J. Hirabayashi, Galectins: a family of animal 
lectins that decipher glycocodes. J. Biochem. 119 (1996) 
1-8, 
[45] A.E. Cleves, D N. Cooper, H.S. Barondes, R.B. Kelly, A 
new pathway for protein export in Saccharomyces cerevi-
siav, J. Cell Biol. 133 (1996) 1017-1026. 
[46] J,D. Hernandez, L.G. Baum, Ah, sweet mystery of death! 
Galectins and control of cell fate, Glycobiology 12 (2002) 
127-136 
[47] M M. Iglesias, G.A. Rabinovich, V. Ivanovic, C.E. Soto-
mayor, C. Wolfenstein-Todel, Galectin-1 from ovine pla-
centa: amino-acid sequence, physicochemical properties 
and implications in T<ell death, Eur. J. Biochem. 252 
(1998)400-407. 
[48] G.A. Rabinovich, Galectins: an evolutionarily conserved 
family of animal lectins with multifunctional properties; a 
trip from the gene to clinical therapy. Cell Death Differ. 6 
(1999)711-721. 
[49] M.M. Iglesias, G.A. Rabinovich, A.L. Ambrosio, C.E. 
Sotomayor, C.W. Todel, Lectin-induced immunoregulation 
in ovine placenta, in: E. van Driessche, S. Beeckmans, T.C. 
Bog-Hansen(Eds.), Lectins, Biol. Biochem. Clin. Biochem., 
vol. 12, Lextop, Hellerup Denmark, 1998. 
[50] J. Dumic, S. Dabelic, M. Flogel, Galectin-3: an open-ended 
story, Biochim. Biophys. Acta 1760 (2006) 616-635. 
[51] F. van den Brule, S. Califice, V. Castronovo, Expression of 
galectins in cancer: a critical review, Glycoconj. J. 19 (2004) 
537-542. 
[52] A. Paz, R. Haklai, G. Elad-Sfadai, E. Ballan, Y. Kloog. 
Galectin-1 binds oncogenic H-Ras to mediate Ras mem-
brane anchorage and cell transformation, Oncogene 20 
(2001) 7486-7493. 
[53] P. Mataresse, O. Fusco, N. Tinari, C. Natoli, F.T. Liu, 
M.L. Semeraro, W. Malorni, S. lacobelli, Galectin-3 
overexpression protects from apoptosis by improving cell 
adhesion properties. Int. J. Cancer 85 (2000) 545-554. 
[54] P.R. Warlield, P.N. Makker, A. Raz, J. Ochieng, Adhesion 
of human breast carcinoma to extracellular matrix proteins 
is modulated by galectin-3, Inv. Metastas. 17 (1997) 
101-112. 
32 S.S, Hasan et at. I Cancer Utters 253 (2007) 25-33 
[55] M.M. Lotz, C.W. Andrews Jr., C.A. Korzelius, E.G. Lee, 
C D . Steele Jr., A. Clarke, A.M. Mercurio, Decreased 
expression of Mac-2 (carbohydrate binding protein 35) and 
loss of its nuclear localization are associated with the 
neoplastic progression of colon carcinoma, Proc. Natl. 
Acad. Sci. USA 90 (1993) 3466-3470. 
[56] X. Sanjuan, P.L. Fernandez, A. Castells, V. Castronovo, F. 
van den Brule, F.-T. Liu, A. Cardesa, E. Campo, 
Differential expression of galectin 3 and galeclin 1 in 
colorectal cancer progression. Gastroenterology 113 (1997) 
1906-1915. 
[57] Y. Honjo, H. Inohara, S. Akahani, T. Yoshii, Y. Takenaka, 
J. Yoshida, K. Hattori, Y. Tomiyama, A. Raz, T. Kubo, 
Expression of cytoplasmic galectin-3 as a prognostic 
marker in tongue carcinoma, Clin. Cancer Res. 6 (2000) 
4635-4640. 
[58] F.A. van den Brule, D. Waltregny, F.-T. Liu, V. Castro-
novo, Alteration of the cytoplasmic/nuclear expression 
pattern of galectin-3 correlates with prostate carcinoma 
progression. Int. J. Cancer 89 (2000) 361-367. 
[59] F. Puglisi, A.M. Minisini, F. Barbone, D. Intersimone, G. 
Aprile, C. Puppin, G. Damante, L Paron, G. Tell, A. Piga, 
C. Di Loreto, Galectin-3 expression in non-small cell lung 
carcinoma. Cancer Lett. 212 (2004) 233-239. 
[60] S. Califice, V. Castronovo, M. Bracke, F. van den Brule, 
Dual activities of galectin-3 in human prostate cancer: 
tumor suppression of nuclear galectin-3 vs tumor 
promotion of cytoplasmic galectin-3. Oncogene 23 (2004) 
7527-7536. 
[61] D.L. Rossi, A. Acebran, P. Santisteban, Function of the 
homeo and paired domain proteins TTF-1 and Pax-8 
in thyroid cell proliferation, J. Biol. Chem. 270 (1995) 
23139-23142. 
[62] A. Krzeslak, A. Lipinska, Galectin-3 as a multifuncDonaJ 
protein. Cell. Mol. Biol. Lett. 9 (2004) 305-328. 
[63] X.C. Xu, A.K. el-Naggar, R. Lotan, Diflerential expression 
of galectin-1 and galectin-3 in thyroid tumors. Potential 
diagnostic implications. Am. J. Pathol. 147 (1995) 815-822. 
[64] S. Rorive, N. Belot, C. Decaestecker, F. Lefrane, L. 
Gorodower, S. Micik, C.A. Maurage, jpsj^jjitner, M.M. 
Ruchoux, A. Danguy, H.J. Gabius;:;J,^}jiiip|!|: R. Kiss, L 
Camby, galectin-1 is highly expressed in fiuman gliomas 
with relevance for modulation ^ 5 , invasion of tumor 
astrocytes into brain parenchym^j^jf8:;33 (2001) 241-245. 
[65] F.A. van Den Brule, D. V|sitr| |ny, V. Castronovo, 
Increased expression of galeicjiti^w-carcinoma-associated 
stroma predicts poor :;igj|.!^ iiiiife:.:.in prostrate carcinoma 
patients, J. Pathol. 19 | J i i | | . 8 ( i^87 . 
[66] J. Ellehorst, T. Nguv«i|:jjp|l!W. Cooper, D. Lotan, R. 
Lotan, Differential exj^sssiSS of endogenous galectin-1 and 
galectin-3 in humaftfproisiStte cancer cell lines and effects of 
overexpressing galec8iS*J'on cell phenotype, Int. J. Oncol. 
14 (1999) inimBw 
[67] G.A. Rabinovi^l N. Rubinstein, P. Matar, V. Rozados, S. 
Gervasoni, O.G. iScharovsky, The anti-metastatic effect of 
single low-dose cyclophosphamide involves modulation of 
galectin-1 and Bcl-2 expression. Cancer Immunol. Immun-
other. 50 (2002) 587-603. 
[68] K. Yamaoka, K. Mishima, Y. Nagashima, A. Asai, Y. 
Sanai, T. Kirino, Expression of galectin-1 mRNA correlates 
with the malignant potential of hujnan gliomas and 
expression of antisense galectin-1 inhibits the growth of 9 
glioma cells, J. Neurosci. Res. 59 (2000) 722-730. 
[69] F.A. van Den Brule, C. Buicu, M. Baldet, M E . Sobel, 
D.N.W. Cooper, P. Marschal, V. Castronovo, Galectin-1 
modulates human melanoma cell adhesion to laminin, 
Biochem. Biophys. Res. Commun. 209 (1995) 760-767. 
[70] F. Bernard, A. Sarasin, T. Magnaldo, Galectin-7 overex-
pression is associated with the apoptotic process in UVB-
induced sunburn keratmocytes, Proc Natl Acad. Sci. USA 
96(1999) 11329-11334 
[71] H. Lahm, S. Andre, A Hoefljeh, 3 R focher, B. Sordat, h. 
Kaltner, E. Wolf, H J Gabius, comprehensive galectin 
fingerprinting in a panel of 6t human tumor cell lines 
by RT-PCR and its implicattons for diagnostic and 
therapeutic procedures, J. Cancer Res Clin. Oncol. 127 
(2001)375-386. 
[72] R.V. Gopalkrishnaft, T. Roberts, S Tuli, D. Kang, K.A. 
Christiansen, P.B. Fisher, Molecular characterization of 
prostate carcinoma tumor antigen-I, a human galectin-8 
related gene. Oncogene 19 (2000) 4405-4416. 
[73] H. Lahm, A Hoeflich, S. Andre, B. Sordat, H. Kaltner, E. 
Wolf, H, Cabiiis, Gene expression of galectin-9/ecalectin, a 
potent eostttophil chemoattractant, and/ or the insertional 
isoform tn human colorectal carcinoma cell lines and 
detection of frameshift mutations for protein sequence 
trattcations in the second functional lectin domain. Int. J. 
(tecol. 17 (2000) 519-524. 
[74] F, Poirier, E.J. Robertson, Normal development of mice 
carrying a null mutation in the gene encoding the L-14S-
type lectm. Development 119 (1993) 1229-1236. 
[75] C. Colnot, D. Fowlis, M.A. Ripoche, I. Bouchaert, F. 
Poirier, Embryonic implantation in galectin-l/galectin-3 
double mutant mice, Dev. Dyn. 211 (1998) 306-313. 
[76] S. Hakomori, Glycosylation defining cancer malignancy: 
new wine in an old bottle. Proc. Natl. Acad. Sci. USA 99 
(2002)10231-10233. 
[77] N. Kojima, S. Hakomori, Cell Adhesion, Spreading, and 
motility of GM3-expressing cells based on glycolipid-glyco-
lipidinteraction, J. Biol. Chem. 266(1991) 17552-17558. 
[78] Y. Miura, M. Kainuma, H. Jiang, H. Velasco, P.K. Vogt, S. 
Hakomori, Reversion of the Jun-induced oncogenic phe-
notype by enhanced synthesis of sialosyllactosylceramide 
(GM3 ganglioside), Proc. Natl. Acad. Sci. USA 101 (2004) 
16204-16209. 
[79] M. Ono, K. Handa, S. Sonnino, D.A. Withers, H. Nagai, S. 
Hakomori, GM3 ganglioside inhibits CD9-facilitated 
haptotactic cell motility: coexpression of GM3 and CD9 
is essential in the downregulation of tumor cell motility and 
malignancy. Biochemistry 4 (2001) 6414-6421. 
[80] M. Satoh, A. Ito, H. Nojiri, K. Handa, K. Numahata, C. 
Ohyama, S. Saito, S. Hoshi, S.I. Hakomori, Enhanced 
GM3 expression, associated with decreased invasiveness, is 
induced by brefeldin A in bladder cancer cells. Int. J. Oncol. 
19(2001)723-731. 
[81] H. Ideo, A. Seko, I. Ishizuka, K. Yamashita, The A'-
terminal carbohydrate recognition domain of galectin-8 
recognizes specific glycosphingolipids with high affinity, 
Glycobiology 13 (2003) 713-723. 
[82] C.F. Brewer, Cross-linking activities of galectins and other 
multivalent lectins. Trends Glycosci. Glycotechnol. 9 (1997) 
155-165. 
S.S. Hasan el al. I Cancer Utters 253 (2007) 25-33 33 
[83] J. Hirabayashi, K. Kasai, The family of metazoan metal-
independent P-galactoside-binding lectins: structure, func-
tion and molecular evolution, Glycobiology 3 (1993) 297-
304. 
[84JT.P. Nowak, D. Kobiler, L.E. Roel, S.H. Barondes, 
Developmentally regulated lectin from embryonic chick 
pectoral muscle. Purification by affinity chromatography, J. 
Biol. Chem. 252 (1977) 6026-6030. 
[85] R.H. Turner, I E. Liener, The use of glutaraldehyde-treated 
erythrocytes for assaying the agglutinating activity of 
lectins. Anal. Biochem. 68 (1975) 651-653. 
[86] M. von Wolff, X. Wang, H.-J. Gabius, T Strowitzki, 
Galectin tingerprmting in human endometrium and decidua 
during the menstrual cycle and in early gestation, Mol. 
Hum. Reprod. 11 (2005) 189-194. 
[87] A. Hittelet, H. Legendre, N. Nagy, Y. Bronckart, J.-C. 
Pector, I. Salmon, P. Yeaton, H.-J. Gabius, R. Kiss, I. 
Camby, Upregulation of galectins-1 and -3 in himian colon 
cancer and their role m regulating cell migration. Int. J. 
Cancer 103 (2003) 370-379. 
[88] N.L. Penllo, M.E. Marcus, L.G. Baum, Galectins: versatile 
modulators of cell adhesion, cell proliferation and cell 
death, J. Mol. Med. 76 (1998) 402-412. 
[89] R.J. Pieters, Inhibition and detection of galectins, Chem-
BioChem 7 (2006) 721-728. 
[90] C. Debray, P. Vereecken, N. Belot, P. Teillard, J.P. Brion, 
M. Pandolfo, R. Pocher, Multifaceted role of galectin-3 on 
human glioblastoma cell motility, Biochem. Biophys. Res. 
Commun. 325 (2004) 1393-1398. 
[91] J. Shen, M.D Person, J. Zhu, J.L. Abbruzzese, D. Li, 
Protein expression profiles in pancreatic adenocarcinoma 
compared vb'ith normal pancreatic tissue and tissue affected 
by pancreatitis as detected by two-dimensional gel electro-
phoresis and mass spectrometry. Cancer Res. 64 (2004) 
9018-9026 
[92] T Sz?ke, K Kayser, J.-D. BaumhUkel, I. Trojan, J. Pwak. 
L. Tiszlavicz, A. Horvath, K. Szluha, H.-J. Gabius, S. 
AndrR, Prognostic significance of endogenous adhesion/ 
growth-regulatory lectins in lung. Cancer Oncol. 69 (2005) 
167-174. 
[93] K. Kamemura, S. Kato, Detection of JeiiiSS u$ing ligand 
blotting and polyacrylamide-type glycoconjugate probes. 
Anal. Biochem. 258 (1998) 305-310. 
[94] Human Galectin-3 ELISA, BMS279i Be»der MedSystems 
GmbH, Vienna (Austria). 
[95] E.V. Moiseeva, E.M. Rapoport, 1!>J.V. Bovin, A.I. Mir-
oshnikov, A V Chaad$$v$, M>S. Krasilshchikova, V. 
Bojenko, C Bijleveld^ i.K van Dijk, W. den Otter, 
Galectins as markers of aggressiveness of mouse mammary 
carcinoma- towards a te(Sti]i target therapy of human breast 
cancer. Breast Cancer Re*. Treat. 91 (2005) 227-241 
[96] A C. Puche, F. Poirier,M. Hair, P.F. Barlett, B. Key, Role 
of galectin-1 in the developing mouse olfactory system, 
Dev Biol 179 (19%) 274-287. 
[97] C. Colnot, M A. Ripoche, G. Milon, X. Montagutelli, P.R 
Crocker, F. Poirier, Maintenance of granulocyte numbers 
during acute peritonitis is defective in galectin-3-null 
mutanat mice, Immunology 94 (1998) 290-296 
[98] P. Nangia-Makker, V. Hogan, Y Honjo, S Baccarini, L 
Tait, R Bresalier, A. Raz, Inhibition of human cancer cell 
growth and metastasis in nude mice by oral intake of 
modified citrus pectin, J. Natl. Cancer Inst. 94 (2002) 1854. 
[99] D. Chauhan, G. Li, K Podar, T Hideshima, P Neri, D. 
He, N. Mitsiades, P. Richardson, Y Chang, J. Schindler, B. 
Carver, K.C. Anderson, A novel carbohydrate-based ther-
apeutic GCS-lOO overcomes Bortezomib resistance and 
enhances dexamethasone-induced apoptosis in multiple 
myeloma cells. Cancer Res. 65 (2005) 8350-8358 
[100] B. Monzavi-Karbassi, G. Cuflto-Atnesty, P. Luo, T 
Kieber-Enmions, Peptide mimotopes as surrogate antigens 
of carbohydrates in vaccine dj^ eovery, Trends Biotechnol 
20 (2002) 207-214 
[101] K.R. Oldenburg, D. Lftganathan, LJ Goldstein, P.G 
Schultz, M A. Gallop, Peptide ligands for a sugar-binding 
protein isolated from, a random peptide library, Proc. Natl. 
Acad. Sci USA 89 (1992) 5393-5397 
[102] J K. Scott, D. Loganathan, R B. Easley, X Gong, I.J 
Goldstein, A family of concanavalin A-bindmg peptides 
from a hexapeptide epitope library, Proc. Natl Acad Sci 
USA 891(1992)5398-5402. 
[103] K J. Kauf, $- Khurana, D.M. Salunke, Topological anal-
ysis of the functional mimicry between a peptide and a 
carbohydrate moiety, J. Biol. Chem. 272 (1997) 5539-5543 
[104] R, R^vishankar, C.J. Thomas, K Suguna. A. Surolia, M 
Vijftyan, Structure, function and genetics. Proteins 43 
(2001) 260-270. 
{105} M. Meldal, F.I. Auzanneau, O. Hindsgaul, M M Palcic, A 
PEGA resin for use in the solid phase chemical/enzymatic 
synthesis of glycopeptides, J Chem Soc Chem. Commun 
(1994) 1849-1850. 
[106] M.A.J. Westerink, PC. Giardina, MA Apicella, T Kie-
ber-Emmons, Peptide mimicry of the meningococcal group 
c capsular polysaccharide, Proc Natl Acad Sci USA 92 
(1995)4021-4025. 
[107] C.J Arnusch, S. Andre, P Valentini, M. Lensch, R 
Russworm, H.-C. Siebert, M.J.E. Fischer, H -J. Gabius, 
R.J. Pieters, Interference of the galactose-dependant bind-
ing of lectins by novel pentapeptide ligands. Bioorg. Med 
Chem. Lett. 14 (2004) 1437-1440 
[108] J. Zou, VV. Glinsky, LA. Landon, L. Matthews, SL 
Deutscher, Peptides specific to the galectin-3 carbohydrate 
recognition domain inhibit metastasis-associated cancer cell 
adhesion. Carcinogenesis 26 (2005) 309-318 
[109] T. Yoshii, T. Fukumori, Y Honjo, H. Inohara, H.-R C 
Kim, A. Raz, Galectin-3 phosphorylation is required for its 
anti-apoptotic function and cell cycle arrest, J. Biol Chem. 
277 (2002) 6852-6857. 
[110] N Mazurek, J Conklin, J.C. Byrd, A Raz, R S. Bresalier, 
Phosphorylation of the p-galactoside- binding protein 
galectin-3 modulates binding to its ligands, J. Biol Chem 
275(2000)36311-36315 
[111] H.-J. Gabius. S. Andre, H Kaltner, H.-C Siebert, The 
sugar code: functional lectinomics, Biochim Biophys Acta 
1572 (2002) 165-177. 
[112] WC. Willett, G.A. Colditz, NE Mueller, Strategies for 
minimizing cancer risk, Sci Am. 275 (1996) 58-63 
